activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	72285	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	CON=C1CCN(c2ccc(-c3cc(-c4cccc(Br)c4)c4c(N)ncnc4n3)nn2)CC1		CHEMBL102524	=	IC50	nM	18.8	CHEMBL3589	Homo sapiens	IC50	nM	18.8
	72285	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	CON=C1CCN(c2ccc(-c3cc(-c4cccc(Br)c4)c4c(N)ncnc4n3)nn2)CC1		CHEMBL102524	=	IC50	nM	18.8	CHEMBL3589	Homo sapiens	IC50	nM	18.8
	72286	CHEMBL643560	Inhibitory concentration against adenosine kinase was determined in cell assay	B	CON=C1CCN(c2ccc(-c3cc(-c4cccc(Br)c4)c4c(N)ncnc4n3)nn2)CC1		CHEMBL102524	=	IC50	nM	74.4	CHEMBL3589	Homo sapiens	IC50	nM	74.4
	73284	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	Nc1ncnc2nc(-c3ccc(N4CCC(O)(C5CCOC5=O)CC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL103909	=	IC50	nM	8.1	CHEMBL3589	Homo sapiens	IC50	nM	8.1
	73285	CHEMBL643560	Inhibitory concentration against adenosine kinase was determined in cell assay	B	Nc1ncnc2nc(-c3ccc(N4CCC(O)(C5CCOC5=O)CC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL103909	=	IC50	nM	50.2	CHEMBL3589	Homo sapiens	IC50	nM	50.2
	74355	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	Nc1ncnc2nc(-c3ccc(N4CCC(=NOC5CCOCC5)CC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL65664	=	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	74356	CHEMBL643560	Inhibitory concentration against adenosine kinase was determined in cell assay	B	Nc1ncnc2nc(-c3ccc(N4CCC(=NOC5CCOCC5)CC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL65664	=	IC50	nM	71.0	CHEMBL3589	Homo sapiens	IC50	nM	71.0
	74488	CHEMBL651356	Inhibition of adenosine kinase-induced MMPR (6-methylmercaptopurine riboside) toxicity in human CEM lymphoblasts	F	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	Non standard unit for type	CHEMBL477	=	ED50	uM	10.0	CHEMBL3589	Homo sapiens	ED50	uM	10.0
	74490	CHEMBL850213	Selectivity for adenosine kinase, Ratio of non-specific cellular (ID50) and specific MMPR-related (ED50) toxicity	F	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL477	=	Ratio		1.0	CHEMBL3589	Homo sapiens	Ratio		1.0
	76648	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	C/C(=N/OC1CCOCC1)C1(O)CCN(c2ccc(-c3cc(-c4cccc(Br)c4)c4c(N)ncnc4n3)cn2)CC1		CHEMBL322448	=	IC50	nM	31.7	CHEMBL3589	Homo sapiens	IC50	nM	31.7
	76649	CHEMBL643560	Inhibitory concentration against adenosine kinase was determined in cell assay	B	C/C(=N/OC1CCOCC1)C1(O)CCN(c2ccc(-c3cc(-c4cccc(Br)c4)c4c(N)ncnc4n3)cn2)CC1		CHEMBL322448	=	IC50	nM	43.7	CHEMBL3589	Homo sapiens	IC50	nM	43.7
	76652	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	N#C[C@H]1CN(c2ccc(-c3cc(-c4cccc(Br)c4)c4c(N)ncnc4n3)cn2)C[C@H]1O		CHEMBL319197	=	IC50	nM	7.5	CHEMBL3589	Homo sapiens	IC50	nM	7.5
	76653	CHEMBL643560	Inhibitory concentration against adenosine kinase was determined in cell assay	B	N#C[C@H]1CN(c2ccc(-c3cc(-c4cccc(Br)c4)c4c(N)ncnc4n3)cn2)C[C@H]1O		CHEMBL319197	=	IC50	nM	495.6	CHEMBL3589	Homo sapiens	IC50	nM	495.6
	77817	CHEMBL873055	Inhibition of human placental adenosine kinase	B	C[C@H]1OC(n2nc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL612205	=	Ki	nM	170.0	CHEMBL3589	Homo sapiens	Ki	uM	0.17
	77818	CHEMBL651356	Inhibition of adenosine kinase-induced MMPR (6-methylmercaptopurine riboside) toxicity in human CEM lymphoblasts	F	C[C@H]1OC(n2nc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Non standard unit for type	CHEMBL612205	=	ED50	uM	1.1	CHEMBL3589	Homo sapiens	ED50	uM	1.1
	77820	CHEMBL850213	Selectivity for adenosine kinase, Ratio of non-specific cellular (ID50) and specific MMPR-related (ED50) toxicity	F	C[C@H]1OC(n2nc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL612205	=	Ratio		7.3	CHEMBL3589	Homo sapiens	Ratio		7.3
	79963	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	Nc1ncnc2nc(-c3ccc(N4CC5CC4CO5)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL104983	=	IC50	nM	7.5	CHEMBL3589	Homo sapiens	IC50	nM	7.5
	79964	CHEMBL643560	Inhibitory concentration against adenosine kinase was determined in cell assay	B	Nc1ncnc2nc(-c3ccc(N4CC5CC4CO5)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL104983	=	IC50	nM	19.5	CHEMBL3589	Homo sapiens	IC50	nM	19.5
	80107	CHEMBL873055	Inhibition of human placental adenosine kinase	B	NC[C@H]1OC(n2nc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL607761	=	Ki	nM	150.0	CHEMBL3589	Homo sapiens	Ki	uM	0.15
	80108	CHEMBL651356	Inhibition of adenosine kinase-induced MMPR (6-methylmercaptopurine riboside) toxicity in human CEM lymphoblasts	F	NC[C@H]1OC(n2nc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Non standard unit for type	CHEMBL607761	=	ED50	uM	0.013	CHEMBL3589	Homo sapiens	ED50	uM	0.013
	80110	CHEMBL850213	Selectivity for adenosine kinase, Ratio of non-specific cellular (ID50) and specific MMPR-related (ED50) toxicity	F	NC[C@H]1OC(n2nc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL607761	=	Ratio		5769.0	CHEMBL3589	Homo sapiens	Ratio		5769.0
	81170	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	Nc1ncnc2nc(-c3ccc(N4CCC(=NOC5CCOCC5)CC4)nn3)cc(-c3cccc(Br)c3)c12		CHEMBL103812	=	IC50	nM	7.1	CHEMBL3589	Homo sapiens	IC50	nM	7.1
	81171	CHEMBL643560	Inhibitory concentration against adenosine kinase was determined in cell assay	B	Nc1ncnc2nc(-c3ccc(N4CCC(=NOC5CCOCC5)CC4)nn3)cc(-c3cccc(Br)c3)c12		CHEMBL103812	=	IC50	nM	52.0	CHEMBL3589	Homo sapiens	IC50	nM	52.0
	81174	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	CCOC1CCN(c2ccc(-c3cc(-c4cccc(Br)c4)c4c(N)ncnc4n3)nn2)CC1		CHEMBL106386	=	IC50	nM	10.4	CHEMBL3589	Homo sapiens	IC50	nM	10.4
	81175	CHEMBL643560	Inhibitory concentration against adenosine kinase was determined in cell assay	B	CCOC1CCN(c2ccc(-c3cc(-c4cccc(Br)c4)c4c(N)ncnc4n3)nn2)CC1		CHEMBL106386	=	IC50	nM	51.7	CHEMBL3589	Homo sapiens	IC50	nM	51.7
	82406	CHEMBL873055	Inhibition of human placental adenosine kinase	B	[N-]=[N+]=NC[C@H]1OC(n2nc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL607762	=	Ki	nM	8500.0	CHEMBL3589	Homo sapiens	Ki	uM	8.5
	82407	CHEMBL651356	Inhibition of adenosine kinase-induced MMPR (6-methylmercaptopurine riboside) toxicity in human CEM lymphoblasts	F	[N-]=[N+]=NC[C@H]1OC(n2nc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Non standard unit for type	CHEMBL607762	=	ED50	uM	2.1	CHEMBL3589	Homo sapiens	ED50	uM	2.1
	82409	CHEMBL850213	Selectivity for adenosine kinase, Ratio of non-specific cellular (ID50) and specific MMPR-related (ED50) toxicity	F	[N-]=[N+]=NC[C@H]1OC(n2nc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL607762	=	Ratio		2.6	CHEMBL3589	Homo sapiens	Ratio		2.6
	85355	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	Nc1ncnc2nc(-c3ccc(N4CCC5(CC4)COCO5)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL102712	=	IC50	nM	8.3	CHEMBL3589	Homo sapiens	IC50	nM	8.3
	85356	CHEMBL643560	Inhibitory concentration against adenosine kinase was determined in cell assay	B	Nc1ncnc2nc(-c3ccc(N4CCC5(CC4)COCO5)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL102712	=	IC50	nM	378.1	CHEMBL3589	Homo sapiens	IC50	nM	378.1
	86392	CHEMBL873055	Inhibition of human placental adenosine kinase	B	Nc1ncnc2c1c(I)nn2C1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL608051	=	Ki	nM	40.0	CHEMBL3589	Homo sapiens	Ki	uM	0.04
	86393	CHEMBL651356	Inhibition of adenosine kinase-induced MMPR (6-methylmercaptopurine riboside) toxicity in human CEM lymphoblasts	F	Nc1ncnc2c1c(I)nn2C1O[C@H](CO)[C@@H](O)[C@H]1O	Non standard unit for type	CHEMBL608051	=	ED50	uM	0.012	CHEMBL3589	Homo sapiens	ED50	uM	0.012
	86399	CHEMBL850213	Selectivity for adenosine kinase, Ratio of non-specific cellular (ID50) and specific MMPR-related (ED50) toxicity	F	Nc1ncnc2c1c(I)nn2C1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL608051	=	Ratio		1250.0	CHEMBL3589	Homo sapiens	Ratio		1250.0
	94250	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	COCCOC1CCN(c2ccc(-c3cc(-c4cccc(Br)c4)c4c(N)ncnc4n3)nn2)CC1		CHEMBL103729	=	IC50	nM	15.1	CHEMBL3589	Homo sapiens	IC50	nM	15.1
	94251	CHEMBL643560	Inhibitory concentration against adenosine kinase was determined in cell assay	B	COCCOC1CCN(c2ccc(-c3cc(-c4cccc(Br)c4)c4c(N)ncnc4n3)nn2)CC1		CHEMBL103729	=	IC50	nM	81.9	CHEMBL3589	Homo sapiens	IC50	nM	81.9
	94254	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	Nc1ncnc2nc(-c3ccc(N4CCC[C@H]4CO)nn3)cc(-c3cccc(Br)c3)c12		CHEMBL319412	=	IC50	nM	16.2	CHEMBL3589	Homo sapiens	IC50	nM	16.2
	94255	CHEMBL643560	Inhibitory concentration against adenosine kinase was determined in cell assay	B	Nc1ncnc2nc(-c3ccc(N4CCC[C@H]4CO)nn3)cc(-c3cccc(Br)c3)c12		CHEMBL319412	=	IC50	nM	153.8	CHEMBL3589	Homo sapiens	IC50	nM	153.8
	95255	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	Nc1ncnc2nc(-c3ccc(N4CCC(COC5CCOCC5)CC4)nn3)cc(-c3cccc(Br)c3)c12		CHEMBL101805	=	IC50	nM	2.8	CHEMBL3589	Homo sapiens	IC50	nM	2.8
	95256	CHEMBL643560	Inhibitory concentration against adenosine kinase was determined in cell assay	B	Nc1ncnc2nc(-c3ccc(N4CCC(COC5CCOCC5)CC4)nn3)cc(-c3cccc(Br)c3)c12		CHEMBL101805	=	IC50	nM	17.3	CHEMBL3589	Homo sapiens	IC50	nM	17.3
	97345	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	Nc1ncnc2nc(-c3ccc(N4C[C@H](O)[C@H](O)C4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL105216	=	IC50	nM	6.5	CHEMBL3589	Homo sapiens	IC50	nM	6.5
	97346	CHEMBL643560	Inhibitory concentration against adenosine kinase was determined in cell assay	B	Nc1ncnc2nc(-c3ccc(N4C[C@H](O)[C@H](O)C4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL105216	=	IC50	nM	130.1	CHEMBL3589	Homo sapiens	IC50	nM	130.1
	97478	CHEMBL873055	Inhibition of human placental adenosine kinase	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Ki	nM	30.0	CHEMBL3589	Homo sapiens	Ki	uM	0.03
	97479	CHEMBL651356	Inhibition of adenosine kinase-induced MMPR (6-methylmercaptopurine riboside) toxicity in human CEM lymphoblasts	F	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	Non standard unit for type	CHEMBL99203	=	ED50	uM	0.008	CHEMBL3589	Homo sapiens	ED50	uM	0.008
	97485	CHEMBL850213	Selectivity for adenosine kinase, Ratio of non-specific cellular (ID50) and specific MMPR-related (ED50) toxicity	F	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Ratio		115.0	CHEMBL3589	Homo sapiens	Ratio		115.0
Not Determined	98831	CHEMBL642222	Binding affinity towards Toxoplasma gondii adenosine kinase; Could not be determined	B	OC[C@H]1O[C@@H](n2cnc3c(SCc4ccccc4F)ncnc32)[C@H](O)[C@@H]1O		CHEMBL60735		Km	nM		CHEMBL3589	Homo sapiens	Km	uM	
	99282	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	CCO[C@H]1CN(c2ccc(-c3cc(-c4cccc(Br)c4)c4c(N)ncnc4n3)nn2)C[C@H]1OCC		CHEMBL102989	=	IC50	nM	7.2	CHEMBL3589	Homo sapiens	IC50	nM	7.2
	99283	CHEMBL643560	Inhibitory concentration against adenosine kinase was determined in cell assay	B	CCO[C@H]1CN(c2ccc(-c3cc(-c4cccc(Br)c4)c4c(N)ncnc4n3)nn2)C[C@H]1OCC		CHEMBL102989	=	IC50	nM	40.7	CHEMBL3589	Homo sapiens	IC50	nM	40.7
	101340	CHEMBL643559	Inhibitory concentration against adenosine kinase was determined	B	Nc1ncnc2nc(-c3ccc(N4CCC(CCOC5CCOCC5)CC4)nn3)cc(-c3cccc(Br)c3)c12		CHEMBL317711	=	IC50	nM	22.8	CHEMBL3589	Homo sapiens	IC50	nM	22.8
	101341	CHEMBL643560	Inhibitory concentration against adenosine kinase was determined in cell assay	B	Nc1ncnc2nc(-c3ccc(N4CCC(CCOC5CCOCC5)CC4)nn3)cc(-c3cccc(Br)c3)c12		CHEMBL317711	=	IC50	nM	89.5	CHEMBL3589	Homo sapiens	IC50	nM	89.5
	103455	CHEMBL873055	Inhibition of human placental adenosine kinase	B	Nc1ncnc2c1c(I)nn2C1O[C@H](CCl)[C@@H](O)[C@H]1O		CHEMBL611890	=	Ki	nM	300.0	CHEMBL3589	Homo sapiens	Ki	uM	0.3
	103456	CHEMBL651356	Inhibition of adenosine kinase-induced MMPR (6-methylmercaptopurine riboside) toxicity in human CEM lymphoblasts	F	Nc1ncnc2c1c(I)nn2C1O[C@H](CCl)[C@@H](O)[C@H]1O	Non standard unit for type	CHEMBL611890	>	ED50	uM	10.0	CHEMBL3589	Homo sapiens	ED50	uM	10.0
	103458	CHEMBL850213	Selectivity for adenosine kinase, Ratio of non-specific cellular (ID50) and specific MMPR-related (ED50) toxicity	F	Nc1ncnc2c1c(I)nn2C1O[C@H](CCl)[C@@H](O)[C@H]1O		CHEMBL611890	<	Ratio		0.4	CHEMBL3589	Homo sapiens	Ratio		0.4
	104330	CHEMBL873055	Inhibition of human placental adenosine kinase	B	Nc1ncnc2c1c(I)nn2C1O[C@H](CF)[C@@H](O)[C@H]1O		CHEMBL607766	=	Ki	nM	160.0	CHEMBL3589	Homo sapiens	Ki	uM	0.16
	104331	CHEMBL651356	Inhibition of adenosine kinase-induced MMPR (6-methylmercaptopurine riboside) toxicity in human CEM lymphoblasts	F	Nc1ncnc2c1c(I)nn2C1O[C@H](CF)[C@@H](O)[C@H]1O	Non standard unit for type	CHEMBL607766	=	ED50	uM	0.3	CHEMBL3589	Homo sapiens	ED50	uM	0.3
	104333	CHEMBL850213	Selectivity for adenosine kinase, Ratio of non-specific cellular (ID50) and specific MMPR-related (ED50) toxicity	F	Nc1ncnc2c1c(I)nn2C1O[C@H](CF)[C@@H](O)[C@H]1O		CHEMBL607766	>	Ratio		333.0	CHEMBL3589	Homo sapiens	Ratio		333.0
	193531	CHEMBL643558	Inhibitory concentration against adenosine kinase	B	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL66089	=	IC50	nM	1.7	CHEMBL3589	Homo sapiens	IC50	uM	0.0017
	200532	CHEMBL643558	Inhibitory concentration against adenosine kinase	B	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(NCc3c[nH]c4ccccc34)c12		CHEMBL116872	=	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	uM	0.01
	207789	CHEMBL644802	Dissociation constant against adenosine kinase	B	c1ccc2[nH]ccc2c1		CHEMBL15844	=	Kd	nM	3000000.0	CHEMBL3589	Homo sapiens	Kd	uM	3000.0
NT	208964	CHEMBL885301	Inhibitory concentration against adenosine kinase; Not reported	B	Nc1cc(C#Cc2ccc(N3CCOCC3)nc2)ncn1		CHEMBL119839		IC50	nM		CHEMBL3589	Homo sapiens	IC50	uM	
	304847	CHEMBL643547	Inhibition of human adenosine kinase activity	B	CNc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL319177	=	IC50	nM	1200.0	CHEMBL3589	Homo sapiens	IC50	uM	1.2
	304848	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	CNc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL319177	=	IC50	nM	833297348.63	CHEMBL3589	Homo sapiens	Log IC50		-0.0792
	304849	CHEMBL643547	Inhibition of human adenosine kinase activity	B	N#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL99668	=	IC50	nM	310.0	CHEMBL3589	Homo sapiens	IC50	uM	0.31
	304850	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	N#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12	Outside typical range	CHEMBL99668	=	IC50	nM	3228494121.71	CHEMBL3589	Homo sapiens	Log IC50		0.509
	311467	CHEMBL643547	Inhibition of human adenosine kinase activity	B	Cc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(Cl)c12		CHEMBL99662	=	IC50	nM	535.0	CHEMBL3589	Homo sapiens	IC50	uM	0.535
	311468	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	Cc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(Cl)c12	Outside typical range	CHEMBL99662	=	IC50	nM	1868959971.65	CHEMBL3589	Homo sapiens	Log IC50		0.2716
	311505	CHEMBL643547	Inhibition of human adenosine kinase activity	B	CSc1ncnc2c1c(I)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL95481	=	IC50	nM	45.0	CHEMBL3589	Homo sapiens	IC50	uM	0.045
	311506	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	CSc1ncnc2c1c(I)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL95481	=	IC50	nM	22222862543.28	CHEMBL3589	Homo sapiens	Log IC50		1.3468
	312864	CHEMBL643547	Inhibition of human adenosine kinase activity	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL97437	=	IC50	nM	63.0	CHEMBL3589	Homo sapiens	IC50	uM	0.063
	312865	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL97437	=	IC50	nM	15874497982.96	CHEMBL3589	Homo sapiens	Log IC50		1.2007
	312866	CHEMBL643547	Inhibition of human adenosine kinase activity	B	NC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL322611	=	IC50	nM	0.6	CHEMBL3589	Homo sapiens	IC50	uM	0.0006
	312867	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	NC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL322611	=	IC50	nM	1666479593599.83	CHEMBL3589	Homo sapiens	Log IC50		3.2218
	312868	CHEMBL643547	Inhibition of human adenosine kinase activity	B	C[C@H]1O[C@@H](n2cc(C(N)=O)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98638	=	IC50	nM	460.0	CHEMBL3589	Homo sapiens	IC50	uM	0.46
	312869	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(C(N)=O)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL98638	=	IC50	nM	2172701178.86	CHEMBL3589	Homo sapiens	Log IC50		0.337
	315338	CHEMBL643547	Inhibition of human adenosine kinase activity	B	C[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98909	=	IC50	nM	40.0	CHEMBL3589	Homo sapiens	IC50	uM	0.04
	315339	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL98909	=	IC50	nM	24997697021.79	CHEMBL3589	Homo sapiens	Log IC50		1.3979
	315379	CHEMBL643547	Inhibition of human adenosine kinase activity	B	COC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL322217	=	IC50	nM	1200.0	CHEMBL3589	Homo sapiens	IC50	uM	1.2
	316514	CHEMBL643547	Inhibition of human adenosine kinase activity	B	CC[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL95721	=	IC50	nM	500.0	CHEMBL3589	Homo sapiens	IC50	uM	0.5
	316515	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	CC[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL95721	=	IC50	nM	1999861869.63	CHEMBL3589	Homo sapiens	Log IC50		0.301
	317831	CHEMBL643547	Inhibition of human adenosine kinase activity	B	C=C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL97553	=	IC50	nM	100.0	CHEMBL3589	Homo sapiens	IC50	uM	0.1
	317832	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	C=C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL97553	=	IC50	nM	10000000000.0	CHEMBL3589	Homo sapiens	Log IC50		1.0
	317833	CHEMBL643547	Inhibition of human adenosine kinase activity	B	NC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL330432	=	IC50	nM	0.1	CHEMBL3589	Homo sapiens	IC50	uM	0.0001
	317834	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	NC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL330432	=	IC50	nM	10000000000000.0	CHEMBL3589	Homo sapiens	Log IC50		4.0
	317835	CHEMBL643547	Inhibition of human adenosine kinase activity	B	C[C@H]1O[C@@H](n2cc(C#N)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99388	=	IC50	nM	310.0	CHEMBL3589	Homo sapiens	IC50	uM	0.31
	317836	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(C#N)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL99388	=	IC50	nM	3228494121.71	CHEMBL3589	Homo sapiens	Log IC50		0.509
	322824	CHEMBL844221	Micromolar concentration required for 50% inhibition of Adenosine Kinase enzyme activity	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL318043	=	IC50	nM	35.0	CHEMBL3589	Homo sapiens	IC50	uM	0.035
	322825	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL318043	=	IC50	nM	28569326345.84	CHEMBL3589	Homo sapiens	Log IC50		1.4559
	322826	CHEMBL643547	Inhibition of human adenosine kinase activity	B	NC[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99707	=	IC50	nM	0.2	CHEMBL3589	Homo sapiens	IC50	uM	0.0002
	322827	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	NC[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL99707	=	IC50	nM	5000345349769.78	CHEMBL3589	Homo sapiens	Log IC50		3.699
	325187	CHEMBL643547	Inhibition of human adenosine kinase activity	B	Cc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL318634	=	IC50	nM	16500.0	CHEMBL3589	Homo sapiens	IC50	uM	16.5
	325188	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	Cc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12	Outside typical range	CHEMBL318634	=	IC50	nM	60603820.05	CHEMBL3589	Homo sapiens	Log IC50		-1.2175
	326403	CHEMBL643547	Inhibition of human adenosine kinase activity	B	Nc1ncnc2c1c(Br)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL62099	=	IC50	nM	120.0	CHEMBL3589	Homo sapiens	IC50	uM	0.12
	326404	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	Nc1ncnc2c1c(Br)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL62099	=	IC50	nM	8336811846.2	CHEMBL3589	Homo sapiens	Log IC50		0.921
	329249	CHEMBL643547	Inhibition of human adenosine kinase activity	B	CSc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(Cl)c12		CHEMBL318056	=	IC50	nM	70.0	CHEMBL3589	Homo sapiens	IC50	uM	0.07
	329250	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	CSc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(Cl)c12	Outside typical range	CHEMBL318056	=	IC50	nM	14285649813.95	CHEMBL3589	Homo sapiens	Log IC50		1.1549
	329251	CHEMBL643547	Inhibition of human adenosine kinase activity	B	COC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99359	=	IC50	nM	450.0	CHEMBL3589	Homo sapiens	IC50	uM	0.45
	331758	CHEMBL643547	Inhibition of human adenosine kinase activity	B	NC(=O)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL101892	=	IC50	nM	470.0	CHEMBL3589	Homo sapiens	IC50	uM	0.47
	331759	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	NC(=O)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12	Outside typical range	CHEMBL101892	=	IC50	nM	2127649080.27	CHEMBL3589	Homo sapiens	Log IC50		0.3279
	334530	CHEMBL643547	Inhibition of human adenosine kinase activity	B	C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL66280	=	IC50	nM	9.0	CHEMBL3589	Homo sapiens	IC50	uM	0.009
	334561	CHEMBL643547	Inhibition of human adenosine kinase activity	B	CC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL97494	=	IC50	nM	60.0	CHEMBL3589	Homo sapiens	IC50	uM	0.06
	334562	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	CC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL97494	=	IC50	nM	16664795936.0	CHEMBL3589	Homo sapiens	Log IC50		1.2218
	336964	CHEMBL643547	Inhibition of human adenosine kinase activity	B	C[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL329724	=	IC50	nM	3.0	CHEMBL3589	Homo sapiens	IC50	uM	0.003
	336965	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL329724	=	IC50	nM	333349647332.76	CHEMBL3589	Homo sapiens	Log IC50		2.5229
	339675	CHEMBL643547	Inhibition of human adenosine kinase activity	B	Nc1ncnc2c1c(Cl)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL98933	=	IC50	nM	210.0	CHEMBL3589	Homo sapiens	IC50	uM	0.21
	339676	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	Nc1ncnc2c1c(Cl)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL98933	=	IC50	nM	4764309868.05	CHEMBL3589	Homo sapiens	Log IC50		0.678
	339677	CHEMBL643547	Inhibition of human adenosine kinase activity	B	C[C@H]1O[C@@H](n2cc(Br)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98910	=	IC50	nM	50.0	CHEMBL3589	Homo sapiens	IC50	uM	0.05
	339678	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(Br)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL98910	=	IC50	nM	19998618696.33	CHEMBL3589	Homo sapiens	Log IC50		1.301
	340998	CHEMBL643547	Inhibition of human adenosine kinase activity	B	CSc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL317927	=	IC50	nM	1350.0	CHEMBL3589	Homo sapiens	IC50	uM	1.35
	340999	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	CSc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12	Outside typical range	CHEMBL317927	=	IC50	nM	740798339.15	CHEMBL3589	Homo sapiens	Log IC50		-0.1303
	342166	CHEMBL643547	Inhibition of human adenosine kinase activity	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(Br)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99119	=	IC50	nM	100.0	CHEMBL3589	Homo sapiens	IC50	uM	0.1
	342167	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(Br)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL99119	=	IC50	nM	10000000000.0	CHEMBL3589	Homo sapiens	Log IC50		1.0
	343250	CHEMBL643547	Inhibition of human adenosine kinase activity	B	OC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL328824	=	IC50	nM	24.0	CHEMBL3589	Homo sapiens	IC50	uM	0.024
	343251	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	OC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL328824	=	IC50	nM	41667745222.19	CHEMBL3589	Homo sapiens	Log IC50		1.6198
	343267	CHEMBL643547	Inhibition of human adenosine kinase activity	B	CCOC(=O)c1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL95256	=	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	uM	1.0
	343268	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	CCOC(=O)c1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12	Outside typical range	CHEMBL95256	=	IC50	nM	1000000000.0	CHEMBL3589	Homo sapiens	Log IC50		0.0
	343269	CHEMBL643547	Inhibition of human adenosine kinase activity	B	C[C@H]1O[C@@H](n2cc(I)c3c(S)ncnc32)[C@H](O)[C@@H]1O		CHEMBL420640	=	IC50	nM	6500.0	CHEMBL3589	Homo sapiens	IC50	uM	6.5
	344640	CHEMBL643547	Inhibition of human adenosine kinase activity	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	IC50	nM	26.0	CHEMBL3589	Homo sapiens	IC50	uM	0.026
	344641	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL99203	=	IC50	nM	38459178204.54	CHEMBL3589	Homo sapiens	Log IC50		1.585
	344642	CHEMBL643547	Inhibition of human adenosine kinase activity	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL449407	=	IC50	nM	9.0	CHEMBL3589	Homo sapiens	IC50	uM	0.009
	344643	CHEMBL643550	Inhibition concentration against human adenosine kinase	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL449407	=	IC50	nM	111121987376.87	CHEMBL3589	Homo sapiens	Log IC50		2.0458
	391411	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL318281	=	IC50	nM	100.0	CHEMBL3589	Homo sapiens	IC50	uM	0.1
	392721	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccc(Cl)cc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL318918	=	IC50	nM	1.2	CHEMBL3589	Homo sapiens	IC50	uM	0.0012
	396555	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	OC[C@H]1O[C@@H](n2cc(I)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL317176	=	IC50	nM	120.0	CHEMBL3589	Homo sapiens	IC50	uM	0.12
	396556	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	Cc1ccc(Nc2ncnc3c2c(-c2ccccc2)cn3[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1		CHEMBL318929	=	IC50	nM	1.5	CHEMBL3589	Homo sapiens	IC50	uM	0.0015
	397766	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2c(Br)c(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL328826	=	IC50	nM	1.0	CHEMBL3589	Homo sapiens	IC50	uM	0.001
	400133	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL329484	=	IC50	nM	320.0	CHEMBL3589	Homo sapiens	IC50	uM	0.32
	400134	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	OC[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)C[C@@H]1O		CHEMBL330221	=	IC50	nM	300.0	CHEMBL3589	Homo sapiens	IC50	uM	0.3
	403083	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL100421	=	IC50	nM	0.5	CHEMBL3589	Homo sapiens	IC50	uM	0.0005
	403086	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL66277	=	IC50	nM	1.5	CHEMBL3589	Homo sapiens	IC50	uM	0.0015
	403089	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NC4CCCCC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98174	=	IC50	nM	250.0	CHEMBL3589	Homo sapiens	IC50	uM	0.25
	403090	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	OC[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL319315	=	IC50	nM	0.8	CHEMBL3589	Homo sapiens	IC50	uM	0.0008
	403093	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98867	=	IC50	nM	1.5	CHEMBL3589	Homo sapiens	IC50	uM	0.0015
	405829	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4cccnc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99536	=	IC50	nM	25.0	CHEMBL3589	Homo sapiens	IC50	uM	0.025
	407099	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)C[C@@H]1O		CHEMBL319611	=	IC50	nM	100.0	CHEMBL3589	Homo sapiens	IC50	uM	0.1
	408245	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccc(O)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98551	=	IC50	nM	1.0	CHEMBL3589	Homo sapiens	IC50	uM	0.001
	409460	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccc(C#N)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL318645	=	IC50	nM	14.0	CHEMBL3589	Homo sapiens	IC50	uM	0.014
	414315	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(Nc4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL431628	=	IC50	nM	550.0	CHEMBL3589	Homo sapiens	IC50	uM	0.55
	414316	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	COc1ccc(-c2cn([C@@H]3O[C@H](C)[C@@H](O)[C@H]3O)c3ncnc(Nc4ccc(C#N)cc4)c23)cc1		CHEMBL317603	=	IC50	nM	1.0	CHEMBL3589	Homo sapiens	IC50	uM	0.001
	414319	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@@H]1C[C@@H](O)[C@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)O1		CHEMBL442002	=	IC50	nM	44.0	CHEMBL3589	Homo sapiens	IC50	uM	0.044
	415612	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(NCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL317583	=	IC50	nM	800.0	CHEMBL3589	Homo sapiens	IC50	uM	0.8
	415613	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	COc1ccc(Nc2ncnc3c2c(I)cn3[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1		CHEMBL98887	=	IC50	nM	775.0	CHEMBL3589	Homo sapiens	IC50	uM	0.775
	415614	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(Nc4ccc(O)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL442003	=	IC50	nM	200.0	CHEMBL3589	Homo sapiens	IC50	uM	0.2
	416806	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	COc1ccc(Nc2ncnc3c2c(-c2ccccc2)cn3[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1		CHEMBL98744	=	IC50	nM	6.0	CHEMBL3589	Homo sapiens	IC50	uM	0.006
	416809	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	COc1ccc(Nc2ncnc3c2c(-c2ccco2)cn3[C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)cc1		CHEMBL99025	=	IC50	nM	9.0	CHEMBL3589	Homo sapiens	IC50	uM	0.009
	419104	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccc(F)cc3)c3c(Nc4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL100262	=	IC50	nM	26.0	CHEMBL3589	Homo sapiens	IC50	uM	0.026
	419107	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	Cc1nc(Nc2ccccc2)c2c(-c3ccccc3)cn([C@@H]3O[C@H](C)[C@@H](O)[C@H]3O)c2n1		CHEMBL99062	=	IC50	nM	47.0	CHEMBL3589	Homo sapiens	IC50	uM	0.047
	420445	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccc(Cl)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL317818	=	IC50	nM	2.3	CHEMBL3589	Homo sapiens	IC50	uM	0.0023
	424459	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccc(Cl)cc3)c3c(Nc4ccc(Cl)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL432062	=	IC50	nM	2.7	CHEMBL3589	Homo sapiens	IC50	uM	0.0027
	425661	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(Nc4ccc(C#N)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99923	=	IC50	nM	1200.0	CHEMBL3589	Homo sapiens	IC50	uM	1.2
	428340	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL316668	=	IC50	nM	30.0	CHEMBL3589	Homo sapiens	IC50	uM	0.03
	428341	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	NC[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99829	=	IC50	nM	6.3	CHEMBL3589	Homo sapiens	IC50	uM	0.0063
	429596	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	OC[C@H]1O[C@@H](n2ccc3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98424	=	IC50	nM	1250.0	CHEMBL3589	Homo sapiens	IC50	uM	1.25
	429597	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccco3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99565	=	IC50	nM	3.6	CHEMBL3589	Homo sapiens	IC50	uM	0.0036
	430739	CHEMBL643544	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(NC4CCCCC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL319338	=	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	475342	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	Nc1ncnc2nc(-c3ccc([N+](=O)[O-])cc3)cnc12		CHEMBL308008	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	nM	10000.0
	479020	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	COc1ccc(-c2cc3c(N)ncnc3nc2-c2ccc(N(C)C)cc2)cc1		CHEMBL302938	=	IC50	nM	567.0	CHEMBL3589	Homo sapiens	IC50	nM	567.0
	480236	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	Nc1ncnc2nc(-c3ccc(N4CCOCC4)cc3)cnc12		CHEMBL65852	=	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	480238	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	COC(=O)c1cccc(-c2cc3c(N)ncnc3nc2-c2ccc(N(C)C)cc2)c1		CHEMBL416498	=	IC50	nM	700.0	CHEMBL3589	Homo sapiens	IC50	nM	700.0
	485155	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	CN(C)c1ccc(-c2nc3ncnc(N)c3nc2-c2ccccc2)cc1		CHEMBL305746	=	IC50	nM	333.0	CHEMBL3589	Homo sapiens	IC50	nM	333.0
	485157	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	CN(C)c1ccc(-c2nc3ncnc(N)c3cc2-c2ccc(C(C)(C)C)cc2)cc1		CHEMBL66568	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	486249	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	COc1ccc(-c2cnc3c(N)ncnc3n2)cc1		CHEMBL67267	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	nM	10000.0
	492169	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	Nc1ccc(-c2cnc3c(N)ncnc3n2)cc1		CHEMBL67043	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	nM	10000.0
	494496	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	CN(C)c1ccc(-c2ccc3c(N)ncnc3n2)cc1		CHEMBL303499	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	nM	10000.0
	496693	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	CN(C)c1ccc(-c2cc(C3CCCCC3)c3c(N)ncnc3n2)cc1		CHEMBL302921	=	IC50	nM	467.0	CHEMBL3589	Homo sapiens	IC50	nM	467.0
	499040	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	CN(C)c1ccc(-c2cc(-c3cccc(Br)c3)c3c(N)ncnc3n2)cc1		CHEMBL68749	=	IC50	nM	167.0	CHEMBL3589	Homo sapiens	IC50	nM	167.0
	500352	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	CN(C)c1ccc(-c2cc(-c3ccccc3)c3c(N)ncnc3n2)cc1		CHEMBL68492	=	IC50	nM	467.0	CHEMBL3589	Homo sapiens	IC50	nM	467.0
	502793	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	Nc1ncnc(N[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1[N+](=O)[O-]		CHEMBL304179	=	IC50	nM	26000.0	CHEMBL3589	Homo sapiens	IC50	nM	26000.0
	504090	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL66089	=	IC50	nM	50.0	CHEMBL3589	Homo sapiens	IC50	nM	50.0
	505279	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL66280	=	IC50	nM	22.8	CHEMBL3589	Homo sapiens	IC50	nM	22.8
	505281	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL66277	=	IC50	nM	134.0	CHEMBL3589	Homo sapiens	IC50	nM	134.0
	507777	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	Nc1ncnc2nc(-c3ccccc3)cnc12		CHEMBL419063	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	nM	10000.0
	508919	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	NC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL302376	=	IC50	nM	6330.0	CHEMBL3589	Homo sapiens	IC50	nM	6330.0
	510190	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	Cc1ccc(-c2cc3c(N)ncnc3nc2-c2ccc(N(C)C)cc2)cc1		CHEMBL66977	=	IC50	nM	500.0	CHEMBL3589	Homo sapiens	IC50	nM	500.0
	510192	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	CN(C)c1ccc(-c2cc(-c3cccc(Br)c3)c3c(N)ncnc3n2)cn1		CHEMBL68748	=	IC50	nM	32.0	CHEMBL3589	Homo sapiens	IC50	nM	32.0
	511350	CHEMBL700683	Inhibition of adenosine phosphorylation in confluent IMR-32 (human neuroblastoma) cells.	F	CN(C)c1ccc(-c2cnc3c(N)ncnc3n2)cc1		CHEMBL66338	=	IC50	nM	3600.0	CHEMBL3589	Homo sapiens	IC50	nM	3600.0
	565166	CHEMBL643548	Binding affinity towards adenosine kinase	B	Nc1ncnc(N[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1[N+](=O)[O-]		CHEMBL304179	=	Ki	nM	300.0	CHEMBL3589	Homo sapiens	Ki	M	3E-7
	565168	CHEMBL643551	Inhibition of rabbit liver adenosine kinase	B	Nc1ncnc(N[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1[N+](=O)[O-]		CHEMBL304179	=	Ki	nM	2500.0	CHEMBL3589	Homo sapiens	Ki	uM	2.5
	565169	CHEMBL643549	Inhibition of adenosine kinase from undialyzed W1-L2 lysate (0-50 uM)	B	Nc1ncnc(N[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1[N+](=O)[O-]		CHEMBL304179	=	Ki	nM	3000.0	CHEMBL3589	Homo sapiens	Ki	uM	3.0
	592790	CHEMBL645534	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of enzyme	B	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL66089	=	IC50	nM	1.3	CHEMBL3589	Homo sapiens	IC50	nM	1.3
	592791	CHEMBL645535	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of intact cells	B	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL66089	=	IC50	nM	43.3	CHEMBL3589	Homo sapiens	IC50	nM	43.3
	600364	CHEMBL645534	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of enzyme	B	Nc1ncnc2nc(-c3ccc(N4CCC(=NOC5CCOCC5)CC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL65664	=	IC50	nM	8.0	CHEMBL3589	Homo sapiens	IC50	nM	8.0
	600365	CHEMBL645535	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of intact cells	B	Nc1ncnc2nc(-c3ccc(N4CCC(=NOC5CCOCC5)CC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL65664	=	IC50	nM	70.9	CHEMBL3589	Homo sapiens	IC50	nM	70.9
	601621	CHEMBL645534	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of enzyme	B	CN(Cc1cccnc1)c1ccc(-c2cc(-c3cccc(Br)c3)c3c(N)ncnc3n2)cn1		CHEMBL62524	=	IC50	nM	4.1	CHEMBL3589	Homo sapiens	IC50	nM	4.1
	601622	CHEMBL645535	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of intact cells	B	CN(Cc1cccnc1)c1ccc(-c2cc(-c3cccc(Br)c3)c3c(N)ncnc3n2)cn1		CHEMBL62524	=	IC50	nM	42.3	CHEMBL3589	Homo sapiens	IC50	nM	42.3
	602800	CHEMBL645534	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of enzyme	B	Nc1ncnc2nc(-c3ccc(N4CCCC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL302404	=	IC50	nM	3.4	CHEMBL3589	Homo sapiens	IC50	nM	3.4
	602801	CHEMBL645535	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of intact cells	B	Nc1ncnc2nc(-c3ccc(N4CCCC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL302404	=	IC50	nM	45.0	CHEMBL3589	Homo sapiens	IC50	nM	45.0
	604110	CHEMBL645534	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of enzyme	B	CO[C@@H]1CCCN1c1ccc(-c2cc(-c3cccc(Br)c3)c3c(N)ncnc3n2)cn1		CHEMBL62342	=	IC50	nM	4.12	CHEMBL3589	Homo sapiens	IC50	nM	4.12
	604111	CHEMBL645535	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of intact cells	B	CO[C@@H]1CCCN1c1ccc(-c2cc(-c3cccc(Br)c3)c3c(N)ncnc3n2)cn1		CHEMBL62342	=	IC50	nM	37.7	CHEMBL3589	Homo sapiens	IC50	nM	37.7
	610118	CHEMBL645534	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of enzyme	B	Nc1ncnc2nc(-c3ccc(N4CCSCC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL62576	=	IC50	nM	1.3	CHEMBL3589	Homo sapiens	IC50	nM	1.3
	610119	CHEMBL645535	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of intact cells	B	Nc1ncnc2nc(-c3ccc(N4CCSCC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL62576	=	IC50	nM	42.5	CHEMBL3589	Homo sapiens	IC50	nM	42.5
	612604	CHEMBL645534	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of enzyme	B	Nc1ncnc2nc(-c3ccc(N4CCC(O)CC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL62974	=	IC50	nM	1.8	CHEMBL3589	Homo sapiens	IC50	nM	1.8
	612605	CHEMBL645535	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of intact cells	B	Nc1ncnc2nc(-c3ccc(N4CCC(O)CC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL62974	=	IC50	nM	33.0	CHEMBL3589	Homo sapiens	IC50	nM	33.0
	624154	CHEMBL645534	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of enzyme	B	Nc1ncnc2nc(-c3ccc(N4CCC5(CC4)OCCO5)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL65665	=	IC50	nM	1.4	CHEMBL3589	Homo sapiens	IC50	nM	1.4
	624155	CHEMBL645535	In vitro concentration required for 50% inhibition against Adenosine Kinase (AK) in the presence of intact cells	B	Nc1ncnc2nc(-c3ccc(N4CCC5(CC4)OCCO5)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL65665	=	IC50	nM	28.3	CHEMBL3589	Homo sapiens	IC50	nM	28.3
	672509	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	CN(C)c1ccc(-c2nc3ncnc(N)c3c(-c3ccccc3)c2-c2ccccc2)cc1		CHEMBL356256	=	IC50	nM	250.0	CHEMBL3589	Homo sapiens	IC50	nM	250.0
	673851	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	OC[C@@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL343247	=	IC50	nM	0.47	CHEMBL3589	Homo sapiens	IC50	nM	0.47
	673853	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	Nc1ncnc2c1ncn2[C@@H]1O[C@@H](CO)[C@@H](O)[C@H]1O		CHEMBL145188	=	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	673867	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	CN(C)c1ccc(-c2cc(-c3ccccc3)c3c(N)ncnc3n2)cc1		CHEMBL68492	=	IC50	nM	467.0	CHEMBL3589	Homo sapiens	IC50	nM	467.0
	673869	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)c(-c3ccc(F)cc3)c(-c3cccc(Br)c3)c12		CHEMBL151214	=	IC50	nM	197.0	CHEMBL3589	Homo sapiens	IC50	nM	197.0
	675255	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	NC[C@H]1O[C@@H](n2nc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL356141	=	IC50	nM	4.0	CHEMBL3589	Homo sapiens	IC50	nM	4.0
	675258	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	CN(C)c1ccc(-c2cnc3c(N)ncnc3n2)cc1		CHEMBL66338	=	IC50	nM	3600.0	CHEMBL3589	Homo sapiens	IC50	nM	3600.0
	675260	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	COc1ccc(-c2c(-c3ccc(N(C)C)cc3)nc3ncnc(N)c3c2-c2cccc(Br)c2)cc1OC		CHEMBL342310	=	IC50	nM	350.0	CHEMBL3589	Homo sapiens	IC50	nM	350.0
	679046	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	NC[C@@H]1O[C@@H](n2nc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL342959	=	IC50	nM	170.0	CHEMBL3589	Homo sapiens	IC50	nM	170.0
	681733	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	NC[C@@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL422122	=	IC50	nM	36.0	CHEMBL3589	Homo sapiens	IC50	nM	36.0
	683292	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	Nc1ncnc2nc(-c3cccs3)c(-c3ccccc3)c(-c3ccccc3)c12		CHEMBL348712	=	IC50	nM	49.0	CHEMBL3589	Homo sapiens	IC50	nM	49.0
	686013	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	Nc1ncnc2c1c(Br)cn2[C@@H]1O[C@@H](CO)[C@@H](O)[C@H]1O		CHEMBL141606	=	IC50	nM	280.0	CHEMBL3589	Homo sapiens	IC50	nM	280.0
	686014	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	NC[C@@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL144936	=	IC50	nM	16.0	CHEMBL3589	Homo sapiens	IC50	nM	16.0
	686019	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	CC(C)c1c(-c2ccc(N3CCOCC3)nc2)nc2ncnc(N)c2c1-c1cccc(Br)c1		CHEMBL147356	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	688778	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	CN(C)c1ccc(-c2nc3ncnc(N)c3c(-c3cccc(Cl)c3)c2-c2ccccc2)cn1		CHEMBL422489	=	IC50	nM	130.0	CHEMBL3589	Homo sapiens	IC50	nM	130.0
	688782	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	CN(C)c1ccc(-c2nc3ncnc(N)c3c(-c3cc(Br)cs3)c2C2CC2)cn1		CHEMBL265251	=	IC50	nM	625.0	CHEMBL3589	Homo sapiens	IC50	nM	625.0
	690092	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	CN(C)c1ccc(-c2nc3ncnc(N)c3c(-c3cccc(Br)c3)c2C2CCCCC2)cn1		CHEMBL147390	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	691399	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	Clc1ccc(-c2cnc3c(N4CCOCC4)ncnc3n2)cc1		CHEMBL151553	=	IC50	nM	22000.0	CHEMBL3589	Homo sapiens	IC50	nM	22000.0
	692550	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	CN(C)c1ccc(-c2c(-c3ccc(N4CCOCC4)nc3)nc3ncnc(N)c3c2-c2cccc(Cl)c2)cc1		CHEMBL358714	=	IC50	nM	130.0	CHEMBL3589	Homo sapiens	IC50	nM	130.0
	693660	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	CN(C)c1ccc(-c2nc3ncnc(N)c3cc2-c2ccccc2)cc1		CHEMBL150978	=	IC50	nM	1500.0	CHEMBL3589	Homo sapiens	IC50	nM	1500.0
	696616	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	COC[C@@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL358584	=	IC50	nM	15.0	CHEMBL3589	Homo sapiens	IC50	nM	15.0
	697982	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	C[C@@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL145388	=	IC50	nM	400.0	CHEMBL3589	Homo sapiens	IC50	nM	400.0
	699610	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	Cc1ccc(-c2c(-c3cccs3)nc3ncnc(N)c3c2-c2ccc(C)c(F)c2)cc1F		CHEMBL150370	=	IC50	nM	288.0	CHEMBL3589	Homo sapiens	IC50	nM	288.0
	699612	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)c(Cc3ccccc3)c(-c3cccc(Br)c3)c12		CHEMBL439635	=	IC50	nM	450.0	CHEMBL3589	Homo sapiens	IC50	nM	450.0
	700811	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	Nc1ncnc2c1c(Br)nn2[C@@H]1O[C@@H](CO)[C@@H](O)[C@H]1O		CHEMBL143644	=	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	nM	10000.0
	702047	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	CN(C)c1ccc(-c2nc3ncnc(N)c3c(-c3ccccc3)c2-c2ccccc2)cn1		CHEMBL151448	=	IC50	nM	53.0	CHEMBL3589	Homo sapiens	IC50	nM	53.0
	703277	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	C[C@@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL436598	=	IC50	nM	0.8	CHEMBL3589	Homo sapiens	IC50	nM	0.8
	703279	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	NC[C@@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL356312	=	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	nM	10000.0
	703291	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	CC(C)c1ccc(-c2c(-c3ccc(N(C)C)cc3)nc3ncnc(N)c3c2-c2ccc(C(C)C)cc2)cc1		CHEMBL151079	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	707295	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	COC[C@@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL142234	=	IC50	nM	2000.0	CHEMBL3589	Homo sapiens	IC50	nM	2000.0
	707308	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	COC(=O)Cc1c(-c2cccs2)nc2ncnc(N)c2c1-c1cccc(Br)c1		CHEMBL346622	=	IC50	nM	163.0	CHEMBL3589	Homo sapiens	IC50	nM	163.0
	707310	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	CCCCCc1c(-c2ccc(N(C)C)nc2)nc2ncnc(N)c2c1-c1cccc(Br)c1		CHEMBL435646	=	IC50	nM	625.0	CHEMBL3589	Homo sapiens	IC50	nM	625.0
	709907	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	C[C@@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL145092	=	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	nM	10000.0
	709911	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	COc1ccc(-c2c(-c3cccs3)nc3ncnc(N)c3c2-c2cc(Br)cs2)cc1OC		CHEMBL150478	=	IC50	nM	25.0	CHEMBL3589	Homo sapiens	IC50	nM	25.0
	709913	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)c(-c3ccccc3)c(-c3cccc(Br)c3)c12		CHEMBL151812	=	IC50	nM	155.0	CHEMBL3589	Homo sapiens	IC50	nM	155.0
	711183	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	IC50	nM	26.0	CHEMBL3589	Homo sapiens	IC50	nM	26.0
	711184	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL66277	=	IC50	nM	5.0	CHEMBL3589	Homo sapiens	IC50	nM	5.0
	711186	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	OC[C@@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL344529	=	IC50	nM	1.5	CHEMBL3589	Homo sapiens	IC50	nM	1.5
	711191	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	CN(C)c1ccc(-c2ccc3c(N)ncnc3n2)cc1		CHEMBL303499	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	nM	10000.0
	711193	CHEMBL642226	Inhibition of adenosine kinase activity in IMR-32 human neuroblastoma cells	B	COCCN(C)c1ccc(-c2nc3ncnc(N)c3c(-c3cc(Br)cs3)c2-c2ccc(OC)c(OC)c2)cc1		CHEMBL356896	=	IC50	nM	367.0	CHEMBL3589	Homo sapiens	IC50	nM	367.0
	712464	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	OC[C@@H]1O[C@@H](n2nc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL141327	=	IC50	nM	2.8	CHEMBL3589	Homo sapiens	IC50	nM	2.8
	713709	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@@H](CO)[C@@H](O)[C@H]1O		CHEMBL356952	=	IC50	nM	68.0	CHEMBL3589	Homo sapiens	IC50	nM	68.0
	713711	CHEMBL642224	Inhibitory activity against human recombinant adenosine kinase	B	NC[C@@H]1O[C@@H](n2nc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL356758	=	IC50	nM	42.0	CHEMBL3589	Homo sapiens	IC50	nM	42.0
	849746	CHEMBL822078	Inhibition of human adenosine kinase	B	c1ccc2[nH]ccc2c1		CHEMBL15844	=	Kd	nM	3000000.0	CHEMBL3589	Homo sapiens	Kd	mM	3.0
	850904	CHEMBL822078	Inhibition of human adenosine kinase	B	c1ccc(-c2ncc[nH]2)cc1		CHEMBL14189	=	Kd	nM	3000000.0	CHEMBL3589	Homo sapiens	Kd	mM	3.0
	851999	CHEMBL822077	Tested for inhibitory activity against AK in an in vitro cell-free enzyme assay	B	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL66089	=	IC50	nM	1.7	CHEMBL3589	Homo sapiens	IC50	nM	1.7
	853069	CHEMBL822077	Tested for inhibitory activity against AK in an in vitro cell-free enzyme assay	B	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(NCCc3c[nH]c4ccccc34)c12		CHEMBL356339	=	IC50	nM	23.0	CHEMBL3589	Homo sapiens	IC50	nM	23.0
	857602	CHEMBL822077	Tested for inhibitory activity against AK in an in vitro cell-free enzyme assay	B	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(NCc3c[nH]c4ccccc34)c12		CHEMBL116872	=	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	865111	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	Cc1cn(C2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(Cl)c12	Outside typical range	CHEMBL608326	=	IC50	nM	1862087136.66	CHEMBL3589	Homo sapiens	Log IC50		0.27
	865112	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	C=C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL97553	=	IC50	nM	10000000000.0	CHEMBL3589	Homo sapiens	Log IC50		1.0
	866360	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	NC[C@H]1OC(n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL610115	=	IC50	nM	10000000000000.0	CHEMBL3589	Homo sapiens	Log IC50		4.0
	870271	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	CSc1cn(C2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12	Outside typical range	CHEMBL610114	=	IC50	nM	741310241.3	CHEMBL3589	Homo sapiens	Log IC50		-0.13
	871511	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	OC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL328824	=	IC50	nM	41686938347.03	CHEMBL3589	Homo sapiens	Log IC50		1.62
	871512	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	C[C@H]1OC(n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL611880	=	IC50	nM	331131121482.59	CHEMBL3589	Homo sapiens	Log IC50		2.52
	873899	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	Nc1ncnc2c1c(Br)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL62099	=	IC50	nM	8317637711.03	CHEMBL3589	Homo sapiens	Log IC50		0.92
	875030	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	NC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL322611	=	IC50	nM	1659586907437.56	CHEMBL3589	Homo sapiens	Log IC50		3.22
	876212	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	[N-]=[N+]=NC[C@H]1OC(n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL612189	=	IC50	nM	112201845430.2	CHEMBL3589	Homo sapiens	Log IC50		2.05
	881320	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	C[C@H]1OC(n2cc(Br)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL608043	=	IC50	nM	19952623149.69	CHEMBL3589	Homo sapiens	Log IC50		1.3
	883662	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	Nc1ncnc2c1c(Cl)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL98933	=	IC50	nM	4786300923.23	CHEMBL3589	Homo sapiens	Log IC50		0.68
	884943	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL99203	=	IC50	nM	38904514499.43	CHEMBL3589	Homo sapiens	Log IC50		1.59
	884944	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	C[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL98909	=	IC50	nM	25118864315.1	CHEMBL3589	Homo sapiens	Log IC50		1.4
	884945	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	COC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL99359	=	IC50	nM	2238721138.57	CHEMBL3589	Homo sapiens	Log IC50		0.35
	884946	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	C[C@H]1OC(n2cc(I)c3c(S)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL608627	=	IC50	nM	154881661.89	CHEMBL3589	Homo sapiens	Log IC50		-0.81
	884947	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	NC[C@H]1OC(n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL607751	=	IC50	nM	5011872336272.71	CHEMBL3589	Homo sapiens	Log IC50		3.7
	886352	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	CC[C@H]1OC(n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL611869	=	IC50	nM	16595869074.38	CHEMBL3589	Homo sapiens	Log IC50		1.22
	887450	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	CSc1cn(C2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(Cl)c12	Outside typical range	CHEMBL611873	=	IC50	nM	14125375446.23	CHEMBL3589	Homo sapiens	Log IC50		1.15
	888653	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	NC(=O)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12	Outside typical range	CHEMBL101892	=	IC50	nM	2137962089.5	CHEMBL3589	Homo sapiens	Log IC50		0.33
	889936	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	[N-]=[N+]=NC[C@H]1OC(n2cc(Br)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL608925	=	IC50	nM	10000000000.0	CHEMBL3589	Homo sapiens	Log IC50		1.0
	889937	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	Cc1cn(C2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12	Outside typical range	CHEMBL611878	=	IC50	nM	60255958.61	CHEMBL3589	Homo sapiens	Log IC50		-1.22
	889938	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	C[C@H]1OC(n2cc(C#N)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL611270	=	IC50	nM	3235936569.3	CHEMBL3589	Homo sapiens	Log IC50		0.51
	891170	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	COC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL322217	=	IC50	nM	831763771.1	CHEMBL3589	Homo sapiens	Log IC50		-0.08
	891171	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	CC[C@H]1OC(n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL611870	=	IC50	nM	1995262314.97	CHEMBL3589	Homo sapiens	Log IC50		0.3
	892329	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	CCOC(=O)c1cn(C2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12	Outside typical range	CHEMBL608926	=	IC50	nM	1000000000.0	CHEMBL3589	Homo sapiens	Log IC50		0.0
	893385	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	CSc1ncnc2c1c(I)cn2C1O[C@H](C)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL612198	=	IC50	nM	22387211385.68	CHEMBL3589	Homo sapiens	Log IC50		1.35
	895674	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	N#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12	Outside typical range	CHEMBL99668	=	IC50	nM	3235936569.3	CHEMBL3589	Homo sapiens	Log IC50		0.51
	895675	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	C[C@H]1OC(n2cc(C(N)=O)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL611551	=	IC50	nM	2187761623.95	CHEMBL3589	Homo sapiens	Log IC50		0.34
	898076	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	CNc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O	Outside typical range	CHEMBL319177	=	IC50	nM	831763771.1	CHEMBL3589	Homo sapiens	Log IC50		-0.08
	899382	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL66280	=	IC50	nM	112201845430.2	CHEMBL3589	Homo sapiens	Log IC50		2.05
	899383	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	[N-]=[N+]=NC[C@H]1OC(n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL612193	=	IC50	nM	28840315031.27	CHEMBL3589	Homo sapiens	Log IC50		1.46
	899384	CHEMBL644803	Concentration required for 50% inhibition of the adenosine kinase (AK) activity.	B	[N-]=[N+]=NC[C@H]1OC(n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O	Outside typical range	CHEMBL609519	=	IC50	nM	15848931924.61	CHEMBL3589	Homo sapiens	Log IC50		1.2
	987115	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	c1ccc(CN2C[C@@H]3CCCN(c4ncnc5oc(-c6ccccc6)nc45)[C@@H]3C2)cc1		CHEMBL174158	=	IC50	nM	1.0	CHEMBL3589	Homo sapiens	IC50	nM	1.0
	987116	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	c1ccc(CNc2ncnc3oc(-c4ccccc4)nc23)cc1		CHEMBL177663	>	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	987117	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	O=C(Nc1cccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)c1)c1ccccc1		CHEMBL424966	=	IC50	nM	90.0	CHEMBL3589	Homo sapiens	IC50	nM	90.0
	990723	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	c1ccc(CCCNc2ncnc3oc(-c4ccccc4)nc23)cc1		CHEMBL366694	=	IC50	nM	230.0	CHEMBL3589	Homo sapiens	IC50	nM	230.0
	990724	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	Fc1ccc(-c2ccc(-c3nc4c(N5CC6CCN(Cc7ccccc7)C6C5)ncnc4o3)cc2)cc1		CHEMBL177680	>	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	991938	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	c1ccc(CN2CC3CN(c4ncnc5oc(-c6ccccc6)nc45)CC3C2)cc1		CHEMBL435552	>	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	991939	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	O=C(Nc1ccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)cc1)c1ccccc1		CHEMBL175041	=	IC50	nM	70.0	CHEMBL3589	Homo sapiens	IC50	nM	70.0
	991940	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	c1ccc(CN2CCC3CN(c4ncnc5oc(-c6ccncc6)nc45)CC32)cc1		CHEMBL369374	>	IC50	nM	1.0	CHEMBL3589	Homo sapiens	IC50	nM	1.0
	992950	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	c1ccc(CCNc2ncnc3oc(-c4ccccc4)nc23)cc1		CHEMBL177664	>	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	992951	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	Clc1ccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)cn1		CHEMBL175440	=	IC50	nM	70.0	CHEMBL3589	Homo sapiens	IC50	nM	70.0
	994216	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	CN(CCCNc1ncnc2oc(-c3ccccc3)nc12)c1ccccc1		CHEMBL425507	=	IC50	nM	270.0	CHEMBL3589	Homo sapiens	IC50	nM	270.0
	999345	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	O=C(Nc1ccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)cc1)c1ccc(F)cc1		CHEMBL366606	=	IC50	nM	130.0	CHEMBL3589	Homo sapiens	IC50	nM	130.0
	1000406	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	Brc1cccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)c1		CHEMBL367498	=	IC50	nM	260.0	CHEMBL3589	Homo sapiens	IC50	nM	260.0
	1000407	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	CN(C)c1ccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)cn1		CHEMBL366539	=	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	1002848	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	O=C(Cc1ccccc1)Nc1ccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)cc1		CHEMBL361797	=	IC50	nM	70.0	CHEMBL3589	Homo sapiens	IC50	nM	70.0
	1004146	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	COCC(=O)Nc1ccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)cc1		CHEMBL368401	=	IC50	nM	40.0	CHEMBL3589	Homo sapiens	IC50	nM	40.0
	1005543	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL66089	=	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	1006787	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	Fc1ccc(CN2CCCN(c3ncnc4oc(-c5ccccc5)nc34)CC2)cc1		CHEMBL366908	>	IC50	nM	1.0	CHEMBL3589	Homo sapiens	IC50	nM	1.0
	1007927	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	O=C(Nc1ccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)cc1)c1ccc(C(F)(F)F)cc1		CHEMBL368003	>	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	1007928	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	O=C(Cc1ccccc1)Nc1cccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)c1		CHEMBL369435	=	IC50	nM	210.0	CHEMBL3589	Homo sapiens	IC50	nM	210.0
	1009209	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	c1ccc(CN2CCN(c3ncnc4oc(-c5ccccc5)nc34)CC2)cc1		CHEMBL177368	>	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	1010445	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	O=C(Nc1ccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)cc1)C1CC1		CHEMBL174700	=	IC50	nM	30.0	CHEMBL3589	Homo sapiens	IC50	nM	30.0
	1010446	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	COCC(=O)Nc1cccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)c1		CHEMBL175074	=	IC50	nM	40.0	CHEMBL3589	Homo sapiens	IC50	nM	40.0
	1012889	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	CCCCNc1ncnc2oc(-c3ccccc3)nc12		CHEMBL175626	>	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	1015599	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	c1ccc(CN2CCC3CN(c4ncnc5oc(-c6ccc(-c7cccs7)cc6)nc45)CC32)cc1		CHEMBL425500	=	IC50	nM	90.0	CHEMBL3589	Homo sapiens	IC50	nM	90.0
	1015600	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	O=C(Nc1cccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)c1)C1CC1		CHEMBL174992	=	IC50	nM	60.0	CHEMBL3589	Homo sapiens	IC50	nM	60.0
	1016891	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	c1ccc(CN2CCC3CN(c4ncnc5oc(-c6ccccc6)nc45)CC32)cc1		CHEMBL177540	=	IC50	nM	200.0	CHEMBL3589	Homo sapiens	IC50	nM	200.0
	1018262	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	c1ccc(CN2CC[C@H]3CN(c4ncnc5oc(-c6ccccc6)nc45)C[C@H]32)cc1		CHEMBL360273	=	IC50	nM	1.5	CHEMBL3589	Homo sapiens	IC50	nM	1.5
	1018263	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	Brc1ccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)cc1		CHEMBL355801	=	IC50	nM	240.0	CHEMBL3589	Homo sapiens	IC50	nM	240.0
Not Determined	1018264	CHEMBL643546	Inhibitory activity against human adenosine Kinase expressed in E. coli; ND = not determined	B	Nc1cccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)c1		CHEMBL175666		IC50	nM		CHEMBL3589	Homo sapiens	IC50	nM	
	1019513	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	Nc1ccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)cc1		CHEMBL362464	=	IC50	nM	50.0	CHEMBL3589	Homo sapiens	IC50	nM	50.0
	1019514	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	O=C(Nc1cccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)c1)c1ccc(F)cc1		CHEMBL176718	=	IC50	nM	200.0	CHEMBL3589	Homo sapiens	IC50	nM	200.0
	1019515	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	c1ccc(CN2CCC3CN(c4ncnc5oc(-c6cccnc6)nc45)CC32)cc1		CHEMBL369761	=	IC50	nM	130.0	CHEMBL3589	Homo sapiens	IC50	nM	130.0
	1022052	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	COCCNc1ncnc2oc(-c3ccccc3)nc12		CHEMBL177317	>	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	1022053	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	c1ccc(CN2CC[C@@H]3CN(c4ncnc5oc(-c6ccccc6)nc45)C[C@@H]32)cc1		CHEMBL175809	=	IC50	nM	120.0	CHEMBL3589	Homo sapiens	IC50	nM	120.0
	1022054	CHEMBL643545	Inhibitory activity against human adenosine kinase expressed in Escherichia coli	B	O=C(Nc1cccc(-c2nc3c(N4CC5CCN(Cc6ccccc6)C5C4)ncnc3o2)c1)c1ccc(C(F)(F)F)cc1		CHEMBL177314	>	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	1266873	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	CSc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL317927	=	IC50	nM	1350.0	CHEMBL3589	Homo sapiens	IC50	uM	1.35
	1266874	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(S)ncnc32)[C@H](O)[C@@H]1O		CHEMBL420640	=	IC50	nM	6500.0	CHEMBL3589	Homo sapiens	IC50	uM	6.5
	1268388	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(SCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL419517	=	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	uM	1.0
	1268389	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(SCc4ccc([N+](=O)[O-])cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL95482	=	IC50	nM	2000.0	CHEMBL3589	Homo sapiens	IC50	uM	2.0
	1269748	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	CC[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL95721	=	IC50	nM	500.0	CHEMBL3589	Homo sapiens	IC50	uM	0.5
	1272393	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL329724	=	IC50	nM	3.0	CHEMBL3589	Homo sapiens	IC50	uM	0.003
	1273546	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	COC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99359	=	IC50	nM	450.0	CHEMBL3589	Homo sapiens	IC50	uM	0.45
	1273547	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	NC(=O)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL101892	=	IC50	nM	470.0	CHEMBL3589	Homo sapiens	IC50	uM	0.47
	1274943	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	Cc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL318634	=	IC50	nM	16500.0	CHEMBL3589	Homo sapiens	IC50	uM	16.5
	1276210	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	CCOC(=O)c1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL95256	=	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	uM	1.0
	1277726	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL318043	=	IC50	nM	35.0	CHEMBL3589	Homo sapiens	IC50	uM	0.035
	1277727	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	Nc1ncnc2c1ccn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL267099	=	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	1282594	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	CSc1ncnc2c1c(I)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL95481	=	IC50	nM	45.0	CHEMBL3589	Homo sapiens	IC50	uM	0.045
	1283779	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	C=CCSc1ncnc2c1c(I)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL95608	=	IC50	nM	2800.0	CHEMBL3589	Homo sapiens	IC50	uM	2.8
	1283780	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	CCCCSc1ncnc2c1c(I)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL95211	=	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	uM	1.0
	1285062	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	CC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL97494	=	IC50	nM	60.0	CHEMBL3589	Homo sapiens	IC50	uM	0.06
	1286230	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	OC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL328824	=	IC50	nM	24.0	CHEMBL3589	Homo sapiens	IC50	uM	0.024
	1286231	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	CSc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(Cl)c12		CHEMBL318056	=	IC50	nM	70.0	CHEMBL3589	Homo sapiens	IC50	uM	0.07
	1286232	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	C=C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL97553	=	IC50	nM	100.0	CHEMBL3589	Homo sapiens	IC50	uM	0.1
	1287531	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	Nc1ncnc2c1c(Cl)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL98933	=	IC50	nM	210.0	CHEMBL3589	Homo sapiens	IC50	uM	0.21
	1287532	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL449407	=	IC50	nM	9.0	CHEMBL3589	Homo sapiens	IC50	uM	0.009
	1289001	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	NC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL322611	=	IC50	nM	0.6	CHEMBL3589	Homo sapiens	IC50	uM	0.0006
	1289003	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(C(N)=O)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98638	=	IC50	nM	460.0	CHEMBL3589	Homo sapiens	IC50	uM	0.46
	1290275	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	CNc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL319177	=	IC50	nM	1200.0	CHEMBL3589	Homo sapiens	IC50	uM	1.2
	1290276	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	NC[C@H]1O[C@@H](n2ccc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98641	=	IC50	nM	13000.0	CHEMBL3589	Homo sapiens	IC50	uM	13.0
	1291639	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(Br)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98910	=	IC50	nM	50.0	CHEMBL3589	Homo sapiens	IC50	uM	0.05
	1292896	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	COC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL322217	=	IC50	nM	1200.0	CHEMBL3589	Homo sapiens	IC50	uM	1.2
	1294243	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL97437	=	IC50	nM	63.0	CHEMBL3589	Homo sapiens	IC50	uM	0.063
	1295682	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98909	=	IC50	nM	40.0	CHEMBL3589	Homo sapiens	IC50	uM	0.04
	1295684	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	Cc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(Cl)c12		CHEMBL99662	=	IC50	nM	535.0	CHEMBL3589	Homo sapiens	IC50	uM	0.535
	1295685	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	NC[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99707	=	IC50	nM	0.2	CHEMBL3589	Homo sapiens	IC50	uM	0.0002
	1297114	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	Nc1ncnc2c1c(Br)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL62099	=	IC50	nM	120.0	CHEMBL3589	Homo sapiens	IC50	uM	0.12
	1297115	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(C#N)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99388	=	IC50	nM	310.0	CHEMBL3589	Homo sapiens	IC50	uM	0.31
	1298607	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	NC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL302376	=	IC50	nM	170.0	CHEMBL3589	Homo sapiens	IC50	uM	0.17
	1299857	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	IC50	nM	26.0	CHEMBL3589	Homo sapiens	IC50	uM	0.026
	1301235	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(Br)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99119	=	IC50	nM	100.0	CHEMBL3589	Homo sapiens	IC50	uM	0.1
	1302452	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL66280	=	IC50	nM	9.0	CHEMBL3589	Homo sapiens	IC50	uM	0.009
	1305505	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	NC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL330432	=	IC50	nM	0.1	CHEMBL3589	Homo sapiens	IC50	uM	0.0001
	1308256	CHEMBL642225	Inhibition of recombinant human adenosine kinase	B	N#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL99668	=	IC50	nM	310.0	CHEMBL3589	Homo sapiens	IC50	uM	0.31
	1443004	CHEMBL828146	In vitro inhibitory concentration against Adenosine kinase in cycstolic assay	B	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cnc12		CHEMBL182654	=	IC50	nM	460.0	CHEMBL3589	Homo sapiens	IC50	nM	460.0
	1443005	CHEMBL828146	In vitro inhibitory concentration against Adenosine kinase in cycstolic assay	B	c1ccc(CCNc2ncnc3nc(-c4ccc(N5CCOCC5)nc4)cnc23)cc1		CHEMBL359631	=	IC50	nM	120.0	CHEMBL3589	Homo sapiens	IC50	nM	120.0
	1443006	CHEMBL828146	In vitro inhibitory concentration against Adenosine kinase in cycstolic assay	B	c1ccc(CCCNc2ncnc3nc(-c4ccc(N5CCOCC5)nc4)cnc23)cc1		CHEMBL182969	=	IC50	nM	72.0	CHEMBL3589	Homo sapiens	IC50	nM	72.0
	1443007	CHEMBL828146	In vitro inhibitory concentration against Adenosine kinase in cycstolic assay	B	c1ccc(CCCCNc2ncnc3nc(-c4ccc(N5CCOCC5)nc4)cnc23)cc1		CHEMBL182321	=	IC50	nM	82.0	CHEMBL3589	Homo sapiens	IC50	nM	82.0
	1443008	CHEMBL828146	In vitro inhibitory concentration against Adenosine kinase in cycstolic assay	B	c1ccc2c(CCNc3ncnc4nc(-c5ccc(N6CCOCC6)nc5)cnc34)c[nH]c2c1		CHEMBL369112	=	IC50	nM	300.0	CHEMBL3589	Homo sapiens	IC50	nM	300.0
	1443009	CHEMBL828146	In vitro inhibitory concentration against Adenosine kinase in cycstolic assay	B	CN(C)c1ccc(C#Cc2[nH]cnc3nnc(-c4ccccc4)c2-3)cn1		CHEMBL362855	=	IC50	nM	100.0	CHEMBL3589	Homo sapiens	IC50	nM	100.0
	1443010	CHEMBL828146	In vitro inhibitory concentration against Adenosine kinase in cycstolic assay	B	CN(C)c1ccc(C#Cc2[nH]cnc3nnc(-c4cccc(Br)c4)c2-3)cn1		CHEMBL183671	=	IC50	nM	75.0	CHEMBL3589	Homo sapiens	IC50	nM	75.0
	1443011	CHEMBL828146	In vitro inhibitory concentration against Adenosine kinase in cycstolic assay	B	CN(C)c1ccc(C#Cc2ncnc3c2c(-c2cccc(Br)c2)nn3C)cn1		CHEMBL185372	=	IC50	nM	7.5	CHEMBL3589	Homo sapiens	IC50	nM	7.5
	1443012	CHEMBL828146	In vitro inhibitory concentration against Adenosine kinase in cycstolic assay	B	Brc1cccc(-c2[nH]nc3ncnc(C#Cc4ccc(N5CCOCC5)nc4)c23)c1		CHEMBL183535	=	IC50	nM	22.0	CHEMBL3589	Homo sapiens	IC50	nM	22.0
	1443013	CHEMBL828146	In vitro inhibitory concentration against Adenosine kinase in cycstolic assay	B	Cn1nc(-c2cccc(Br)c2)c2c(C#Cc3ccc(N4CCOCC4)nc3)ncnc21		CHEMBL181551	=	IC50	nM	82.0	CHEMBL3589	Homo sapiens	IC50	nM	82.0
	1443014	CHEMBL828146	In vitro inhibitory concentration against Adenosine kinase in cycstolic assay	B	Brc1cccc(-c2nn(Cc3ccccc3)c3ncnc(C#Cc4ccc(N5CCOCC5)nc4)c23)c1		CHEMBL363442	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1443015	CHEMBL828146	In vitro inhibitory concentration against Adenosine kinase in cycstolic assay	B	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nc2)c1Cc1cccc(Br)c1		CHEMBL120650	=	IC50	nM	22.0	CHEMBL3589	Homo sapiens	IC50	nM	22.0
	1443016	CHEMBL828146	In vitro inhibitory concentration against Adenosine kinase in cycstolic assay	B	Nc1ncnc2cc(-c3ccc(N4CCOCC4)nc3)n(Cc3ccccc3)c12		CHEMBL184909	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1443017	CHEMBL828146	In vitro inhibitory concentration against Adenosine kinase in cycstolic assay	B	CN(Cc1ccccc1)c1c(N)ncnc1C#Cc1ccc(N2CCOCC2)nc1		CHEMBL120976	=	IC50	nM	30.0	CHEMBL3589	Homo sapiens	IC50	nM	30.0
	1481496	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	CN(C)c1ccc(-c2nc3ncnc(N)c3cc2-c2cccc(Br)c2)cc1		CHEMBL189576	=	IC50	nM	70.0	CHEMBL3589	Homo sapiens	IC50	nM	70.0
	1481497	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	CN(C)c1ccc(-c2nc3ncnc(N)c3cc2-c2cccc(Br)c2)cc1		CHEMBL189576	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1481530	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	Cc1ccc(-c2cc3c(N)ncnc3nc2-c2ccc(-c3cncnc3)cc2)cc1		CHEMBL371857	=	IC50	nM	180.0	CHEMBL3589	Homo sapiens	IC50	nM	180.0
Not Determined	1481531	CHEMBL833541	Inhibitory concentration against Adenosine Kinase (intact cells); ND=not determined	B	Cc1ccc(-c2cc3c(N)ncnc3nc2-c2ccc(-c3cncnc3)cc2)cc1		CHEMBL371857		IC50	nM		CHEMBL3589	Homo sapiens	IC50	nM	
	1481628	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	COc1ccc(-c2cc3c(N)ncnc3nc2-c2ccc(N(C)C)cc2)cc1		CHEMBL302938	=	IC50	nM	92.0	CHEMBL3589	Homo sapiens	IC50	nM	92.0
	1481629	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	COc1ccc(-c2cc3c(N)ncnc3nc2-c2ccc(N(C)C)cc2)cc1		CHEMBL302938	=	IC50	nM	567.0	CHEMBL3589	Homo sapiens	IC50	nM	567.0
	1481641	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	COc1cccc(-c2cc3c(N)ncnc3nc2-c2ccc(N(C)C)cc2)c1		CHEMBL191526	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
Not Determined	1481642	CHEMBL833541	Inhibitory concentration against Adenosine Kinase (intact cells); ND=not determined	B	COc1cccc(-c2cc3c(N)ncnc3nc2-c2ccc(N(C)C)cc2)c1		CHEMBL191526		IC50	nM		CHEMBL3589	Homo sapiens	IC50	nM	
	1481759	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	COc1ccc(-c2cc3c(N)ncnc3nc2-c2ccc(N(C)C)cc2)cc1Br		CHEMBL192887	=	IC50	nM	33.0	CHEMBL3589	Homo sapiens	IC50	nM	33.0
	1481760	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	COc1ccc(-c2cc3c(N)ncnc3nc2-c2ccc(N(C)C)cc2)cc1Br		CHEMBL192887	=	IC50	nM	225.0	CHEMBL3589	Homo sapiens	IC50	nM	225.0
	1481781	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	COc1ccc(-c2cc3c(N)ncnc3nc2-c2ccc(N(C)C)cc2)cc1OC		CHEMBL191679	=	IC50	nM	45.0	CHEMBL3589	Homo sapiens	IC50	nM	45.0
	1481782	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	COc1ccc(-c2cc3c(N)ncnc3nc2-c2ccc(N(C)C)cc2)cc1OC		CHEMBL191679	=	IC50	nM	350.0	CHEMBL3589	Homo sapiens	IC50	nM	350.0
	1482019	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	CN(C)c1ccc(-c2nc3ncnc(N)c3cc2-c2ccccc2)cc1		CHEMBL150978	=	IC50	nM	350.0	CHEMBL3589	Homo sapiens	IC50	nM	350.0
	1482020	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	CN(C)c1ccc(-c2nc3ncnc(N)c3cc2-c2ccccc2)cc1		CHEMBL150978	=	IC50	nM	1500.0	CHEMBL3589	Homo sapiens	IC50	nM	1500.0
	1482032	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	CN(C)c1ccc(-c2nc3ncnc(N)c3cc2Cc2ccccc2)cc1		CHEMBL426992	=	IC50	nM	114.0	CHEMBL3589	Homo sapiens	IC50	nM	114.0
	1482033	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	CN(C)c1ccc(-c2nc3ncnc(N)c3cc2Cc2ccccc2)cc1		CHEMBL426992	=	IC50	nM	650.0	CHEMBL3589	Homo sapiens	IC50	nM	650.0
	1482044	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	CN(C)c1ccc(-c2nc3ncnc(N)c3cc2CCc2ccccc2)cc1		CHEMBL189971	=	IC50	nM	433.0	CHEMBL3589	Homo sapiens	IC50	nM	433.0
Not Determined	1482045	CHEMBL833541	Inhibitory concentration against Adenosine Kinase (intact cells); ND=not determined	B	CN(C)c1ccc(-c2nc3ncnc(N)c3cc2CCc2ccccc2)cc1		CHEMBL189971		IC50	nM		CHEMBL3589	Homo sapiens	IC50	nM	
	1482162	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	CN(C)c1ccc(-c2nc3ncnc(N)c3cc2CCCc2ccccc2)cc1		CHEMBL192754	=	IC50	nM	2230.0	CHEMBL3589	Homo sapiens	IC50	nM	2230.0
Not Determined	1482163	CHEMBL833541	Inhibitory concentration against Adenosine Kinase (intact cells); ND=not determined	B	CN(C)c1ccc(-c2nc3ncnc(N)c3cc2CCCc2ccccc2)cc1		CHEMBL192754		IC50	nM		CHEMBL3589	Homo sapiens	IC50	nM	
	1482174	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	CCCCCc1cc2c(N)ncnc2nc1-c1ccc(N(C)C)cc1		CHEMBL189632	=	IC50	nM	30.0	CHEMBL3589	Homo sapiens	IC50	nM	30.0
	1482175	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	CCCCCc1cc2c(N)ncnc2nc1-c1ccc(N(C)C)cc1		CHEMBL189632	=	IC50	nM	700.0	CHEMBL3589	Homo sapiens	IC50	nM	700.0
	1482453	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	CC(C)Cc1cc2c(N)ncnc2nc1-c1ccc(N(C)C)cc1		CHEMBL190400	=	IC50	nM	200.0	CHEMBL3589	Homo sapiens	IC50	nM	200.0
	1482454	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	CC(C)Cc1cc2c(N)ncnc2nc1-c1ccc(N(C)C)cc1		CHEMBL190400	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1482595	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	CN(C)c1ccc(-c2cc3c(N)ncnc3nc2-c2ccncc2)cc1		CHEMBL193223	=	IC50	nM	467.0	CHEMBL3589	Homo sapiens	IC50	nM	467.0
	1482596	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	CN(C)c1ccc(-c2cc3c(N)ncnc3nc2-c2ccncc2)cc1		CHEMBL193223	=	IC50	nM	4170.0	CHEMBL3589	Homo sapiens	IC50	nM	4170.0
	1482706	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	Cc1ccc(-c2cc3c(N)ncnc3nc2-c2ccc(/C=C/c3ccccn3)cc2)cc1		CHEMBL193122	=	IC50	nM	115.0	CHEMBL3589	Homo sapiens	IC50	nM	115.0
Not Determined	1482707	CHEMBL833541	Inhibitory concentration against Adenosine Kinase (intact cells); ND=not determined	B	Cc1ccc(-c2cc3c(N)ncnc3nc2-c2ccc(/C=C/c3ccccn3)cc2)cc1		CHEMBL193122		IC50	nM		CHEMBL3589	Homo sapiens	IC50	nM	
	1483233	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	CN(C)c1ccc(-c2cnc3c(N)ncnc3n2)cc1		CHEMBL66338	=	IC50	nM	440.0	CHEMBL3589	Homo sapiens	IC50	nM	440.0
	1483234	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	CN(C)c1ccc(-c2cnc3c(N)ncnc3n2)cc1		CHEMBL66338	=	IC50	nM	3600.0	CHEMBL3589	Homo sapiens	IC50	nM	3600.0
	1483251	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	CN(C)c1ccc(-c2ccc3c(N)ncnc3n2)cc1		CHEMBL303499	=	IC50	nM	773.0	CHEMBL3589	Homo sapiens	IC50	nM	773.0
	1483252	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	CN(C)c1ccc(-c2ccc3c(N)ncnc3n2)cc1		CHEMBL303499	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	nM	10000.0
	1483374	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	CN(C)c1ccc(-c2cc3c(N)ncnc3nc2-c2ccc(N(C)C)cc2)cc1		CHEMBL189480	=	IC50	nM	183.0	CHEMBL3589	Homo sapiens	IC50	nM	183.0
	1483375	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	CN(C)c1ccc(-c2cc3c(N)ncnc3nc2-c2ccc(N(C)C)cc2)cc1		CHEMBL189480	=	IC50	nM	367.0	CHEMBL3589	Homo sapiens	IC50	nM	367.0
	1483498	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	CN(C)c1ccc(-c2nc3ncnc(N)c3cc2-c2ccc(Br)cc2)cc1		CHEMBL191161	=	IC50	nM	20.0	CHEMBL3589	Homo sapiens	IC50	nM	20.0
	1483499	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	CN(C)c1ccc(-c2nc3ncnc(N)c3cc2-c2ccc(Br)cc2)cc1		CHEMBL191161	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
Not Determined	1483613	CHEMBL833541	Inhibitory concentration against Adenosine Kinase (intact cells); ND=not determined	B	Cc1ccc(-c2cc3c(N)ncnc3nc2-c2cc3ccccc3o2)cc1		CHEMBL190144		IC50	nM		CHEMBL3589	Homo sapiens	IC50	nM	
	1485315	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	Cc1ccc(-c2cc3c(N)ncnc3nc2-c2cc3ccccc3o2)cc1		CHEMBL190144	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1485698	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	COc1ccc(-c2cc3c(N)ncnc3nc2-c2cccs2)cc1OC		CHEMBL189575	=	IC50	nM	38.0	CHEMBL3589	Homo sapiens	IC50	nM	38.0
	1485709	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	COc1ccc(-c2cc3c(N)ncnc3nc2-c2cccs2)cc1OC		CHEMBL189575	=	IC50	nM	300.0	CHEMBL3589	Homo sapiens	IC50	nM	300.0
	1486083	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	COc1ccc(-c2cc3c(N)ncnc3nc2-c2cccs2)cc1Br		CHEMBL372666	=	IC50	nM	8.0	CHEMBL3589	Homo sapiens	IC50	nM	8.0
	1486293	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	Cc1ccc(-c2cc3c(N)ncnc3nc2-c2ccsc2)cc1		CHEMBL189161	=	IC50	nM	47.0	CHEMBL3589	Homo sapiens	IC50	nM	47.0
	1486294	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	Cc1ccc(-c2cc3c(N)ncnc3nc2-c2ccsc2)cc1		CHEMBL189161	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1486320	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	COc1ccc(-c2cc3c(N)ncnc3nc2-c2cccs2)cc1Br		CHEMBL372666	=	IC50	nM	375.0	CHEMBL3589	Homo sapiens	IC50	nM	375.0
	1486742	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	Nc1ncnc2nc(-c3nccs3)c(Cc3cccc(Br)c3)cc12		CHEMBL364732	=	IC50	nM	900.0	CHEMBL3589	Homo sapiens	IC50	nM	900.0
Not Determined	1486743	CHEMBL833541	Inhibitory concentration against Adenosine Kinase (intact cells); ND=not determined	B	Nc1ncnc2nc(-c3nccs3)c(Cc3cccc(Br)c3)cc12		CHEMBL364732		IC50	nM		CHEMBL3589	Homo sapiens	IC50	nM	
	1486950	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	Cc1ccc(-c2cc3c(N)ncnc3nc2-c2cccs2)cc1		CHEMBL193286	=	IC50	nM	9.0	CHEMBL3589	Homo sapiens	IC50	nM	9.0
	1487065	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	Cc1ccc(-c2cc3c(N)ncnc3nc2-c2cccs2)cc1		CHEMBL193286	=	IC50	nM	800.0	CHEMBL3589	Homo sapiens	IC50	nM	800.0
	1487826	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	CCCCc1cc2c(N)ncnc2nc1-c1cccs1		CHEMBL193253	=	IC50	nM	11.0	CHEMBL3589	Homo sapiens	IC50	nM	11.0
	1487827	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	CCCCc1cc2c(N)ncnc2nc1-c1cccs1		CHEMBL193253	=	IC50	nM	767.0	CHEMBL3589	Homo sapiens	IC50	nM	767.0
	1488297	CHEMBL877308	Inhibitory concentration against Adenosine Kinase (enzyme)	B	Nc1ncnc2nc(-c3cccs3)c(Cc3cccc(Br)c3)cc12		CHEMBL191309	=	IC50	nM	3.8	CHEMBL3589	Homo sapiens	IC50	nM	3.8
	1488298	CHEMBL829358	Inhibitory concentration against Adenosine Kinase (intact cells)	B	Nc1ncnc2nc(-c3cccs3)c(Cc3cccc(Br)c3)cc12		CHEMBL191309	=	IC50	nM	650.0	CHEMBL3589	Homo sapiens	IC50	nM	650.0
	1507028	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL100421	=	IC50	nM	0.5	CHEMBL3589	Homo sapiens	IC50	uM	0.0005
	1507029	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	C[C@H]1O[C@@H](n2c(Br)c(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL328826	=	IC50	nM	1.0	CHEMBL3589	Homo sapiens	IC50	uM	0.001
	1507030	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(N4CCc5ccccc54)ncnc32)[C@H](O)[C@@H]1O		CHEMBL189105	=	IC50	nM	51.0	CHEMBL3589	Homo sapiens	IC50	uM	0.051
	1507031	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	NC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL302376	=	IC50	nM	170.0	CHEMBL3589	Homo sapiens	IC50	uM	0.17
	1507032	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	OC[C@H]1O[C@@H](n2cnc3c(N4CCc5ccccc54)ncnc32)[C@H](O)[C@@H]1O		CHEMBL191760	=	IC50	nM	500.0	CHEMBL3589	Homo sapiens	IC50	uM	0.5
	1507033	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	OC[C@H]1O[C@@H](n2c(Nc3ccccc3)nc3c(N4CCc5ccccc54)ncnc32)[C@H](O)[C@@H]1O		CHEMBL364496	=	IC50	nM	19.0	CHEMBL3589	Homo sapiens	IC50	uM	0.019
	1507034	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	OC[C@H]1O[C@@H](n2c(Nc3ccccc3)nc3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL192504	=	IC50	nM	90.0	CHEMBL3589	Homo sapiens	IC50	uM	0.09
	1507035	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	C[C@H]1O[C@@H](n2c(Nc3ccccc3)nc3c(N4CCc5ccccc54)ncnc32)[C@H](O)[C@@H]1O		CHEMBL193065	=	IC50	nM	200.0	CHEMBL3589	Homo sapiens	IC50	uM	0.2
	1507036	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	OC[C@H]1O[C@@H](n2c(N3CCc4ccccc43)nc3c(N4CCc5ccccc54)ncnc32)[C@H](O)[C@@H]1O		CHEMBL373129	=	IC50	nM	2000.0	CHEMBL3589	Homo sapiens	IC50	uM	2.0
	1507037	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	OC[C@H]1O[C@@H](n2c(N3CCc4ccccc43)nc3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL193246	=	IC50	nM	7100.0	CHEMBL3589	Homo sapiens	IC50	uM	7.1
	1507038	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	OC[C@H]1O[C@@H](n2c(Cl)nc3c(N4CCc5ccccc54)ncnc32)[C@H](O)[C@@H]1O		CHEMBL193265	=	IC50	nM	480.0	CHEMBL3589	Homo sapiens	IC50	uM	0.48
	1507039	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	OC[C@H]1O[C@@H](n2c(Cl)nc3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL192259	=	IC50	nM	3600.0	CHEMBL3589	Homo sapiens	IC50	uM	3.6
	1507040	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	OC[C@H]1O[C@@H](n2c(I)nc3c(N4CCc5ccccc54)ncnc32)[C@H](O)[C@@H]1O		CHEMBL189781	=	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	uM	1.0
	1507041	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	OC[C@H]1O[C@@H](n2c(I)nc3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL364457	=	IC50	nM	4500.0	CHEMBL3589	Homo sapiens	IC50	uM	4.5
	1507042	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	CSc1nc2c(N3CCc4ccccc43)ncnc2n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL192903	=	IC50	nM	150.0	CHEMBL3589	Homo sapiens	IC50	uM	0.15
	1507043	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	CSc1nc2c(Nc3ccccc3)ncnc2n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL192727	=	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	uM	1.0
	1507044	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	CCc1nc2c(N3CCc4ccccc43)ncnc2n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL371350	=	IC50	nM	230.0	CHEMBL3589	Homo sapiens	IC50	uM	0.23
	1507045	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	C=Cc1nc2c(N3CCc4ccccc43)ncnc2n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL362987	=	IC50	nM	60.0	CHEMBL3589	Homo sapiens	IC50	uM	0.06
	1507046	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	C=Cc1nc2c(Nc3ccccc3)ncnc2n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL189106	=	IC50	nM	300.0	CHEMBL3589	Homo sapiens	IC50	uM	0.3
	1507047	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	C#Cc1nc2c(N3CCc4ccccc43)ncnc2n1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL193175	=	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	uM	1.0
	1507048	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	OC[C@H]1O[C@@H](n2c(-c3ccco3)nc3c(N4CCc5ccccc54)ncnc32)[C@H](O)[C@@H]1O		CHEMBL363354	=	IC50	nM	2900.0	CHEMBL3589	Homo sapiens	IC50	uM	2.9
	1508696	CHEMBL876476	Inhibitory activity against Human Recombinant Adenosine Kinase	B	OC[C@H]1O[C@@H](n2c(-c3ccco3)nc3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL363215	=	IC50	nM	6900.0	CHEMBL3589	Homo sapiens	IC50	uM	6.9
	1612791	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	IC50	nM	26.0	CHEMBL3589	Homo sapiens	IC50	nM	26.0
	1612792	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL66280	=	IC50	nM	9.0	CHEMBL3589	Homo sapiens	IC50	nM	9.0
	1612793	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@@H](CO)[C@@H](O)[C@H]1O		CHEMBL356952	=	IC50	nM	68.0	CHEMBL3589	Homo sapiens	IC50	nM	68.0
	1612794	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	C[C@@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL145388	=	IC50	nM	400.0	CHEMBL3589	Homo sapiens	IC50	nM	400.0
	1612795	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	OC[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL319315	=	IC50	nM	0.8	CHEMBL3589	Homo sapiens	IC50	nM	0.8
	1612797	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL100421	=	IC50	nM	0.5	CHEMBL3589	Homo sapiens	IC50	nM	0.5
	1612799	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	OC[C@@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL343247	=	IC50	nM	0.47	CHEMBL3589	Homo sapiens	IC50	nM	0.47
	1612801	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	C[C@@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL436598	=	IC50	nM	0.8	CHEMBL3589	Homo sapiens	IC50	nM	0.8
	1612802	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	Nc1ncnc2c1c(I)cn2[C@@H]1OC2(CC2)[C@@H](O)[C@H]1O		CHEMBL373104	=	IC50	nM	600.0	CHEMBL3589	Homo sapiens	IC50	nM	600.0
	1612803	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	Nc1ncnc2c1c(I)cn2[C@@H]1OC[C@@H](O)[C@H]1O		CHEMBL194952	=	IC50	nM	6.0	CHEMBL3589	Homo sapiens	IC50	nM	6.0
	1612805	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	O[C@H]1[C@@H](O)[C@H](n2cc(-c3ccccc3)c3c(Nc4ccc(F)cc4)ncnc32)OC12CC2		CHEMBL194294	=	IC50	nM	0.3	CHEMBL3589	Homo sapiens	IC50	nM	0.3
	1612806	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	CC1(C)O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL364265	=	IC50	nM	4000.0	CHEMBL3589	Homo sapiens	IC50	nM	4000.0
	1612807	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	O[C@@H]1CO[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@@H]1O		CHEMBL373218	=	IC50	nM	4.0	CHEMBL3589	Homo sapiens	IC50	nM	4.0
	1612809	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	O[C@@H]1CO[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccc(F)cc4)ncnc32)[C@@H]1O		CHEMBL197801	=	IC50	nM	6.0	CHEMBL3589	Homo sapiens	IC50	nM	6.0
	1612843	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	O[C@@H]1CO[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccc(Br)cc4)ncnc32)[C@@H]1O		CHEMBL381682	=	IC50	nM	5.0	CHEMBL3589	Homo sapiens	IC50	nM	5.0
	1612845	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	CCOc1ccc(Nc2ncnc3c2c(-c2ccccc2)cn3[C@@H]2OC[C@@H](O)[C@H]2O)cc1		CHEMBL197756	=	IC50	nM	3.0	CHEMBL3589	Homo sapiens	IC50	nM	3.0
	1612847	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	CCOc1cccc(Nc2ncnc3c2c(-c2ccccc2)cn3[C@@H]2OC[C@@H](O)[C@H]2O)c1		CHEMBL371704	=	IC50	nM	2.0	CHEMBL3589	Homo sapiens	IC50	nM	2.0
	1612850	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	O[C@@H]1CO[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccc5c(c4)OCCO5)ncnc32)[C@@H]1O		CHEMBL364049	=	IC50	nM	4.0	CHEMBL3589	Homo sapiens	IC50	nM	4.0
	1612853	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	Nc1cccc(-c2cn([C@@H]3OC[C@@H](O)[C@H]3O)c3ncnc(Nc4ccc(F)cc4)c23)c1		CHEMBL380998	=	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	1612855	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	CCOc1ccc(-c2cn([C@@H]3OC[C@@H](O)[C@H]3O)c3ncnc(Nc4ccc(C#N)cc4)c23)cc1		CHEMBL435120	=	IC50	nM	2.0	CHEMBL3589	Homo sapiens	IC50	nM	2.0
	1612859	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	N#Cc1ccc(Nc2ncnc3c2c(-c2ccc(Cl)cc2)cn3[C@@H]2OC[C@@H](O)[C@H]2O)cc1		CHEMBL198143	=	IC50	nM	7.0	CHEMBL3589	Homo sapiens	IC50	nM	7.0
	1612862	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	Cc1ccccc1-c1cn([C@@H]2OC[C@@H](O)[C@H]2O)c2ncnc(Nc3ccc4c(c3)OCCO4)c12		CHEMBL370218	=	IC50	nM	1.0	CHEMBL3589	Homo sapiens	IC50	nM	1.0
	1612865	CHEMBL872316	Inhibitory concentration against human recombinant adenosine kinase using [14C]AMP as radioligand	B	CCOc1ccc(-c2cn([C@@H]3OC[C@@H](O)[C@H]3O)c3ncnc(Nc4ccccc4OC)c23)cc1		CHEMBL196483	=	IC50	nM	5.3	CHEMBL3589	Homo sapiens	IC50	nM	5.3
	1656974	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL100421	=	IC50	nM	0.5	CHEMBL3589	Homo sapiens	IC50	uM	0.0005
	1656976	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	O=C(CNc1ncnc2c1c(-c1ccccc1)nn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)Nc1ccccc1		CHEMBL198566	=	IC50	nM	0.9	CHEMBL3589	Homo sapiens	IC50	uM	0.0009
	1656977	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	O=C(CNc1ncnc2c1c(-c1ccccc1)nn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)NC1CC1		CHEMBL200457	=	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	uM	0.01
	1656978	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2nc(-c3ccccc3)c3c(NCC(=O)NC4CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL436096	=	IC50	nM	6.0	CHEMBL3589	Homo sapiens	IC50	uM	0.006
	1656979	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	O=C(CNc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1OC[C@@H](O)[C@H]1O)Nc1ccccc1		CHEMBL200169	=	IC50	nM	0.6	CHEMBL3589	Homo sapiens	IC50	uM	0.0006
	1656980	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	O=C(CNc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1OC[C@@H](O)[C@H]1O)NC1CC1		CHEMBL200196	=	IC50	nM	20.0	CHEMBL3589	Homo sapiens	IC50	uM	0.02
	1656981	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	O=C(CNc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O)NC1CC1		CHEMBL198635	=	IC50	nM	3.0	CHEMBL3589	Homo sapiens	IC50	uM	0.003
	1656982	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	O=C(CNc1ncnc2c1c(-c1ccccc1)cn2COCCO)Nc1ccc(Cl)cc1		CHEMBL199371	=	IC50	nM	60.0	CHEMBL3589	Homo sapiens	IC50	uM	0.06
	1656983	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	O=C(CNc1ncnc2c1c(-c1ccccc1)cn2COCCO)NC1CC1		CHEMBL383388	=	IC50	nM	1700.0	CHEMBL3589	Homo sapiens	IC50	uM	1.7
	1656984	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	O=C(CNc1[nH]cnc2ncc(-c3ccccc3)c1-2)NC1CC1		CHEMBL371549	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	1656985	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(NCC(=O)NC4CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL200352	=	IC50	nM	880.0	CHEMBL3589	Homo sapiens	IC50	uM	0.88
	1656986	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NCCC(N)=O)ncnc32)[C@H](O)[C@@H]1O		CHEMBL371924	=	IC50	nM	2500.0	CHEMBL3589	Homo sapiens	IC50	uM	2.5
	1656987	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NCC(=O)N(C)C4CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL372155	=	IC50	nM	460.0	CHEMBL3589	Homo sapiens	IC50	uM	0.46
	1656988	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@@H](Nc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O)C(=O)NC1CC1		CHEMBL382751	=	IC50	nM	2500.0	CHEMBL3589	Homo sapiens	IC50	uM	2.5
	1656989	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H](Nc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O)C(=O)NC1CC1		CHEMBL200393	=	IC50	nM	530.0	CHEMBL3589	Homo sapiens	IC50	uM	0.53
	1656990	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NC(=O)C(=O)NC4CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL372796	=	IC50	nM	1.3	CHEMBL3589	Homo sapiens	IC50	uM	0.0013
	1656991	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NC/C(S)=N\C4CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL370011	=	IC50	nM	0.5	CHEMBL3589	Homo sapiens	IC50	uM	0.0005
	1656992	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	CCN(CC)CCNC(=O)CNc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL198698	=	IC50	nM	210.0	CHEMBL3589	Homo sapiens	IC50	uM	0.21
	1656993	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NCC(=O)NCCCN(C)C)ncnc32)[C@H](O)[C@@H]1O		CHEMBL382911	=	IC50	nM	145.0	CHEMBL3589	Homo sapiens	IC50	uM	0.145
	1656994	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NCC(=O)NCCN(C)C)ncnc32)[C@H](O)[C@@H]1O		CHEMBL382451	=	IC50	nM	300.0	CHEMBL3589	Homo sapiens	IC50	uM	0.3
	1656995	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	COCCCNC(=O)CNc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL200575	=	IC50	nM	2.0	CHEMBL3589	Homo sapiens	IC50	uM	0.002
	1656996	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NCC(=O)NCCCO)ncnc32)[C@H](O)[C@@H]1O		CHEMBL197072	=	IC50	nM	16.0	CHEMBL3589	Homo sapiens	IC50	uM	0.016
	1656997	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	COCCNC(=O)CNc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL371950	=	IC50	nM	38.0	CHEMBL3589	Homo sapiens	IC50	uM	0.038
	1656998	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	CCONC(=O)CNc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL438796	=	IC50	nM	5.0	CHEMBL3589	Homo sapiens	IC50	uM	0.005
	1656999	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NCC(=O)Nc4ccc(Cl)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL370164	=	IC50	nM	0.2	CHEMBL3589	Homo sapiens	IC50	uM	0.0002
	1657000	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NCC(=O)Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL426472	=	IC50	nM	0.5	CHEMBL3589	Homo sapiens	IC50	uM	0.0005
	1657001	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NCC(=O)NC4CCCC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL438449	=	IC50	nM	1.0	CHEMBL3589	Homo sapiens	IC50	uM	0.001
	1657002	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NCC(=O)NC4CCC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL370654	=	IC50	nM	1.3	CHEMBL3589	Homo sapiens	IC50	uM	0.0013
	1657003	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NCC(=O)NCC4CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL381229	=	IC50	nM	6.0	CHEMBL3589	Homo sapiens	IC50	uM	0.006
	1657004	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	CC(C)CNC(=O)CNc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL371044	=	IC50	nM	4.0	CHEMBL3589	Homo sapiens	IC50	uM	0.004
	1657005	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	CC(C)NC(=O)CNc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL425752	=	IC50	nM	25.0	CHEMBL3589	Homo sapiens	IC50	uM	0.025
	1657006	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	CCNC(=O)CNc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL381407	=	IC50	nM	40.0	CHEMBL3589	Homo sapiens	IC50	uM	0.04
	1657007	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	CNC(=O)CNc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL200630	=	IC50	nM	0.8	CHEMBL3589	Homo sapiens	IC50	uM	0.0008
	1657008	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	CCCNC(=O)CNc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL200219	=	IC50	nM	7.0	CHEMBL3589	Homo sapiens	IC50	uM	0.007
	1657009	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NCC(=O)NC4CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL371909	=	IC50	nM	3.0	CHEMBL3589	Homo sapiens	IC50	uM	0.003
	1657010	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NCC(N)=O)ncnc32)[C@H](O)[C@@H]1O		CHEMBL197112	=	IC50	nM	2.0	CHEMBL3589	Homo sapiens	IC50	uM	0.002
	1657011	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NCC4CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL200620	=	IC50	nM	45.0	CHEMBL3589	Homo sapiens	IC50	uM	0.045
	1657012	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	CC(C)CNc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL196955	=	IC50	nM	140.0	CHEMBL3589	Homo sapiens	IC50	uM	0.14
	1657013	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	CCCNc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL198742	=	IC50	nM	100.0	CHEMBL3589	Homo sapiens	IC50	uM	0.1
	1657014	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NC4CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL381005	=	IC50	nM	380.0	CHEMBL3589	Homo sapiens	IC50	uM	0.38
	1657015	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	CCCOC(=O)Nc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL435123	=	IC50	nM	4.0	CHEMBL3589	Homo sapiens	IC50	uM	0.004
	1657016	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	CNC(=O)Nc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL198972	=	IC50	nM	27.0	CHEMBL3589	Homo sapiens	IC50	uM	0.027
	1657017	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(NC4CCCCC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98174	=	IC50	nM	1200.0	CHEMBL3589	Homo sapiens	IC50	uM	1.2
	1657018	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL329484	=	IC50	nM	320.0	CHEMBL3589	Homo sapiens	IC50	uM	0.32
	1657019	CHEMBL864546	Inhibitory activity against recombinant human adenosine kinase	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL66277	=	IC50	nM	1.5	CHEMBL3589	Homo sapiens	IC50	uM	0.0015
	1778474	CHEMBL912349	Inhibition of human cytosolic AK	B	C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL66280	=	IC50	nM	0.9	CHEMBL3589	Homo sapiens	IC50	nM	0.9
	1778475	CHEMBL912349	Inhibition of human cytosolic AK	B	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nc2)c1CCCc1ccccc1		CHEMBL338508	=	IC50	nM	2.5	CHEMBL3589	Homo sapiens	IC50	nM	2.5
	1778476	CHEMBL912349	Inhibition of human cytosolic AK	B	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nc2)c1Cc1ccccc1		CHEMBL420879	=	IC50	nM	40.0	CHEMBL3589	Homo sapiens	IC50	nM	40.0
	1778477	CHEMBL912349	Inhibition of human cytosolic AK	B	Nc1cc(C#Cc2ccc(N3CCOCC3)nc2)ncn1		CHEMBL119839	=	IC50	nM	120.0	CHEMBL3589	Homo sapiens	IC50	nM	120.0
	1778478	CHEMBL912349	Inhibition of human cytosolic AK	B	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccc3c(c2)OCO3)cc1		CHEMBL386316	=	IC50	nM	9.0	CHEMBL3589	Homo sapiens	IC50	nM	9.0
	1778479	CHEMBL912349	Inhibition of human cytosolic AK	B	Cc1nc(N)c(-c2ccccc2)c(C#Cc2ccc(N(C)C)cc2)n1		CHEMBL276470	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1778480	CHEMBL912349	Inhibition of human cytosolic AK	B	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccccc2)cc1		CHEMBL216119	=	IC50	nM	20.0	CHEMBL3589	Homo sapiens	IC50	nM	20.0
	1778481	CHEMBL912349	Inhibition of human cytosolic AK	B	CN(C)c1ccc(-c2c(N)ncnc2C#Cc2ccc(N3CCOCC3)nc2)cc1		CHEMBL216697	=	IC50	nM	68.0	CHEMBL3589	Homo sapiens	IC50	nM	68.0
	1873825	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccccc2)cc1		CHEMBL216119	=	IC50	nM	20.0	CHEMBL3589	Homo sapiens	IC50	nM	20.0
	1873826	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	COCCN(C)c1cc(N2CCOCC2)ncc1C#Cc1ncnc(N)c1-c1ccc2c(c1)OCO2		CHEMBL225680	=	IC50	nM	101.0	CHEMBL3589	Homo sapiens	IC50	nM	101.0
	1873827	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CC(C)NC(=O)Nc1cc(C#Cc2ncnc(N)c2-c2ccc3c(c2)OCO3)cnc1N1CCOCC1		CHEMBL225679	=	IC50	nM	18.0	CHEMBL3589	Homo sapiens	IC50	nM	18.0
	1873828	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1cc(N2CCOCC2)ncc1C#Cc1ncnc(N)c1-c1ccc2c(c1)OCO2		CHEMBL225678	=	IC50	nM	72.0	CHEMBL3589	Homo sapiens	IC50	nM	72.0
	1873829	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1cc(C#Cc2ncnc(N)c2-c2ccc3c(c2)OCO3)cnc1N1CCOCC1		CHEMBL376844	=	IC50	nM	26.0	CHEMBL3589	Homo sapiens	IC50	nM	26.0
	1873830	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nc2)c1-c1cc2ccccc2o1		CHEMBL449402	=	IC50	nM	1.0	CHEMBL3589	Homo sapiens	IC50	nM	1.0
	1873831	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nc2)c1-c1cc2ccccc2s1		CHEMBL226486	=	IC50	nM	0.4	CHEMBL3589	Homo sapiens	IC50	nM	0.4
	1873832	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nc2)c1-c1ccsc1		CHEMBL226428	=	IC50	nM	38.0	CHEMBL3589	Homo sapiens	IC50	nM	38.0
	1873833	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nc2)c1-c1cccs1		CHEMBL225782	=	IC50	nM	13.0	CHEMBL3589	Homo sapiens	IC50	nM	13.0
	1873834	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(-c2c(N)ncnc2C#Cc2ccc(N3CCOCC3)nc2)cc1		CHEMBL216697	=	IC50	nM	2.0	CHEMBL3589	Homo sapiens	IC50	nM	2.0
	1873835	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nc2)c1-c1ccc2c(c1)OCO2		CHEMBL375255	=	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	1873836	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2ccc(N3CCCCC3)nc2)c1-c1ccc(Cl)cc1		CHEMBL225781	=	IC50	nM	9.0	CHEMBL3589	Homo sapiens	IC50	nM	9.0
	1873837	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CC(=O)N1CCN(c2ccc(C#Cc3ncnc(N)c3-c3ccc(Cl)cc3)cn2)CC1		CHEMBL225729	=	IC50	nM	1.0	CHEMBL3589	Homo sapiens	IC50	nM	1.0
	1873838	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CC(C)(C)OC(=O)N1CCN(c2ccc(C#Cc3ncnc(N)c3-c3ccc(Cl)cc3)cn2)CC1		CHEMBL225728	=	IC50	nM	62.0	CHEMBL3589	Homo sapiens	IC50	nM	62.0
	1873839	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)S(=O)(=O)N1CCN(c2ccc(C#Cc3ncnc(N)c3-c3ccc(Cl)cc3)cn2)CC1		CHEMBL225727	=	IC50	nM	6.0	CHEMBL3589	Homo sapiens	IC50	nM	6.0
	1873840	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	COCCN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccc(Cl)cc2)cn1		CHEMBL225672	=	IC50	nM	1.0	CHEMBL3589	Homo sapiens	IC50	nM	1.0
	1873841	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nc2)c1-c1ccc(Cl)cc1		CHEMBL225671	=	IC50	nM	3.0	CHEMBL3589	Homo sapiens	IC50	nM	3.0
	1873842	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccc(Cl)cc2)cn1		CHEMBL225670	=	IC50	nM	6.0	CHEMBL3589	Homo sapiens	IC50	nM	6.0
	1873843	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ccc(C#Cc2ncnc(N)c2-c2ccc(Cl)cc2)cn1		CHEMBL225887	=	IC50	nM	14.0	CHEMBL3589	Homo sapiens	IC50	nM	14.0
	1873844	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2cncc(N3CCOCC3)c2)c1-c1ccc(Cl)cc1		CHEMBL225886	=	IC50	nM	8.0	CHEMBL3589	Homo sapiens	IC50	nM	8.0
	1873845	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nn2)c1-c1ccc(Cl)cc1		CHEMBL225834	=	IC50	nM	45.0	CHEMBL3589	Homo sapiens	IC50	nM	45.0
	1873846	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2cnc(N3CCOCC3)nc2)c1-c1ccc(Cl)cc1		CHEMBL438476	=	IC50	nM	8.0	CHEMBL3589	Homo sapiens	IC50	nM	8.0
	1873847	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2ccc(N3CCOCC3)cc2)c1-c1ccc(Cl)cc1		CHEMBL225833	=	IC50	nM	17.0	CHEMBL3589	Homo sapiens	IC50	nM	17.0
	1873848	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ccc(C#Cc2ncnc(N)c2-c2ccc(Cl)cc2)cc1		CHEMBL387486	=	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	1873849	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2ccc([N+](=O)[O-])cc2)c1-c1ccc(Cl)cc1		CHEMBL225774	=	IC50	nM	43.0	CHEMBL3589	Homo sapiens	IC50	nM	43.0
	1873850	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2cccs2)c1-c1ccc(Cl)cc1		CHEMBL225773	=	IC50	nM	43.0	CHEMBL3589	Homo sapiens	IC50	nM	43.0
	1873851	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2ccccn2)c1-c1ccc(Cl)cc1		CHEMBL225722	=	IC50	nM	500.0	CHEMBL3589	Homo sapiens	IC50	nM	500.0
	1873852	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2cncnc2)c1-c1ccc(Cl)cc1		CHEMBL375060	=	IC50	nM	216.0	CHEMBL3589	Homo sapiens	IC50	nM	216.0
	1873853	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CC(C)c1ccc(C#Cc2ncnc(N)c2-c2ccc(Cl)cc2)cc1		CHEMBL225877	=	IC50	nM	50.0	CHEMBL3589	Homo sapiens	IC50	nM	50.0
	1873854	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Cc1ccc(C#Cc2ncnc(N)c2-c2ccc(Cl)cc2)cc1		CHEMBL390827	=	IC50	nM	25.0	CHEMBL3589	Homo sapiens	IC50	nM	25.0
	1873855	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Nc1ncnc(C#Cc2ccccc2)c1-c1ccc(Cl)cc1		CHEMBL225707	=	IC50	nM	60.0	CHEMBL3589	Homo sapiens	IC50	nM	60.0
	1873856	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2cccc(N)c2)cc1		CHEMBL225706	=	IC50	nM	90.0	CHEMBL3589	Homo sapiens	IC50	nM	90.0
	1873857	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2cccc([N+](=O)[O-])c2)cc1		CHEMBL375294	=	IC50	nM	16.0	CHEMBL3589	Homo sapiens	IC50	nM	16.0
	1873858	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CC(C)c1ccc(-c2c(N)ncnc2C#Cc2ccc(N(C)C)cc2)cc1		CHEMBL225705	=	IC50	nM	22.0	CHEMBL3589	Homo sapiens	IC50	nM	22.0
	1873859	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	COc1ccc(-c2c(N)ncnc2C#Cc2ccc(N(C)C)cc2)cc1OC		CHEMBL226515	=	IC50	nM	20.0	CHEMBL3589	Homo sapiens	IC50	nM	20.0
	1873860	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	COc1ccc(-c2c(N)ncnc2C#Cc2ccc(N(C)C)cc2)cc1		CHEMBL388192	=	IC50	nM	18.0	CHEMBL3589	Homo sapiens	IC50	nM	18.0
	1873861	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Cc1ccc(-c2c(N)ncnc2C#Cc2ccc(N(C)C)cc2)cc1		CHEMBL225696	=	IC50	nM	13.0	CHEMBL3589	Homo sapiens	IC50	nM	13.0
	1873862	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccc(Br)cc2)cc1		CHEMBL225695	=	IC50	nM	3.0	CHEMBL3589	Homo sapiens	IC50	nM	3.0
	1873863	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2cccc(Cl)c2)cc1		CHEMBL389409	=	IC50	nM	10.0	CHEMBL3589	Homo sapiens	IC50	nM	10.0
	1873864	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccccc2Cl)cc1		CHEMBL225694	=	IC50	nM	75.0	CHEMBL3589	Homo sapiens	IC50	nM	75.0
	1873865	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N3CCN(S(=O)(=O)N(C)C)CC3)c2-c2ccc(Cl)cc2)cc1		CHEMBL226505	=	IC50	nM	13.0	CHEMBL3589	Homo sapiens	IC50	nM	13.0
	1873866	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N3CCNCC3)c2-c2ccc(Cl)cc2)cc1		CHEMBL226504	=	IC50	nM	8.0	CHEMBL3589	Homo sapiens	IC50	nM	8.0
	1873867	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N3CCOCC3)c2-c2ccc(Cl)cc2)cc1		CHEMBL387630	=	IC50	nM	6.0	CHEMBL3589	Homo sapiens	IC50	nM	6.0
	1873868	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(NCCc3c[nH]c4ccccc34)c2-c2ccc(Cl)cc2)cc1		CHEMBL226503	=	IC50	nM	38.0	CHEMBL3589	Homo sapiens	IC50	nM	38.0
	1873869	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(NCCc3c[nH]cn3)c2-c2ccc(Cl)cc2)cc1		CHEMBL387629	=	IC50	nM	80.0	CHEMBL3589	Homo sapiens	IC50	nM	80.0
	1873870	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(NC3CCCCC3)c2-c2ccc(Cl)cc2)cc1		CHEMBL226451	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873871	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N(C)C)c2-c2ccc(Cl)cc2)cc1		CHEMBL226450	=	IC50	nM	300.0	CHEMBL3589	Homo sapiens	IC50	nM	300.0
	1873872	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CNc1ncnc(C#Cc2ccc(N(C)C)cc2)c1-c1ccc(Cl)cc1		CHEMBL427272	=	IC50	nM	14.0	CHEMBL3589	Homo sapiens	IC50	nM	14.0
	1873873	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2c(N)ncnc2-c2ccc(N(C)C)cc2)cc1		CHEMBL387628	=	IC50	nM	100.0	CHEMBL3589	Homo sapiens	IC50	nM	100.0
	1873874	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2cc(NCc3ccccc3)ncn2)cc1		CHEMBL226449	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873875	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2cc(N)ncn2)cc1		CHEMBL425305	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873876	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	C#Cc1ncnc(N)c1-c1ccc2c(c1)OCO2		CHEMBL226394	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873877	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	Cc1nc(N)c(-c2ccccc2)c(C#Cc2ccc(N(C)C)cc2)n1		CHEMBL276470	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873878	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N)c2C(c2ccccc2)c2ccccc2)cc1		CHEMBL376831	=	IC50	nM	600.0	CHEMBL3589	Homo sapiens	IC50	nM	600.0
	1873879	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N)c2Cc2ccccc2)cc1		CHEMBL226393	=	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873880	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N)c2C2CCCCC2)cc1		CHEMBL376830	=	IC50	nM	300.0	CHEMBL3589	Homo sapiens	IC50	nM	300.0
	1873881	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccc3c(c2)OCO3)cc1		CHEMBL386316	=	IC50	nM	9.0	CHEMBL3589	Homo sapiens	IC50	nM	9.0
	1873882	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccc(N(C)C)cc2)cc1		CHEMBL226392	=	IC50	nM	5.0	CHEMBL3589	Homo sapiens	IC50	nM	5.0
	1873883	CHEMBL903819	Inhibition of cytosolic adenosine kinase	B	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccc(Cl)cc2)cc1		CHEMBL225633	=	IC50	nM	3.0	CHEMBL3589	Homo sapiens	IC50	nM	3.0
	1873884	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccc(Cl)cc2)cc1		CHEMBL225633	=	IC50	nM	700.0	CHEMBL3589	Homo sapiens	IC50	nM	700.0
	1873885	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	COCCN(C)c1cc(N2CCOCC2)ncc1C#Cc1ncnc(N)c1-c1ccc2c(c1)OCO2		CHEMBL225680	=	IC50	nM	198.0	CHEMBL3589	Homo sapiens	IC50	nM	198.0
	1873886	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CC(C)NC(=O)Nc1cc(C#Cc2ncnc(N)c2-c2ccc3c(c2)OCO3)cnc1N1CCOCC1		CHEMBL225679	=	IC50	nM	88.0	CHEMBL3589	Homo sapiens	IC50	nM	88.0
	1873887	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1cc(N2CCOCC2)ncc1C#Cc1ncnc(N)c1-c1ccc2c(c1)OCO2		CHEMBL225678	=	IC50	nM	215.0	CHEMBL3589	Homo sapiens	IC50	nM	215.0
	1873888	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1cc(C#Cc2ncnc(N)c2-c2ccc3c(c2)OCO3)cnc1N1CCOCC1		CHEMBL376844	=	IC50	nM	161.0	CHEMBL3589	Homo sapiens	IC50	nM	161.0
	1873889	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nc2)c1-c1cc2ccccc2o1		CHEMBL449402	=	IC50	nM	123.0	CHEMBL3589	Homo sapiens	IC50	nM	123.0
	1873890	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nc2)c1-c1cc2ccccc2s1		CHEMBL226486	=	IC50	nM	100.0	CHEMBL3589	Homo sapiens	IC50	nM	100.0
	1873891	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nc2)c1-c1ccsc1		CHEMBL226428	=	IC50	nM	212.0	CHEMBL3589	Homo sapiens	IC50	nM	212.0
	1873892	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nc2)c1-c1cccs1		CHEMBL225782	=	IC50	nM	167.0	CHEMBL3589	Homo sapiens	IC50	nM	167.0
	1873893	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(-c2c(N)ncnc2C#Cc2ccc(N3CCOCC3)nc2)cc1		CHEMBL216697	=	IC50	nM	68.0	CHEMBL3589	Homo sapiens	IC50	nM	68.0
	1873894	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nc2)c1-c1ccc2c(c1)OCO2		CHEMBL375255	=	IC50	nM	120.0	CHEMBL3589	Homo sapiens	IC50	nM	120.0
	1873895	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2ccc(N3CCCCC3)nc2)c1-c1ccc(Cl)cc1		CHEMBL225781	=	IC50	nM	733.0	CHEMBL3589	Homo sapiens	IC50	nM	733.0
	1873896	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CC(=O)N1CCN(c2ccc(C#Cc3ncnc(N)c3-c3ccc(Cl)cc3)cn2)CC1		CHEMBL225729	=	IC50	nM	39.0	CHEMBL3589	Homo sapiens	IC50	nM	39.0
	1873897	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CC(C)(C)OC(=O)N1CCN(c2ccc(C#Cc3ncnc(N)c3-c3ccc(Cl)cc3)cn2)CC1		CHEMBL225728	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873898	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)S(=O)(=O)N1CCN(c2ccc(C#Cc3ncnc(N)c3-c3ccc(Cl)cc3)cn2)CC1		CHEMBL225727	=	IC50	nM	131.0	CHEMBL3589	Homo sapiens	IC50	nM	131.0
	1873899	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	COCCN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccc(Cl)cc2)cn1		CHEMBL225672	=	IC50	nM	80.0	CHEMBL3589	Homo sapiens	IC50	nM	80.0
	1873900	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nc2)c1-c1ccc(Cl)cc1		CHEMBL225671	=	IC50	nM	58.0	CHEMBL3589	Homo sapiens	IC50	nM	58.0
	1873901	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccc(Cl)cc2)cn1		CHEMBL225670	=	IC50	nM	83.0	CHEMBL3589	Homo sapiens	IC50	nM	83.0
	1873902	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ccc(C#Cc2ncnc(N)c2-c2ccc(Cl)cc2)cn1		CHEMBL225887	=	IC50	nM	333.0	CHEMBL3589	Homo sapiens	IC50	nM	333.0
	1873903	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2cncc(N3CCOCC3)c2)c1-c1ccc(Cl)cc1		CHEMBL225886	=	IC50	nM	110.0	CHEMBL3589	Homo sapiens	IC50	nM	110.0
	1873904	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2ccc(N3CCOCC3)nn2)c1-c1ccc(Cl)cc1		CHEMBL225834	=	IC50	nM	700.0	CHEMBL3589	Homo sapiens	IC50	nM	700.0
	1873905	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2cnc(N3CCOCC3)nc2)c1-c1ccc(Cl)cc1		CHEMBL438476	=	IC50	nM	200.0	CHEMBL3589	Homo sapiens	IC50	nM	200.0
	1873906	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2ccc(N3CCOCC3)cc2)c1-c1ccc(Cl)cc1		CHEMBL225833	=	IC50	nM	275.0	CHEMBL3589	Homo sapiens	IC50	nM	275.0
	1873907	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ccc(C#Cc2ncnc(N)c2-c2ccc(Cl)cc2)cc1		CHEMBL387486	=	IC50	nM	230.0	CHEMBL3589	Homo sapiens	IC50	nM	230.0
	1873908	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2ccc([N+](=O)[O-])cc2)c1-c1ccc(Cl)cc1		CHEMBL225774	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873909	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2cccs2)c1-c1ccc(Cl)cc1		CHEMBL225773	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873910	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2ccccn2)c1-c1ccc(Cl)cc1		CHEMBL225722	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873911	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2cncnc2)c1-c1ccc(Cl)cc1		CHEMBL375060	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873912	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CC(C)c1ccc(C#Cc2ncnc(N)c2-c2ccc(Cl)cc2)cc1		CHEMBL225877	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873913	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Cc1ccc(C#Cc2ncnc(N)c2-c2ccc(Cl)cc2)cc1		CHEMBL390827	=	IC50	nM	830.0	CHEMBL3589	Homo sapiens	IC50	nM	830.0
	1873914	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Nc1ncnc(C#Cc2ccccc2)c1-c1ccc(Cl)cc1		CHEMBL225707	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873915	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2cccc(N)c2)cc1		CHEMBL225706	=	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873916	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2cccc([N+](=O)[O-])c2)cc1		CHEMBL375294	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873917	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CC(C)c1ccc(-c2c(N)ncnc2C#Cc2ccc(N(C)C)cc2)cc1		CHEMBL225705	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873918	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	COc1ccc(-c2c(N)ncnc2C#Cc2ccc(N(C)C)cc2)cc1OC		CHEMBL226515	=	IC50	nM	500.0	CHEMBL3589	Homo sapiens	IC50	nM	500.0
	1873919	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	COc1ccc(-c2c(N)ncnc2C#Cc2ccc(N(C)C)cc2)cc1		CHEMBL388192	=	IC50	nM	730.0	CHEMBL3589	Homo sapiens	IC50	nM	730.0
	1873920	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	Cc1ccc(-c2c(N)ncnc2C#Cc2ccc(N(C)C)cc2)cc1		CHEMBL225696	=	IC50	nM	330.0	CHEMBL3589	Homo sapiens	IC50	nM	330.0
	1873921	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccc(Br)cc2)cc1		CHEMBL225695	=	IC50	nM	600.0	CHEMBL3589	Homo sapiens	IC50	nM	600.0
	1873922	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2cccc(Cl)c2)cc1		CHEMBL389409	=	IC50	nM	550.0	CHEMBL3589	Homo sapiens	IC50	nM	550.0
	1873923	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccccc2Cl)cc1		CHEMBL225694	=	IC50	nM	700.0	CHEMBL3589	Homo sapiens	IC50	nM	700.0
	1873924	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(N3CCN(S(=O)(=O)N(C)C)CC3)c2-c2ccc(Cl)cc2)cc1		CHEMBL226505	=	IC50	nM	330.0	CHEMBL3589	Homo sapiens	IC50	nM	330.0
	1873925	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(N3CCNCC3)c2-c2ccc(Cl)cc2)cc1		CHEMBL226504	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873926	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(N3CCOCC3)c2-c2ccc(Cl)cc2)cc1		CHEMBL387630	=	IC50	nM	970.0	CHEMBL3589	Homo sapiens	IC50	nM	970.0
	1873927	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(NCCc3c[nH]c4ccccc34)c2-c2ccc(Cl)cc2)cc1		CHEMBL226503	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873928	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(NCCc3c[nH]cn3)c2-c2ccc(Cl)cc2)cc1		CHEMBL387629	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873929	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(NC3CCCCC3)c2-c2ccc(Cl)cc2)cc1		CHEMBL226451	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873930	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(N(C)C)c2-c2ccc(Cl)cc2)cc1		CHEMBL226450	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873931	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CNc1ncnc(C#Cc2ccc(N(C)C)cc2)c1-c1ccc(Cl)cc1		CHEMBL427272	=	IC50	nM	350.0	CHEMBL3589	Homo sapiens	IC50	nM	350.0
	1873932	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccccc2)cc1		CHEMBL216119	>	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	nM	1000.0
	1873933	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccc3c(c2)OCO3)cc1		CHEMBL386316	=	IC50	nM	250.0	CHEMBL3589	Homo sapiens	IC50	nM	250.0
	1873934	CHEMBL903820	Inhibition of adenosine kinase in intact cells assessed as adenosine phosphorylation	F	CN(C)c1ccc(C#Cc2ncnc(N)c2-c2ccc(N(C)C)cc2)cc1		CHEMBL226392	=	IC50	nM	240.0	CHEMBL3589	Homo sapiens	IC50	nM	240.0
	2026764	CHEMBL887198	Specific activity of human adenosine kinase	B	NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL1643	=	Activity	nmol/mg.hr	203.0	CHEMBL3589	Homo sapiens	Activity	nmol/mg.hr	203.0
	2026765	CHEMBL887198	Specific activity of human adenosine kinase	B	CC(=O)Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL249913	<	Activity	nmol/mg.hr	4.0	CHEMBL3589	Homo sapiens	Activity	nmol/mg.hr	4.0
	2026766	CHEMBL887198	Specific activity of human adenosine kinase	B	COC(=N)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL400748	<	Activity	nmol/mg.hr	4.0	CHEMBL3589	Homo sapiens	Activity	nmol/mg.hr	4.0
	2026767	CHEMBL887198	Specific activity of human adenosine kinase	B	C/N=C(/N)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL1162073	=	Activity	nmol/mg.hr	11.0	CHEMBL3589	Homo sapiens	Activity	nmol/mg.hr	11.0
	2026768	CHEMBL887198	Specific activity of human adenosine kinase	B	CNC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL249709	=	Activity	nmol/mg.hr	19.0	CHEMBL3589	Homo sapiens	Activity	nmol/mg.hr	19.0
	2026769	CHEMBL887198	Specific activity of human adenosine kinase	B	O=C(O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL251526	<	Activity	nmol/mg.hr	4.0	CHEMBL3589	Homo sapiens	Activity	nmol/mg.hr	4.0
	2026770	CHEMBL887198	Specific activity of human adenosine kinase	B	CC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL251525	=	Activity	nmol/mg.hr	20.0	CHEMBL3589	Homo sapiens	Activity	nmol/mg.hr	20.0
	2026771	CHEMBL887198	Specific activity of human adenosine kinase	B	O=[N+]([O-])c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL251320	=	Activity	nmol/mg.hr	36.0	CHEMBL3589	Homo sapiens	Activity	nmol/mg.hr	36.0
	2026772	CHEMBL887199	Activity of human adenosine kinase relative to ribavirin	B	O=[N+]([O-])c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL251320	=	Activity	%	18.0	CHEMBL3589	Homo sapiens	Activity	%	18.0
	2026773	CHEMBL887199	Activity of human adenosine kinase relative to ribavirin	B	CC(=O)Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL249913	<	Activity	%	2.0	CHEMBL3589	Homo sapiens	Activity	%	2.0
	2026774	CHEMBL887199	Activity of human adenosine kinase relative to ribavirin	B	COC(=N)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL400748	<	Activity	%	2.0	CHEMBL3589	Homo sapiens	Activity	%	2.0
	2026775	CHEMBL887199	Activity of human adenosine kinase relative to ribavirin	B	C/N=C(/N)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL1162073	=	Activity	%	5.0	CHEMBL3589	Homo sapiens	Activity	%	5.0
	2026776	CHEMBL887199	Activity of human adenosine kinase relative to ribavirin	B	CNC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL249709	=	Activity	%	9.0	CHEMBL3589	Homo sapiens	Activity	%	9.0
	2026777	CHEMBL887199	Activity of human adenosine kinase relative to ribavirin	B	O=C(O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL251526	<	Activity	%	2.0	CHEMBL3589	Homo sapiens	Activity	%	2.0
	2026778	CHEMBL887199	Activity of human adenosine kinase relative to ribavirin	B	CC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL251525	=	Activity	%	10.0	CHEMBL3589	Homo sapiens	Activity	%	10.0
Not Active	2026779	CHEMBL887197	Inhibition of human adenosine kinase ribavirin phosphorylation activity	B	O=[N+]([O-])c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL251320		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Active	2026780	CHEMBL887197	Inhibition of human adenosine kinase ribavirin phosphorylation activity	B	CC(=O)Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL249913		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Active	2026781	CHEMBL887197	Inhibition of human adenosine kinase ribavirin phosphorylation activity	B	COC(=N)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL400748		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Active	2026782	CHEMBL887197	Inhibition of human adenosine kinase ribavirin phosphorylation activity	B	C/N=C(/N)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL1162073		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Active	2026783	CHEMBL887197	Inhibition of human adenosine kinase ribavirin phosphorylation activity	B	CNC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL249709		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Active	2026784	CHEMBL887197	Inhibition of human adenosine kinase ribavirin phosphorylation activity	B	O=C(O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL251526		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Active	2026785	CHEMBL887197	Inhibition of human adenosine kinase ribavirin phosphorylation activity	B	CC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)n1		CHEMBL251525		Activity			CHEMBL3589	Homo sapiens	Activity		
	2137085	CHEMBL939203	Inhibition of adenosine kinase	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Ki	nM	30.0	CHEMBL3589	Homo sapiens	Ki	nM	30.0
	2187540	CHEMBL969249	Inhibition of adenosine kinase	B	COC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL322217	=	log(10'3/IC50)		2.92	CHEMBL3589	Homo sapiens	log(10'3/IC50)		2.92
	2187541	CHEMBL969249	Inhibition of adenosine kinase	B	NC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL330432	=	log(10'3/IC50)		7.0	CHEMBL3589	Homo sapiens	log(10'3/IC50)		7.0
	2187542	CHEMBL969249	Inhibition of adenosine kinase	B	COC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99359	=	log(10'3/IC50)		3.35	CHEMBL3589	Homo sapiens	log(10'3/IC50)		3.35
	2187543	CHEMBL969249	Inhibition of adenosine kinase	B	OC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL328824	=	log(10'3/IC50)		4.62	CHEMBL3589	Homo sapiens	log(10'3/IC50)		4.62
	2187544	CHEMBL969249	Inhibition of adenosine kinase	B	Nc1ncnc2c1c(Br)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL62099	=	log(10'3/IC50)		3.92	CHEMBL3589	Homo sapiens	log(10'3/IC50)		3.92
	2187545	CHEMBL969249	Inhibition of adenosine kinase	B	C[C@H]1O[C@@H](n2cc(C(N)=O)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98638	=	log(10'3/IC50)		3.34	CHEMBL3589	Homo sapiens	log(10'3/IC50)		3.34
	2187546	CHEMBL969249	Inhibition of adenosine kinase	B	NC(=O)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL101892	=	log(10'3/IC50)		3.33	CHEMBL3589	Homo sapiens	log(10'3/IC50)		3.33
	2187547	CHEMBL969249	Inhibition of adenosine kinase	B	C[C@H]1O[C@@H](n2cc(C#N)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99388	=	log(10'3/IC50)		3.51	CHEMBL3589	Homo sapiens	log(10'3/IC50)		3.51
	2187548	CHEMBL969249	Inhibition of adenosine kinase	B	N#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL99668	=	log(10'3/IC50)		3.51	CHEMBL3589	Homo sapiens	log(10'3/IC50)		3.51
	2187549	CHEMBL969249	Inhibition of adenosine kinase	B	NC[C@H]1O[C@@H](n2ccc3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98641	=	log(10'3/IC50)		1.89	CHEMBL3589	Homo sapiens	log(10'3/IC50)		1.89
	2187550	CHEMBL969249	Inhibition of adenosine kinase	B	NC[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99707	=	log(10'3/IC50)		6.7	CHEMBL3589	Homo sapiens	log(10'3/IC50)		6.7
	2187551	CHEMBL969249	Inhibition of adenosine kinase	B	NC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL322611	=	log(10'3/IC50)		6.22	CHEMBL3589	Homo sapiens	log(10'3/IC50)		6.22
	2187552	CHEMBL969249	Inhibition of adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(SCc4ccc([N+](=O)[O-])cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL95482	=	log(10'3/IC50)		2.7	CHEMBL3589	Homo sapiens	log(10'3/IC50)		2.7
	2187553	CHEMBL969249	Inhibition of adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(SCc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL419517	=	log(10'3/IC50)		3.0	CHEMBL3589	Homo sapiens	log(10'3/IC50)		3.0
	2187554	CHEMBL969249	Inhibition of adenosine kinase	B	CCCCSc1ncnc2c1c(I)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL95211	=	log(10'3/IC50)		3.0	CHEMBL3589	Homo sapiens	log(10'3/IC50)		3.0
	2187555	CHEMBL969249	Inhibition of adenosine kinase	B	C=CCSc1ncnc2c1c(I)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL95608	=	log(10'3/IC50)		2.55	CHEMBL3589	Homo sapiens	log(10'3/IC50)		2.55
	2187556	CHEMBL969249	Inhibition of adenosine kinase	B	CSc1ncnc2c1c(I)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL95481	=	log(10'3/IC50)		4.35	CHEMBL3589	Homo sapiens	log(10'3/IC50)		4.35
	2187557	CHEMBL969249	Inhibition of adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(S)ncnc32)[C@H](O)[C@@H]1O		CHEMBL420640	=	log(10'3/IC50)		2.19	CHEMBL3589	Homo sapiens	log(10'3/IC50)		2.19
	2187558	CHEMBL969249	Inhibition of adenosine kinase	B	CNc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL319177	=	log(10'3/IC50)		2.92	CHEMBL3589	Homo sapiens	log(10'3/IC50)		2.92
	2187559	CHEMBL969249	Inhibition of adenosine kinase	B	CC[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL95721	=	log(10'3/IC50)		3.3	CHEMBL3589	Homo sapiens	log(10'3/IC50)		3.3
	2187560	CHEMBL969249	Inhibition of adenosine kinase	B	CC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL97494	=	log(10'3/IC50)		4.22	CHEMBL3589	Homo sapiens	log(10'3/IC50)		4.22
	2187561	CHEMBL969249	Inhibition of adenosine kinase	B	C=C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL97553	=	log(10'3/IC50)		4.0	CHEMBL3589	Homo sapiens	log(10'3/IC50)		4.0
	2187562	CHEMBL969249	Inhibition of adenosine kinase	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL97437	=	log(10'3/IC50)		4.2	CHEMBL3589	Homo sapiens	log(10'3/IC50)		4.2
	2187563	CHEMBL969249	Inhibition of adenosine kinase	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL318043	=	log(10'3/IC50)		4.46	CHEMBL3589	Homo sapiens	log(10'3/IC50)		4.46
	2187564	CHEMBL969249	Inhibition of adenosine kinase	B	CCOC(=O)c1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL95256	=	log(10'3/IC50)		3.0	CHEMBL3589	Homo sapiens	log(10'3/IC50)		3.0
	2187565	CHEMBL969249	Inhibition of adenosine kinase	B	CSc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL317927	=	log(10'3/IC50)		2.87	CHEMBL3589	Homo sapiens	log(10'3/IC50)		2.87
	2187566	CHEMBL969249	Inhibition of adenosine kinase	B	Cc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL318634	=	log(10'3/IC50)		1.78	CHEMBL3589	Homo sapiens	log(10'3/IC50)		1.78
	2187567	CHEMBL969249	Inhibition of adenosine kinase	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(Br)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99119	=	log(10'3/IC50)		4.0	CHEMBL3589	Homo sapiens	log(10'3/IC50)		4.0
	2187568	CHEMBL969249	Inhibition of adenosine kinase	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL449407	=	log(10'3/IC50)		5.05	CHEMBL3589	Homo sapiens	log(10'3/IC50)		5.05
	2187569	CHEMBL969249	Inhibition of adenosine kinase	B	CSc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(Cl)c12		CHEMBL318056	=	log(10'3/IC50)		4.15	CHEMBL3589	Homo sapiens	log(10'3/IC50)		4.15
	2187570	CHEMBL969249	Inhibition of adenosine kinase	B	Cc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(Cl)c12		CHEMBL99662	=	log(10'3/IC50)		3.27	CHEMBL3589	Homo sapiens	log(10'3/IC50)		3.27
	2187571	CHEMBL969249	Inhibition of adenosine kinase	B	C[C@H]1O[C@@H](n2cc(Br)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98910	=	log(10'3/IC50)		4.3	CHEMBL3589	Homo sapiens	log(10'3/IC50)		4.3
	2187572	CHEMBL969249	Inhibition of adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL329724	=	log(10'3/IC50)		5.52	CHEMBL3589	Homo sapiens	log(10'3/IC50)		5.52
	2187573	CHEMBL969249	Inhibition of adenosine kinase	B	Nc1ncnc2c1c(Cl)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL98933	=	log(10'3/IC50)		3.68	CHEMBL3589	Homo sapiens	log(10'3/IC50)		3.68
	2187574	CHEMBL969249	Inhibition of adenosine kinase	B	C[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98909	=	log(10'3/IC50)		4.4	CHEMBL3589	Homo sapiens	log(10'3/IC50)		4.4
	2187575	CHEMBL969249	Inhibition of adenosine kinase	B	C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL66280	=	log(10'3/IC50)		5.05	CHEMBL3589	Homo sapiens	log(10'3/IC50)		5.05
	2187576	CHEMBL969249	Inhibition of adenosine kinase	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	log(10'3/IC50)		4.59	CHEMBL3589	Homo sapiens	log(10'3/IC50)		4.59
Active	2504729	CHEMBL960404	Binding affinity to ADK in human Jurkat cells at 100 uM by Western blot analysis	B	Nc1ccc(-c2cc3c(Nc4cccc(Cl)c4)ncnc3[nH]2)cc1		CHEMBL473926		Activity			CHEMBL3589	Homo sapiens	Activity		
	2509028	CHEMBL981267	Inhibition of human recombinant adenosine kinase expressed in Escherichia coli	B	Nc1ncnc2c1nc(-c1ccc(P(=O)(O)O)o1)n2CCc1ccccc1		CHEMBL519503	>	IC50	nM	100000.0	CHEMBL3589	Homo sapiens	IC50	uM	100.0
	2509031	CHEMBL981267	Inhibition of human recombinant adenosine kinase expressed in Escherichia coli	B	CC(C)(C)Cn1c(-c2ccc(P(=O)(O)O)o2)nc2c(N)ncnc21		CHEMBL482735	>	IC50	nM	100000.0	CHEMBL3589	Homo sapiens	IC50	uM	100.0
	2988331	CHEMBL1037326	Inhibition of adenosine kinase AMP binding site	B	CCc1cc(F)c(N)c2nc(-c3ccc(P(=O)(O)O)o3)n(CC(C)C)c12		CHEMBL570790	>	IC50	nM	100000.0	CHEMBL3589	Homo sapiens	IC50	uM	100.0
	5304931	CHEMBL1694989	Inhibition of human adenosine kinase	B	O=C1c2cccn2-c2ccccc2SC1c1ccccc1	Outside typical range	CHEMBL32718	=	IC50	nM	130000.0	CHEMBL3589	Homo sapiens	IC50	uM	130.0
	5304932	CHEMBL1694989	Inhibition of human adenosine kinase	B	O=C1c2cccn2-c2ccccc2OC1c1ccccc1		CHEMBL327869	=	IC50	nM	100000.0	CHEMBL3589	Homo sapiens	IC50	uM	100.0
	5304933	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccccc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL329653	=	IC50	nM	85000.0	CHEMBL3589	Homo sapiens	IC50	uM	85.0
	5304934	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(C)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL342620	=	IC50	nM	80000.0	CHEMBL3589	Homo sapiens	IC50	uM	80.0
	5304935	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2cccc(C)c2)Oc2ccccc2-n2cccc2C1=O	Outside typical range	CHEMBL139532	=	IC50	nM	150000.0	CHEMBL3589	Homo sapiens	IC50	uM	150.0
	5304936	CHEMBL1694989	Inhibition of human adenosine kinase	B	CN(C)c1ccc2n1-c1ccccc1SC(c1ccccc1)C2=O	Outside typical range	CHEMBL1688495	>	IC50	nM	1000000.0	CHEMBL3589	Homo sapiens	IC50	uM	1000.0
Not Active	5304937	CHEMBL1694989	Inhibition of human adenosine kinase	B	CC(=O)OC1=C(c2ccccc2)Oc2ccccc2-n2cccc21		CHEMBL326943		IC50			CHEMBL3589	Homo sapiens	IC50		
Not Active	5304938	CHEMBL1694989	Inhibition of human adenosine kinase	B	CC(=O)OC1=C(c2ccccc2)Sc2ccccc2-n2cccc21		CHEMBL33083		IC50			CHEMBL3589	Homo sapiens	IC50		
	5304939	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccccc3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688496	=	IC50	nM	1200.0	CHEMBL3589	Homo sapiens	IC50	uM	1.2
	5304940	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccccc3F)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688497	=	IC50	nM	4500.0	CHEMBL3589	Homo sapiens	IC50	uM	4.5
	5304941	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccccc3Cl)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688498	=	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	uM	1.0
	5304942	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3cccc(C)c3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688499	=	IC50	nM	21400.0	CHEMBL3589	Homo sapiens	IC50	uM	21.4
	5304943	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3cccc(F)c3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688500	=	IC50	nM	4000.0	CHEMBL3589	Homo sapiens	IC50	uM	4.0
	5304944	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3cccc(Cl)c3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688501	=	IC50	nM	3500.0	CHEMBL3589	Homo sapiens	IC50	uM	3.5
	5304945	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3cccc(C(F)(F)F)c3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688502	=	IC50	nM	2500.0	CHEMBL3589	Homo sapiens	IC50	uM	2.5
	5304946	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3cccc(OC)c3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1687951	=	IC50	nM	12500.0	CHEMBL3589	Homo sapiens	IC50	uM	12.5
	5304947	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3cccc(OC(F)(F)F)c3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688503	=	IC50	nM	3200.0	CHEMBL3589	Homo sapiens	IC50	uM	3.2
	5304948	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccc(F)cc3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688504	=	IC50	nM	1000.0	CHEMBL3589	Homo sapiens	IC50	uM	1.0
	5304949	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccc(Br)cc3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688505	=	IC50	nM	2000.0	CHEMBL3589	Homo sapiens	IC50	uM	2.0
	5304950	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccc(I)cc3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688506	=	IC50	nM	2500.0	CHEMBL3589	Homo sapiens	IC50	uM	2.5
	5304951	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccc([N+](=O)[O-])cc3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688507	=	IC50	nM	6200.0	CHEMBL3589	Homo sapiens	IC50	uM	6.2
	5304952	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccc(OC(F)(F)F)cc3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688508	=	IC50	nM	6700.0	CHEMBL3589	Homo sapiens	IC50	uM	6.7
	5304953	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccc(OC)cc3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688509	=	IC50	nM	14000.0	CHEMBL3589	Homo sapiens	IC50	uM	14.0
	5304954	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccc(C#C[Si](C)(C)C)cc3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688510	=	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	5304955	CHEMBL1694989	Inhibition of human adenosine kinase	B	C#Cc1ccc(SCc2ccc(C3(CC)Oc4ccccc4-n4cccc4C3=O)cc2)cc1		CHEMBL1688511	=	IC50	nM	15000.0	CHEMBL3589	Homo sapiens	IC50	uM	15.0
	5304956	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3c(C)cccc3Cl)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688512	=	IC50	nM	3000.0	CHEMBL3589	Homo sapiens	IC50	uM	3.0
	5304957	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3c(Cl)cccc3Cl)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688513	=	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	5304958	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3c(Cl)cccc3Cl)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688513	=	IC50	nM	40000.0	CHEMBL3589	Homo sapiens	IC50	uM	40.0
	5304959	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3c(Cl)cccc3Cl)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688513	=	IC50	nM	7500.0	CHEMBL3589	Homo sapiens	IC50	uM	7.5
	5304960	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3cccc(Cl)c3Cl)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688570	=	IC50	nM	3000.0	CHEMBL3589	Homo sapiens	IC50	uM	3.0
	5304961	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3cc(Cl)ccc3Cl)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688571	=	IC50	nM	14000.0	CHEMBL3589	Homo sapiens	IC50	uM	14.0
	5304962	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccc(Cl)cc3Cl)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688572	=	IC50	nM	22500.0	CHEMBL3589	Homo sapiens	IC50	uM	22.5
	5304963	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccc(Cl)c(Cl)c3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688573	=	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	5304964	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccc(F)cc3F)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688574	=	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	5304965	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccc(F)cc3Cl)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688575	=	IC50	nM	2500.0	CHEMBL3589	Homo sapiens	IC50	uM	2.5
	5304966	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccc(F)c(Cl)c3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688576	=	IC50	nM	11000.0	CHEMBL3589	Homo sapiens	IC50	uM	11.0
	5304967	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3cc(OC)ccc3OC)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688577	=	IC50	nM	35000.0	CHEMBL3589	Homo sapiens	IC50	uM	35.0
	5304968	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccc(I)cc3Cl)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688578	=	IC50	nM	2000.0	CHEMBL3589	Homo sapiens	IC50	uM	2.0
	5304969	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3c(F)c(F)cc(F)c3F)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688579	=	IC50	nM	8000.0	CHEMBL3589	Homo sapiens	IC50	uM	8.0
	5304970	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccccn3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688580	=	IC50	nM	4500.0	CHEMBL3589	Homo sapiens	IC50	uM	4.5
	5304971	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ncc[nH]3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688581	=	IC50	nM	3500.0	CHEMBL3589	Homo sapiens	IC50	uM	3.5
	5304972	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3cnccn3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688582	=	IC50	nM	7000.0	CHEMBL3589	Homo sapiens	IC50	uM	7.0
	5304973	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ncccn3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688583	=	IC50	nM	7000.0	CHEMBL3589	Homo sapiens	IC50	uM	7.0
	5304974	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(COc3ccc(I)cc3Cl)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688584	=	IC50	nM	1200.0	CHEMBL3589	Homo sapiens	IC50	uM	1.2
	5304975	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(COc3cccc(CCO)c3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688585	=	IC50	nM	8000.0	CHEMBL3589	Homo sapiens	IC50	uM	8.0
	5304976	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCN(CC)CCc1cccc(OCc2ccc(C3(CC)Oc4ccccc4-n4cccc4C3=O)cc2)c1	Outside typical range	CHEMBL1688586	=	IC50	nM	200000.0	CHEMBL3589	Homo sapiens	IC50	uM	200.0
	5304977	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(COc3cccc(CCN4CCCC4)c3)cc2)Oc2ccccc2-n2cccc2C1=O	Outside typical range	CHEMBL1688587	=	IC50	nM	150000.0	CHEMBL3589	Homo sapiens	IC50	uM	150.0
	5304978	CHEMBL1694989	Inhibition of human adenosine kinase	B	O=C1c2cccn2-c2ccccc2OC1c1ccc(CSc2ccccc2)cc1		CHEMBL1688588	=	IC50	nM	4000.0	CHEMBL3589	Homo sapiens	IC50	uM	4.0
	5304979	CHEMBL1694989	Inhibition of human adenosine kinase	B	O=C1c2cccn2-c2ccccc2OC1c1ccc(CSc2ccccc2Cl)cc1		CHEMBL1688589	=	IC50	nM	4400.0	CHEMBL3589	Homo sapiens	IC50	uM	4.4
	5304980	CHEMBL1694989	Inhibition of human adenosine kinase	B	O=C1c2cccn2-c2ccccc2OC1c1ccc(CSc2cccc(C(F)(F)F)c2)cc1		CHEMBL1688590	=	IC50	nM	9000.0	CHEMBL3589	Homo sapiens	IC50	uM	9.0
	5304981	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccccc3Cl)cc2)Sc2ccccc2-n2cccc2C1=O		CHEMBL1688591	=	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
	5304982	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccc(I)cc3)cc2)Sc2ccccc2-n2cccc2C1=O		CHEMBL1687952	=	IC50	nM	2200.0	CHEMBL3589	Homo sapiens	IC50	uM	2.2
	5304983	CHEMBL1694989	Inhibition of human adenosine kinase	B	CCC1(c2ccc(CSc3ccc(C#C[Si](C)(C)C)cc3)cc2)Sc2ccccc2-n2cccc2C1=O		CHEMBL1688592	=	IC50	nM	2000.0	CHEMBL3589	Homo sapiens	IC50	uM	2.0
Active	5304994	CHEMBL1694996	Inhibition of human adenosine kinase assessed as [3H]AMP production by scintillation counter in presence of increasing enzyme concentration	B	CCC1(c2ccc(CSc3ccccc3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688496		Inhibition	%		CHEMBL3589	Homo sapiens	INH		
Active	5304995	CHEMBL1694997	Inhibition of human adenosine kinase assessed as [3H]AMP production by scintillation counter in presence of increasing substrate concentration	B	CCC1(c2ccc(CSc3ccccc3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688496		Inhibition	%		CHEMBL3589	Homo sapiens	INH		
Not Active	5305007	CHEMBL1695066	Inhibition of adenosine kinase activity in human HeLa cell crude extract pretreated at 40 uM for 3 days relative to control	B	CCC1(c2ccc(CSc3ccccc3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688496		Inhibition	%		CHEMBL3589	Homo sapiens	INH		
Not Active	5305012	CHEMBL1695065	Inhibition of adenosine kinase activity in human HeLa cell crude extract pretreated at 40 uM for 3 days	B	CCC1(c2ccc(CSc3ccccc3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688496		Inhibition	%		CHEMBL3589	Homo sapiens	INH		
	6312126	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	Nc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814762	>	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
	6312127	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	COc1ccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)cc1		CHEMBL1814763	>	IC50	nM	2000.0	CHEMBL3589	Homo sapiens	IC50	uM	2.0
	6312128	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	CSc1ccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)cc1		CHEMBL1814764	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	6312129	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	Nc1ncnc2c1c(-c1cccc3ccccc13)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814765	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	6312130	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814766	>	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
	6312131	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	Nc1ncnc2c1c(-c1ccco1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814767	>	IC50	nM	2000.0	CHEMBL3589	Homo sapiens	IC50	uM	2.0
	6312132	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	Nc1ncnc2c1c(-c1cccs1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814768	>	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
	6312133	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	Nc1ncnc2c1c(-c1ccoc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814769	>	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
	6312134	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	Nc1ncnc2c1c(-c1ccsc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814770	>	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
	6312135	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	Nc1ncnc2c1c(-c1cc3ccccc3o1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814771	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	6312136	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	Nc1ncnc2c1c(-c1cc[nH]c1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814773	>	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
	6312137	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	Nc1ncnc2c1c(-c1cn[nH]c1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814774	=	IC50	nM	50.0	CHEMBL3589	Homo sapiens	IC50	uM	0.05
	6312138	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	Nc1ncnc2c1c(-c1cc[nH]n1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814775	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	6312139	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	C#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL1814776	=	IC50	nM	200.0	CHEMBL3589	Homo sapiens	IC50	uM	0.2
	6312140	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	Nc1ncnc2c1c(-c1c[nH]cn1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814779	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	6312141	CHEMBL1817183	Inhibition of human ADK using [3H]-adenosine by scintillation counting	B	Nc1ncnc2c1c(-c1ncc[nH]1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814780	>	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
Not Active	12205128	CHEMBL2217183	Binding affinity to ADK in human K562 cell lysate after 1 hr by capture compound based LC/MS analysis	B	Cn1c(CNc2ccc(C(=N)NCCCCNC(=O)C[C@H](NC(=O)c3ccc(C4(C(F)(F)F)N=N4)cc3)C(=O)NCCCOCCOCCOCCCNC(=O)CCCC[C@@H]3SC[C@@H]4NC(=O)N[C@H]34)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21		CHEMBL2216801		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	12205136	CHEMBL2217169	Binding affinity to ADK in human HepG2 cell lysate after 1 hr by capture compound based LC/MS analysis	B	Cn1c(CNc2ccc(C(=N)NCCCCNC(=O)C[C@H](NC(=O)c3ccc(C4(C(F)(F)F)N=N4)cc3)C(=O)NCCCOCCOCCOCCCNC(=O)CCCC[C@@H]3SC[C@@H]4NC(=O)N[C@H]34)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21		CHEMBL2216801		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	12205141	CHEMBL2217176	Displacement of 3-(1-methyl-N-(pyridin-2-yl)-2-((4-(N-((S)-6,9,25-trioxo-29-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)-8-(4-(3-(trifluoromethyl)-3H-diazirin-3-yl)benzamido)-14,17,20-trioxa-5,10,24-triazanonacosyl)carbamimidoyl)phenylamino)methyl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid from ADK in human HepG2 cell lysate after 1 hr by capture compound based LC/MS analysis	B	Cn1c(CNc2ccc(C(=N)N)cc2)nc2cc(C(=O)N(CCC(=O)O)c3ccccn3)ccc21		CHEMBL48361		Activity			CHEMBL3589	Homo sapiens	Activity		
	12462996	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	C[C@H]1O[C@@H](n2cc(C(N)=O)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98638	=	logIC50		-0.3372	CHEMBL3589	Homo sapiens	logIC50		-0.3372
	12462997	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	NC(=O)c1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL101892	=	logIC50		-0.3279	CHEMBL3589	Homo sapiens	logIC50		-0.3279
	12462998	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	C[C@H]1O[C@@H](n2cc(C#N)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99388	=	logIC50		-0.5086	CHEMBL3589	Homo sapiens	logIC50		-0.5086
	12462999	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	NC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL330432	=	logIC50		-4.0	CHEMBL3589	Homo sapiens	logIC50		-4.0
	12463000	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	NC[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99707	=	logIC50		-3.699	CHEMBL3589	Homo sapiens	logIC50		-3.699
	12463001	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	NC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL322611	=	logIC50		-3.222	CHEMBL3589	Homo sapiens	logIC50		-3.2218
	12463002	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	CSc1ncnc2c1c(I)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL95481	=	logIC50		-1.347	CHEMBL3589	Homo sapiens	logIC50		-1.3468
	12463003	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	C[C@H]1O[C@@H](n2cc(I)c3c(S)ncnc32)[C@H](O)[C@@H]1O		CHEMBL420640	=	logIC50		0.8129	CHEMBL3589	Homo sapiens	logIC50		0.8129
	12463004	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	CNc1ncnc2c1c(I)cn2[C@@H]1O[C@H](C)[C@@H](O)[C@H]1O		CHEMBL2262188	=	logIC50		0.0792	CHEMBL3589	Homo sapiens	logIC50		0.0792
	12463005	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	Nc1ncnc2c1c(Br)cn2[C@@H]1OC[C@@H](O)[C@H]1O		CHEMBL2262187	=	logIC50		-0.301	CHEMBL3589	Homo sapiens	logIC50		-0.301
	12463006	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	CC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL97494	=	logIC50		-1.222	CHEMBL3589	Homo sapiens	logIC50		-1.2218
	12463007	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	C=C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL97553	=	logIC50		-1.0	CHEMBL3589	Homo sapiens	logIC50		-1.0
	12463008	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	COC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL322217	=	logIC50		0.0792	CHEMBL3589	Homo sapiens	logIC50		0.0792
	12463009	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL97437	=	logIC50		-1.201	CHEMBL3589	Homo sapiens	logIC50		-1.2007
	12463010	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL318043	=	logIC50		-1.456	CHEMBL3589	Homo sapiens	logIC50		-1.4559
	12463011	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	CCOC(=O)c1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL95256	=	logIC50		0.0	CHEMBL3589	Homo sapiens	logIC50		0.0
	12463012	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	CSc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL317927	=	logIC50		0.1303	CHEMBL3589	Homo sapiens	logIC50		0.1303
	12463013	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	Cc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL318634	=	logIC50		-1.218	CHEMBL3589	Homo sapiens	logIC50		-1.2175
	12463014	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	COC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99359	=	logIC50		-0.8239	CHEMBL3589	Homo sapiens	logIC50		-0.8239
	12463015	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(Br)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL99119	=	logIC50		-1.0	CHEMBL3589	Homo sapiens	logIC50		-1.0
	12463016	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	[N-]=[N+]=NC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL449407	=	logIC50		-2.046	CHEMBL3589	Homo sapiens	logIC50		-2.0458
	12463017	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	CSc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(Cl)c12		CHEMBL318056	=	logIC50		-1.155	CHEMBL3589	Homo sapiens	logIC50		-1.1549
	12463018	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	Cc1cn([C@@H]2O[C@H](C)[C@@H](O)[C@H]2O)c2ncnc(Cl)c12		CHEMBL99662	=	logIC50		-0.2716	CHEMBL3589	Homo sapiens	logIC50		-0.2716
	12463019	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	C[C@H]1O[C@@H](n2cc(Br)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98910	=	logIC50		-1.301	CHEMBL3589	Homo sapiens	logIC50		-1.301
	12463020	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	C[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL329724	=	logIC50		-2.523	CHEMBL3589	Homo sapiens	logIC50		-2.5229
	12463021	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	OC[C@H]1O[C@@H](n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL328824	=	logIC50		-1.62	CHEMBL3589	Homo sapiens	logIC50		-1.6198
	12463022	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	Nc1ncnc2c1c(Cl)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL98933	=	logIC50		-0.6778	CHEMBL3589	Homo sapiens	logIC50		-0.6778
	12463023	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	Nc1ncnc2c1c(Br)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL62099	=	logIC50		-0.9208	CHEMBL3589	Homo sapiens	logIC50		-0.9208
	12463024	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	C[C@H]1O[C@@H](n2cc(Br)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL98909	=	logIC50		-1.398	CHEMBL3589	Homo sapiens	logIC50		-1.3979
	12463025	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL66280	=	logIC50		-2.046	CHEMBL3589	Homo sapiens	logIC50		-2.0458
	12463026	CHEMBL3055330	Inhibition of adenosine kinase (unknown origin)	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	logIC50		-1.585	CHEMBL3589	Homo sapiens	logIC50		-1.585
Not Determined	13968720	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4ccoc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571631		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Determined	13968721	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cccc5c4Oc4ccccc4S5)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134380		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Determined	13968722	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cccc5c4sc4ccccc45)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134379		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Determined	13968723	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cc5ccccc5[nH]4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134378		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Determined	13968724	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cc5ccccc5s4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134389		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Determined	13968725	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cc5ccccc5o4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134388		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Determined	13968726	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cccc5c4oc4ccccc45)ncnc32)[C@H](O)[C@@H]1O		CHEMBL1642653		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Determined	13968727	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cccs4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL585761		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Determined	13968728	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cccnc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL576515		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Determined	13968729	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	COc1ccc(-c2ncnc3c2ccn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1		CHEMBL572326		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Determined	13968730	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL585760		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Determined	13968731	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	CCc1ncnc2c1ccn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL578623		Activity			CHEMBL3589	Homo sapiens	Activity		
Not Determined	13968734	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2cc(Cl)c3c(-c4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134381		Activity			CHEMBL3589	Homo sapiens	Activity		
	13968781	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cccs4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL585761	>	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
	13968789	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2cc(Cl)c3c(-c4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134381	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	13968790	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4c[nH]cn4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571630	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	13968791	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4nccs4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571756	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	13968792	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cn[nH]c4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL576702	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	13968793	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccn[nH]4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL572317	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	13968794	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4nccs4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL572327	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	13968795	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(Cc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571406	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	13968796	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	CCc1ncnc2c1ccn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL578623	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	13968815	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2cc(Cl)c3c(-c4ccsc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL570092	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968816	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2cc(Cl)c3c(-c4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL570743	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968817	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4cc[nH]c4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL570091	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968818	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4ccc[nH]4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL584957	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968819	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4ccsc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571757	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968820	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4ccoc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571631	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968821	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL584541	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968822	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4c[nH]cn4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571850	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968823	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cc[nH]c4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL576900	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968824	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccc[nH]4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571978	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968825	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccc[se]4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL576130	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968826	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccsc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL572100	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968827	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccoc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571410	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968828	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cccnc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL576515	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968829	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccccn4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571838	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968830	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL572052	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968831	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	COc1ccc(-c2ncnc3c2ccn3[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)cc1		CHEMBL572326	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968832	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL585760	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968833	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OCc1ncnc2c1ccn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL576514	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968834	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	Cc1ncnc2c1ccn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1269812	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	13968835	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2cc(Cl)c3c(-c4cccs4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL584958	=	Activity	%	100.0	CHEMBL3589	Homo sapiens	Activity	%	100.0
	13968836	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2cc(Cl)c3c(-c4ccoc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571848	=	Activity	%	100.0	CHEMBL3589	Homo sapiens	Activity	%	100.0
	13968840	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2cc(Cl)c3c(-c4ccsc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL570092	=	Activity	%	97.0	CHEMBL3589	Homo sapiens	Activity	%	97.0
	13968841	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4cc[nH]c4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL570091	=	Activity	%	97.0	CHEMBL3589	Homo sapiens	Activity	%	97.0
	13968854	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2cc(Cl)c3c(-c4ccco4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL585759	=	Activity	%	77.0	CHEMBL3589	Homo sapiens	Activity	%	77.0
	13968855	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4ccc[nH]4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL584957	=	Activity	%	76.0	CHEMBL3589	Homo sapiens	Activity	%	76.0
	13968857	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4nccs4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571756	=	Activity	%	75.0	CHEMBL3589	Homo sapiens	Activity	%	75.0
	13968860	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cc[nH]c4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL576900	=	Activity	%	70.0	CHEMBL3589	Homo sapiens	Activity	%	70.0
	13968865	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccsc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL572100	=	Activity	%	56.0	CHEMBL3589	Homo sapiens	Activity	%	56.0
	13968866	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccco4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL572309	=	Activity	%	56.0	CHEMBL3589	Homo sapiens	Activity	%	56.0
	13968867	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	Cc1ncnc2c1ccn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1269812	=	Activity	%	54.0	CHEMBL3589	Homo sapiens	Activity	%	54.0
	13968868	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4cccs4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL569854	=	Activity	%	52.0	CHEMBL3589	Homo sapiens	Activity	%	52.0
	13968869	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4ccsc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571757	=	Activity	%	51.0	CHEMBL3589	Homo sapiens	Activity	%	51.0
	13968870	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4ccco4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571622	=	Activity	%	50.0	CHEMBL3589	Homo sapiens	Activity	%	50.0
	13968886	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccc[se]4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL576130	=	Activity	%	43.0	CHEMBL3589	Homo sapiens	Activity	%	43.0
	13968888	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4nccs4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL572327	=	Activity	%	41.0	CHEMBL3589	Homo sapiens	Activity	%	41.0
	13968890	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccc[nH]4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571978	=	Activity	%	40.0	CHEMBL3589	Homo sapiens	Activity	%	40.0
	13968891	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccccn4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571838	=	Activity	%	39.0	CHEMBL3589	Homo sapiens	Activity	%	39.0
	13968897	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccoc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571410	=	Activity	%	32.0	CHEMBL3589	Homo sapiens	Activity	%	32.0
	13968898	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccn[nH]4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL572317	=	Activity	%	31.0	CHEMBL3589	Homo sapiens	Activity	%	31.0
	13968900	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2cc(Cl)c3c(-c4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL570743	=	Activity	%	29.0	CHEMBL3589	Homo sapiens	Activity	%	29.0
	13968901	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4c[nH]cn4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571850	=	Activity	%	28.0	CHEMBL3589	Homo sapiens	Activity	%	28.0
	13968902	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OCc1ncnc2c1ccn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL576514	=	Activity	%	26.0	CHEMBL3589	Homo sapiens	Activity	%	26.0
	13968905	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL584541	=	Activity	%	17.0	CHEMBL3589	Homo sapiens	Activity	%	17.0
	13968906	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL572052	=	Activity	%	17.0	CHEMBL3589	Homo sapiens	Activity	%	17.0
	13968908	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cccc5c4sc4ccccc45)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134379	=	IC50	nM	15400.0	CHEMBL3589	Homo sapiens	IC50	uM	15.4
	13968912	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4c[nH]cn4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571630	=	Activity	%	11.0	CHEMBL3589	Homo sapiens	Activity	%	11.0
	13968914	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cc5ccccc5[nH]4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134378	=	IC50	nM	8350.0	CHEMBL3589	Homo sapiens	IC50	uM	8.35
	13968916	CHEMBL3135674	Activity of human ADK assessed as compound conversion to 5'-phosphate form incubated at 37 degC for 20 mins by HPLC method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cn[nH]c4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL576702	=	Activity	%	7.0	CHEMBL3589	Homo sapiens	Activity	%	7.0
	13968917	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	CCCCCCCCCCCCCCCCCCOP(=O)(O)OC[C@H]1O[C@@H](n2ccc3c(-c4ccsc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134386	=	IC50	nM	6350.0	CHEMBL3589	Homo sapiens	IC50	uM	6.35
	13968918	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cccc5c4oc4ccccc45)ncnc32)[C@H](O)[C@@H]1O		CHEMBL1642653	=	IC50	nM	5260.0	CHEMBL3589	Homo sapiens	IC50	uM	5.26
	13968919	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	CCCCCCCCCCCCCCCCCCOP(=O)(O)OC[C@H]1O[C@@H](n2ccc3c(-c4ccoc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134384	=	IC50	nM	5150.0	CHEMBL3589	Homo sapiens	IC50	uM	5.15
	13968921	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	CCCCCCCCCCCCCCCCCCOP(=O)(O)OC[C@H]1O[C@@H](n2ccc3c(-c4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134382	=	IC50	nM	4400.0	CHEMBL3589	Homo sapiens	IC50	uM	4.4
	13968922	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2cc(Cl)c3c(-c4ccoc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571848	=	IC50	nM	3400.0	CHEMBL3589	Homo sapiens	IC50	uM	3.4
	13968923	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cccc5c4Oc4ccccc4S5)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134380	=	IC50	nM	3070.0	CHEMBL3589	Homo sapiens	IC50	uM	3.07
	13968925	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	CCCCCCCCCCCCCCCCCCOP(=O)(O)OC[C@H]1O[C@@H](n2ccc3c(-c4cc5ccccc5o4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134387	=	IC50	nM	2900.0	CHEMBL3589	Homo sapiens	IC50	uM	2.9
	13968927	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	CCCCCCCCCCCCCCCCCCOP(=O)(O)OC[C@H]1O[C@@H](n2ccc3c(-c4ccco4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134383	=	IC50	nM	2400.0	CHEMBL3589	Homo sapiens	IC50	uM	2.4
	13968929	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cc5ccccc5o4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134388	=	IC50	nM	2100.0	CHEMBL3589	Homo sapiens	IC50	uM	2.1
	13968931	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	CCCCCCCCCCCCCCCCCCOP(=O)(O)OC[C@H]1O[C@@H](n2ccc3c(-c4cccs4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134385	=	IC50	nM	1970.0	CHEMBL3589	Homo sapiens	IC50	uM	1.97
	13968937	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4ccco4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL571622	=	IC50	nM	1300.0	CHEMBL3589	Homo sapiens	IC50	uM	1.3
	13968938	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4ccco4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL572309	=	IC50	nM	1300.0	CHEMBL3589	Homo sapiens	IC50	uM	1.3
	13968939	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2cc(Cl)c3c(-c4cccs4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL584958	=	IC50	nM	1200.0	CHEMBL3589	Homo sapiens	IC50	uM	1.2
	13968942	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2cc(F)c3c(-c4cccs4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL569854	=	IC50	nM	1100.0	CHEMBL3589	Homo sapiens	IC50	uM	1.1
	13968960	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2ccc3c(-c4cc5ccccc5s4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL3134389	=	IC50	nM	300.0	CHEMBL3589	Homo sapiens	IC50	uM	0.3
	13968961	CHEMBL3135673	Inhibition of human ADK using [3H]-adenosine by scintillation counting method	B	OC[C@H]1O[C@@H](n2cc(Cl)c3c(-c4ccco4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL585759	=	IC50	nM	290.0	CHEMBL3589	Homo sapiens	IC50	uM	0.29
Not Active	14710507	CHEMBL3294649	Activity of adenosine kinase (unknown origin)	B	Nc1ncc(F)c2c1ncn2[C@@H]1CC[C@@H](O)[C@H]1O		CHEMBL3290657		Activity			CHEMBL3589	Homo sapiens	Activity		
	15133948	CHEMBL3385543	Activity of human ADK expressed in Escherichia coli BL21(DE3) cells assessed as compound phosphorylation by measuring conversion of compound to 5'-phosphate	B	C#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL1814776	=	Activity	%	62.0	CHEMBL3589	Homo sapiens	Activity	%	62.0
	15133949	CHEMBL3385543	Activity of human ADK expressed in Escherichia coli BL21(DE3) cells assessed as compound phosphorylation by measuring conversion of compound to 5'-phosphate	B	Nc1ncnc2c1c(-c1ccco1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814767	=	Activity	%	8.0	CHEMBL3589	Homo sapiens	Activity	%	8.0
	15133950	CHEMBL3385543	Activity of human ADK expressed in Escherichia coli BL21(DE3) cells assessed as compound phosphorylation by measuring conversion of compound to 5'-phosphate	B	Nc1ncnc2c1c(-c1ccoc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814769	=	Activity	%	9.0	CHEMBL3589	Homo sapiens	Activity	%	9.0
	15133951	CHEMBL3385543	Activity of human ADK expressed in Escherichia coli BL21(DE3) cells assessed as compound phosphorylation by measuring conversion of compound to 5'-phosphate	B	Nc1ncnc2c1c(-c1cccs1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814768	=	Activity	%	2.0	CHEMBL3589	Homo sapiens	Activity	%	2.0
	15133952	CHEMBL3385543	Activity of human ADK expressed in Escherichia coli BL21(DE3) cells assessed as compound phosphorylation by measuring conversion of compound to 5'-phosphate	B	Nc1ncnc2c1c(-c1ccsc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814770	=	Activity	%	2.0	CHEMBL3589	Homo sapiens	Activity	%	2.0
	15133953	CHEMBL3385543	Activity of human ADK expressed in Escherichia coli BL21(DE3) cells assessed as compound phosphorylation by measuring conversion of compound to 5'-phosphate	B	Nc1ncnc2c1c(-c1ccc[nH]1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814772	=	Activity	%	6.0	CHEMBL3589	Homo sapiens	Activity	%	6.0
	15133954	CHEMBL3385543	Activity of human ADK expressed in Escherichia coli BL21(DE3) cells assessed as compound phosphorylation by measuring conversion of compound to 5'-phosphate	B	Nc1ncnc2c1c(-c1cc[nH]c1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814773	=	Activity	%	20.0	CHEMBL3589	Homo sapiens	Activity	%	20.0
	15133955	CHEMBL3385543	Activity of human ADK expressed in Escherichia coli BL21(DE3) cells assessed as compound phosphorylation by measuring conversion of compound to 5'-phosphate	B	Nc1ncnc2c1c(-c1nccs1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814778	=	Activity	%	3.0	CHEMBL3589	Homo sapiens	Activity	%	3.0
	15133956	CHEMBL3385543	Activity of human ADK expressed in Escherichia coli BL21(DE3) cells assessed as compound phosphorylation by measuring conversion of compound to 5'-phosphate	B	Nc1ncnc2c1c(-c1cc[nH]n1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814775	=	Activity	%	7.0	CHEMBL3589	Homo sapiens	Activity	%	7.0
	15133957	CHEMBL3385543	Activity of human ADK expressed in Escherichia coli BL21(DE3) cells assessed as compound phosphorylation by measuring conversion of compound to 5'-phosphate	B	Nc1ncnc2c1c(-c1cn[nH]c1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814774	=	Activity	%	9.0	CHEMBL3589	Homo sapiens	Activity	%	9.0
	15133958	CHEMBL3385543	Activity of human ADK expressed in Escherichia coli BL21(DE3) cells assessed as compound phosphorylation by measuring conversion of compound to 5'-phosphate	B	Nc1ncnc2c1c(-c1c[nH]cn1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814779	=	Activity	%	47.0	CHEMBL3589	Homo sapiens	Activity	%	47.0
	15133959	CHEMBL3385543	Activity of human ADK expressed in Escherichia coli BL21(DE3) cells assessed as compound phosphorylation by measuring conversion of compound to 5'-phosphate	B	Nc1ncnc2c1c(-c1ncc[nH]1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814780	=	Activity	%	19.0	CHEMBL3589	Homo sapiens	Activity	%	19.0
	15133960	CHEMBL3385543	Activity of human ADK expressed in Escherichia coli BL21(DE3) cells assessed as compound phosphorylation by measuring conversion of compound to 5'-phosphate	B	Nc1ncnc2c1c(-c1c[nH]nn1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814777	=	Activity	%	37.0	CHEMBL3589	Homo sapiens	Activity	%	37.0
	15133961	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	C#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL1814776	=	IC50	nM	200.0	CHEMBL3589	Homo sapiens	IC50	uM	0.2
	15133962	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1ccccc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814762	>	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
	15133963	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	COc1ccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)cc1		CHEMBL1814763	>	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
	15133964	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	CSc1ccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)cc1		CHEMBL1814764	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	15133965	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1cccc3ccccc13)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814765	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	15133966	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1ccc3ccccc3c1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814766	>	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
	15133967	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1ccco1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814767	>	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
	15133968	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1ccoc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814769	>	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
	15133969	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1cccs1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814768	>	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
	15133970	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1ccsc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814770	>	IC50	nM	5000.0	CHEMBL3589	Homo sapiens	IC50	uM	5.0
	15133971	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1ccc[nH]1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814772	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	15133972	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1cc[nH]c1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814773	=	IC50	nM	4500.0	CHEMBL3589	Homo sapiens	IC50	uM	4.5
	15133973	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1nccs1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814778	=	IC50	nM	2300.0	CHEMBL3589	Homo sapiens	IC50	uM	2.3
	15133974	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1cc[nH]n1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814775	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	15133975	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1cn[nH]c1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814774	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	15133976	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1c[nH]cn1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814779	=	IC50	nM	13000.0	CHEMBL3589	Homo sapiens	IC50	uM	13.0
	15133977	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1ncc[nH]1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814780	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	15133978	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1c[nH]nn1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814777	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	15133979	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1cc3ccccc3o1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814771	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	15133980	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Cc1ccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)cc1C		CHEMBL3342659	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	15133981	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	CC(C)c1cccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)c1		CHEMBL3342660	=	IC50	nM	3300.0	CHEMBL3589	Homo sapiens	IC50	uM	3.3
	15133982	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	CC(C)c1ccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)cc1		CHEMBL3342661	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	15133983	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	CC(C)(C)c1ccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)cc1		CHEMBL3342662	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	15133984	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1ccc(C(F)(F)F)cc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342663	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	15133985	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	CC(C)Oc1ccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)cc1		CHEMBL3342664	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	15133986	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1ccc3c(c1)OCO3)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342665	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	15133987	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	COc1cc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)cc(OC)c1OC		CHEMBL3342666	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	15133988	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1ccc3c4c(cccc14)CC3)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342667	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	15133989	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1cc3ccccc3c3ccccc13)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342668	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	15133990	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1cccc3c1oc1ccccc13)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342669	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	15133991	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1cccc3c1Oc1ccccc1S3)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342670	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	15133992	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1cccc3c1Sc1ccccc1S3)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342671	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	15133993	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(/C=C/c1ccccc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342672	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	15133994	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1ccc(-c3ccccc3)cc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342673	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	15133995	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1ccc(-c3ccc4ccccc4c3)cc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342674	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
	15133996	CHEMBL3385544	Inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(-c1ccc(COc3cccc4ccccc34)cc1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342675	>	IC50	nM	20000.0	CHEMBL3589	Homo sapiens	IC50	uM	20.0
Active	15134177	CHEMBL3385550	Mixed uncompetitive inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using varying ATP levels by Lineweaver-Burk plot	B	C#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL1814776		Inhibition	%		CHEMBL3589	Homo sapiens	INH		
Active	15134179	CHEMBL3385552	Mixed competitive inhibition of human ADK expressed in Escherichia coli BL21(DE3) cells using varying adenosine levels by Lineweaver-Burk plot	B	C#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL1814776		Inhibition	%		CHEMBL3589	Homo sapiens	INH		
	15134181	CHEMBL3385554	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-1' at 500 uM by 1H STD NMR spectroscopy	B	C#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL1814776	=	Activity	%	100.0	CHEMBL3589	Homo sapiens	Activity	%	100.0
	15134182	CHEMBL3385554	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-1' at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1c(-c1ccco1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814767	=	Activity	%	100.0	CHEMBL3589	Homo sapiens	Activity	%	100.0
	15134183	CHEMBL3385554	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-1' at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1c(-c1nccs1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814778	=	Activity	%	100.0	CHEMBL3589	Homo sapiens	Activity	%	100.0
	15134184	CHEMBL3385554	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-1' at 500 uM by 1H STD NMR spectroscopy	B	CC(C)c1cccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)c1		CHEMBL3342660	=	Activity	%	100.0	CHEMBL3589	Homo sapiens	Activity	%	100.0
	15134185	CHEMBL3385554	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-1' at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1c(-c1cccc3c1Oc1ccccc1S3)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342670	=	Activity	%	100.0	CHEMBL3589	Homo sapiens	Activity	%	100.0
	15134186	CHEMBL3385554	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-1' at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL477	=	Activity	%	100.0	CHEMBL3589	Homo sapiens	Activity	%	100.0
	15134187	CHEMBL3385554	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-1' at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL14249	=	Activity	%	100.0	CHEMBL3589	Homo sapiens	Activity	%	100.0
	15134188	CHEMBL3385555	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-2 at 500 uM by 1H STD NMR spectroscopy	B	C#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL1814776	=	Activity	%	33.0	CHEMBL3589	Homo sapiens	Activity	%	33.0
	15134189	CHEMBL3385555	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-2 at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1c(-c1ccco1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814767	=	Activity	%	64.0	CHEMBL3589	Homo sapiens	Activity	%	64.0
	15134190	CHEMBL3385555	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-2 at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1c(-c1nccs1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814778	=	Activity	%	57.0	CHEMBL3589	Homo sapiens	Activity	%	57.0
	15134191	CHEMBL3385555	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-2 at 500 uM by 1H STD NMR spectroscopy	B	CC(C)c1cccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)c1		CHEMBL3342660	=	Activity	%	72.0	CHEMBL3589	Homo sapiens	Activity	%	72.0
	15134192	CHEMBL3385555	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-2 at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1c(-c1cccc3c1Oc1ccccc1S3)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342670	=	Activity	%	33.0	CHEMBL3589	Homo sapiens	Activity	%	33.0
	15134193	CHEMBL3385555	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-2 at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL477	=	Activity	%	8.0	CHEMBL3589	Homo sapiens	Activity	%	8.0
	15134194	CHEMBL3385555	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-2 at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL14249	<	Activity	%	1.0	CHEMBL3589	Homo sapiens	Activity	%	1.0
	15134195	CHEMBL3387398	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-8 at 500 uM by 1H STD NMR spectroscopy	B	C#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL1814776	=	Activity	%	17.0	CHEMBL3589	Homo sapiens	Activity	%	17.0
	15134196	CHEMBL3387398	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-8 at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1c(-c1ccco1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814767	=	Activity	%	36.0	CHEMBL3589	Homo sapiens	Activity	%	36.0
	15134197	CHEMBL3387398	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-8 at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1c(-c1nccs1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814778	=	Activity	%	41.0	CHEMBL3589	Homo sapiens	Activity	%	41.0
	15134198	CHEMBL3387398	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-8 at 500 uM by 1H STD NMR spectroscopy	B	CC(C)c1cccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)c1		CHEMBL3342660	=	Activity	%	72.0	CHEMBL3589	Homo sapiens	Activity	%	72.0
	15134199	CHEMBL3387398	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-8 at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1c(-c1cccc3c1Oc1ccccc1S3)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342670	=	Activity	%	39.0	CHEMBL3589	Homo sapiens	Activity	%	39.0
	15134200	CHEMBL3387398	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-8 at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL477	=	Activity	%	20.0	CHEMBL3589	Homo sapiens	Activity	%	20.0
	15134201	CHEMBL3387398	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from H-8 at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL14249	<	Activity	%	1.0	CHEMBL3589	Homo sapiens	Activity	%	1.0
	15134202	CHEMBL3387399	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from Ar at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1c(-c1ccco1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814767	=	Activity	%	74.0	CHEMBL3589	Homo sapiens	Activity	%	74.0
	15134203	CHEMBL3387399	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from Ar at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1c(-c1nccs1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814778	=	Activity	%	52.0	CHEMBL3589	Homo sapiens	Activity	%	52.0
	15134204	CHEMBL3387399	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from Ar at 500 uM by 1H STD NMR spectroscopy	B	CC(C)c1cccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)c1		CHEMBL3342660	=	Activity	%	52.0	CHEMBL3589	Homo sapiens	Activity	%	52.0
	15134205	CHEMBL3387399	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from Ar at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1c(-c1cccc3c1Oc1ccccc1S3)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342670	=	Activity	%	60.0	CHEMBL3589	Homo sapiens	Activity	%	60.0
	15134206	CHEMBL3387400	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from Ar' at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1c(-c1ccco1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814767	=	Activity	%	67.0	CHEMBL3589	Homo sapiens	Activity	%	67.0
	15134207	CHEMBL3387400	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from Ar' at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1c(-c1nccs1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814778	=	Activity	%	78.0	CHEMBL3589	Homo sapiens	Activity	%	78.0
	15134208	CHEMBL3387401	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells assessed as relative STD enhancements of signal from Ar'' at 500 uM by 1H STD NMR spectroscopy	B	Nc1ncnc2c1c(-c1ccco1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814767	=	Activity	%	78.0	CHEMBL3589	Homo sapiens	Activity	%	78.0
Active	15138677	CHEMBL3387408	Binding affinity to free human ADK expressed in Escherichia coli BL21(DE3) cells by two dimensional 15N/1H triple-resonance HSQC NMR spectroscopy	B	C#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL1814776		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	15138678	CHEMBL3387408	Binding affinity to free human ADK expressed in Escherichia coli BL21(DE3) cells by two dimensional 15N/1H triple-resonance HSQC NMR spectroscopy	B	Nc1ncnc2c1c(-c1ccco1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814767		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	15138679	CHEMBL3387408	Binding affinity to free human ADK expressed in Escherichia coli BL21(DE3) cells by two dimensional 15N/1H triple-resonance HSQC NMR spectroscopy	B	Nc1ncnc2c1c(-c1nccs1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814778		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	15138680	CHEMBL3387408	Binding affinity to free human ADK expressed in Escherichia coli BL21(DE3) cells by two dimensional 15N/1H triple-resonance HSQC NMR spectroscopy	B	CC(C)c1cccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)c1		CHEMBL3342660		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	15138681	CHEMBL3387408	Binding affinity to free human ADK expressed in Escherichia coli BL21(DE3) cells by two dimensional 15N/1H triple-resonance HSQC NMR spectroscopy	B	Nc1ncnc2c1c(-c1cccc3c1Oc1ccccc1S3)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342670		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	15138682	CHEMBL3387409	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells in presence of adenosine by two dimensional 15N/1H triple-resonance HSQC NMR spectroscopy	B	C#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL1814776		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	15138683	CHEMBL3387409	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells in presence of adenosine by two dimensional 15N/1H triple-resonance HSQC NMR spectroscopy	B	Nc1ncnc2c1c(-c1ccco1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814767		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	15138684	CHEMBL3387409	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells in presence of adenosine by two dimensional 15N/1H triple-resonance HSQC NMR spectroscopy	B	Nc1ncnc2c1c(-c1nccs1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814778		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	15138685	CHEMBL3387409	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells in presence of adenosine by two dimensional 15N/1H triple-resonance HSQC NMR spectroscopy	B	CC(C)c1cccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)c1		CHEMBL3342660		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	15138686	CHEMBL3387409	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells in presence of adenosine by two dimensional 15N/1H triple-resonance HSQC NMR spectroscopy	B	Nc1ncnc2c1c(-c1cccc3c1Oc1ccccc1S3)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342670		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	15138687	CHEMBL3387410	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells in presence of ATPgammaS by two dimensional 15N/1H triple-resonance HSQC NMR spectroscopy	B	C#Cc1cn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c2ncnc(N)c12		CHEMBL1814776		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	15138688	CHEMBL3387410	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells in presence of ATPgammaS by two dimensional 15N/1H triple-resonance HSQC NMR spectroscopy	B	Nc1ncnc2c1c(-c1ccco1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814767		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	15138689	CHEMBL3387410	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells in presence of ATPgammaS by two dimensional 15N/1H triple-resonance HSQC NMR spectroscopy	B	Nc1ncnc2c1c(-c1nccs1)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL1814778		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	15138690	CHEMBL3387410	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells in presence of ATPgammaS by two dimensional 15N/1H triple-resonance HSQC NMR spectroscopy	B	CC(C)c1cccc(-c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc(N)c23)c1		CHEMBL3342660		Activity			CHEMBL3589	Homo sapiens	Activity		
Active	15138691	CHEMBL3387410	Binding affinity to human ADK expressed in Escherichia coli BL21(DE3) cells in presence of ATPgammaS by two dimensional 15N/1H triple-resonance HSQC NMR spectroscopy	B	Nc1ncnc2c1c(-c1cccc3c1Oc1ccccc1S3)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL3342670		Activity			CHEMBL3589	Homo sapiens	Activity		
	15197527	CHEMBL3412566	Inhibition of adenosine kinase (unknown origin)	B	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL66089	=	IC50	nM	2.0	CHEMBL3589	Homo sapiens	IC50	nM	2.0
	16857674	CHEMBL3879661	Binding affinity to ADK in HEK293T cells at 50 uM incubated for 1 hr by mass spectrometry analysis relative to o-ML349-biotin	B	O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)NCCOCCOCCOCCn1cc(COc2ccc(N3CCN(C(=O)c4cc5c(s4)-c4ccccc4S(=O)(=O)C5)CC3)cc2)nn1		CHEMBL3944678	>	FC		5.0	CHEMBL3589	Homo sapiens	FC		5.0
	16857680	CHEMBL3879670	Binding affinity to ADK in HEK293T cells at 50 uM incubated for 1 hr by mass spectrometry analysis relative to azide-PEG3-biotin	B	O=C(CCCC[C@@H]1SC[C@@H]2NC(=O)N[C@H]12)NCCOCCOCCOCCn1cc(COc2ccc(N3CCN(C(=O)c4cc5c(s4)-c4ccccc4S(=O)(=O)C5)CC3)cc2)nn1		CHEMBL3944678	>	FC		5.0	CHEMBL3589	Homo sapiens	FC		5.0
Inactive	17882003	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882004	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882005	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882006	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882007	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882008	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882009	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882010	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882011	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882012	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882013	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882014	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882015	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882016	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882017	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882018	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882019	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882020	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882021	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882022	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882023	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882024	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882025	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882026	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882027	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882028	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882029	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882030	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882031	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882032	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882033	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882034	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882035	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882036	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882037	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882038	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882039	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882040	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882041	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882042	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882043	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882044	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882045	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882046	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882047	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882048	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882049	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882050	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882051	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882052	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882053	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882054	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882055	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882056	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882057	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882058	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882059	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882060	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882061	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882062	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882063	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882064	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882065	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882066	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882067	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882068	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882069	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882070	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882071	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882072	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882073	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882074	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882075	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882076	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882077	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882078	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882079	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882080	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882081	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882082	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17882083	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	=	Kd	nM	1163.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	1163.0
Inactive	17882084	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17882085	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	=	Kd	nM	1404.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	1404.0
Inactive	17882086	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882087	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882088	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882089	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882090	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882091	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882092	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882093	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882094	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882095	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882096	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882097	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882098	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882099	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882100	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882101	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882102	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882103	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882104	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882105	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882106	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882107	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882108	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882109	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882110	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882111	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Active	17882112	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	=	Kd	nM	13.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	13.0
Inactive	17882113	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882114	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882115	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Active	17882116	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	=	Kd	nM	2507.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	2507.0
Inactive	17882117	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882118	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882119	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882120	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882121	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882122	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882123	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882124	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882125	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882126	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882127	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882128	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882129	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882130	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882131	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882132	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882133	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882134	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882135	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882136	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882137	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882138	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882139	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882140	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882141	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882142	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882143	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17882144	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	=	Kd	nM	2441.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	2441.0
Inactive	17882145	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882146	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882147	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882148	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882149	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882150	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882151	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882152	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882153	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882154	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882155	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882156	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882157	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882158	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882159	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882160	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882161	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882162	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882163	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882164	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882165	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882166	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882167	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882168	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882169	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882170	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882171	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882172	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882173	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882174	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882175	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882176	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882177	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882178	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882179	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882180	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882181	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882182	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882183	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882184	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882185	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882186	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882187	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882188	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882189	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882190	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882191	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882192	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882193	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882194	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882195	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882196	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882197	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882198	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882199	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882200	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882201	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882202	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882203	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882204	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882205	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882206	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882207	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882208	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Active	17882209	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	=	Kd	nM	3493.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	3493.0
Inactive	17882210	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882211	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882212	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882213	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882214	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882215	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882216	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882217	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882218	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882219	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882220	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882221	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882222	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882223	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882224	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882225	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882226	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882227	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882228	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882229	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882230	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882231	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882232	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17882233	CHEMBL3991620	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL3589	Homo sapiens	Kd apparent	nM	30000.0
Metabolite_Detected	18039163	CHEMBL4009446	Drug level assessed as human ADK-mediated compound formation treated with 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3',2':4,5]-pyrrolo[2,3-d]pyrimidine at 50 uM after 30 mins by HPLC analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039164	CHEMBL4009445	Drug level assessed as human ADK-mediated compound formation treated with 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2',3':4,5]-pyrrolo[2,3-d]pyrimidine at 50 uM after 30 mins by HPLC analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039165	CHEMBL4009435	Drug level in human HCT116 cells assessed as ADK-mediated compound formation treated with 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2',3':4,5]-pyrrolo[2,3-d]pyrimidine at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039166	CHEMBL4009434	Drug level in human HCT116 cells assessed as ADK-mediated compound formation treated with 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2',3':4,5]-pyrrolo[2,3-d]pyrimidine at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039167	CHEMBL4009433	Drug level in human HCT116 cells assessed as ADK-mediated compound formation treated with 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2',3':4,5]-pyrrolo[2,3-d]pyrimidine at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039168	CHEMBL4009432	Drug level in human HCT116 cells assessed as ADK-mediated compound formation treated with 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2',3':4,5]-pyrrolo[2,3-d]pyrimidine at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039169	CHEMBL4009431	Drug level in human BJ cells assessed as ADK-mediated compound formation treated with 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2',3':4,5]-pyrrolo[2,3-d]pyrimidine at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039170	CHEMBL4009430	Drug level in human BJ cells assessed as ADK-mediated compound formation treated with 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2',3':4,5]-pyrrolo[2,3-d]pyrimidine at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039171	CHEMBL4009429	Drug level in human BJ cells assessed as ADK-mediated compound formation treated with 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2',3':4,5]-pyrrolo[2,3-d]pyrimidine at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039172	CHEMBL4009428	Drug level in human BJ cells assessed as ADK-mediated compound formation treated with 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2',3':4,5]-pyrrolo[2,3-d]pyrimidine at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
	18039344	CHEMBL4009402	Drug metabolism in human BJ cells assessed as ADK-mediated 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2, 3:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001	=	Drug metabolism	pmol	19751.3	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	19751.3
	18039345	CHEMBL4009403	Drug metabolism in human HCT116 cells assessed as ADK-mediated 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2, 3:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001	=	Drug metabolism	pmol	4124.0	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	4124.0
	18039346	CHEMBL4009404	Drug metabolism in human BJ cells assessed as ADK-mediated 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2, 3:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001	=	Drug metabolism	pmol	27253.4	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	27253.4
	18039347	CHEMBL4009405	Drug metabolism in human HCT116 cells assessed as ADK-mediated 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2, 3:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001	=	Drug metabolism	pmol	5737.8	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	5737.8
	18039348	CHEMBL4009406	Drug metabolism in human BJ cells assessed as ADK-mediated 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2, 3:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001	=	Drug metabolism	pmol	62703.9	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	62703.9
	18039349	CHEMBL4009407	Drug metabolism in human HCT116 cells assessed as ADK-mediated 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2, 3:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001	=	Drug metabolism	pmol	6108.2	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	6108.2
	18039350	CHEMBL4009408	Drug metabolism in human BJ cells assessed as ADK-mediated 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2, 3:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001	=	Drug metabolism	pmol	65894.4	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	65894.4
	18039351	CHEMBL4009409	Drug metabolism in human HCT116 cells assessed as ADK-mediated 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2, 3:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4084001	=	Drug metabolism	pmol	15246.3	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	15246.3
	18039352	CHEMBL4009425	Drug metabolism assessed as conversion to human ADK-mediated 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3,2:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt at 50 uM after 30 mins by HPLC analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4100457	=	Drug metabolism	%	11.0	CHEMBL3589	Homo sapiens	Drug metabolism	%	11.0
	18039537	CHEMBL4009416	Drug metabolism in human BJ cells assessed as ADK-mediated 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3,2:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283	=	Drug metabolism	pmol	13.8	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	13.8
	18039538	CHEMBL4009417	Drug metabolism in human HCT116 cells assessed as ADK-mediated 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3,2:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283	=	Drug metabolism	pmol	76.2	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	76.2
	18039539	CHEMBL4009418	Drug metabolism in human BJ cells assessed as ADK-mediated 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3,2:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283	=	Drug metabolism	pmol	4933.3	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	4933.3
	18039540	CHEMBL4009419	Drug metabolism in human HCT116 cells assessed as ADK-mediated 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3,2:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283	=	Drug metabolism	pmol	75.6	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	75.6
	18039541	CHEMBL4009420	Drug metabolism in human BJ cells assessed as ADK-mediated 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3,2:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283	=	Drug metabolism	pmol	6694.3	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	6694.3
	18039542	CHEMBL4009421	Drug metabolism in human HCT116 cells assessed as ADK-mediated 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3,2:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283	=	Drug metabolism	pmol	98.5	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	98.5
	18039543	CHEMBL4009422	Drug metabolism in human BJ cells assessed as ADK-mediated 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3,2:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283	=	Drug metabolism	pmol	6862.8	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	6862.8
	18039544	CHEMBL4009423	Drug metabolism in human HCT116 cells assessed as ADK-mediated 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3,2:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt formation per 5 x10'5 cells at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283	=	Drug metabolism	pmol	144.3	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	144.3
	18039545	CHEMBL4009424	Drug metabolism assessed as conversion to human ADK-mediated 4-(Methylsulfanyl)-8-(beta-D-ribofuranosyl)-8H-thieno[2, 3:4,5]-pyrrolo[2,3-d]pyrimidine-5-O-monophosphate Sodium Salt at 50 uM after 30 mins by HPLC analysis	A	CSc1ncnc2c1c1sccc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4078608	=	Drug metabolism	%	41.0	CHEMBL3589	Homo sapiens	Drug metabolism	%	41.0
Metabolite_Detected	18039546	CHEMBL4009436	Drug level in human BJ cells assessed as ADK-mediated compound formation treated with 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3',2':4,5]-pyrrolo[2,3-d]pyrimidine at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039547	CHEMBL4009437	Drug level in human BJ cells assessed as ADK-mediated compound formation treated with 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3',2':4,5]-pyrrolo[2,3-d]pyrimidine at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039548	CHEMBL4009438	Drug level in human BJ cells assessed as ADK-mediated compound formation treated with 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3',2':4,5]-pyrrolo[2,3-d]pyrimidine at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039549	CHEMBL4009439	Drug level in human BJ cells assessed as ADK-mediated compound formation treated with 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3',2':4,5]-pyrrolo[2,3-d]pyrimidine at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039550	CHEMBL4009440	Drug level in human HCT116 cells assessed as ADK-mediated compound formation treated with 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3',2':4,5]-pyrrolo[2,3-d]pyrimidine at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039551	CHEMBL4009441	Drug level in human HCT116 cells assessed as ADK-mediated compound formation treated with 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3',2':4,5]-pyrrolo[2,3-d]pyrimidine at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039552	CHEMBL4009442	Drug level in human HCT116 cells assessed as ADK-mediated compound formation treated with 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3',2':4,5]-pyrrolo[2,3-d]pyrimidine at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
Metabolite_Detected	18039553	CHEMBL4009443	Drug level in human HCT116 cells assessed as ADK-mediated compound formation treated with 4-Methylsulfanyl-8-(beta-D-ribofuranosyl)-8H-thieno[3',2':4,5]-pyrrolo[2,3-d]pyrimidine at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	CSc1ncnc2c1c1ccsc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4062283		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
	18039554	CHEMBL4009427	Drug metabolism assessed as conversion to human ADK-mediated adenosine monophosphate at 50 uM after 30 mins by HPLC analysis	A	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL477	=	Drug metabolism	%	60.0	CHEMBL3589	Homo sapiens	Drug metabolism	%	60.0
Metabolite_Detected	18039555	CHEMBL4009444	Drug level assessed as human ADK-mediated compound formation treated with adenosine at 50 uM after 30 mins by HPLC analysis	A	Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O		CHEMBL752		Drug metabolism			CHEMBL3589	Homo sapiens	Drug metabolism		
	18513464	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	O=C1c2cccn2-c2ccccc2SC1c1cccc2ccccc12		CHEMBL4214720	>	Ki	nM	50000.0	CHEMBL3589	Homo sapiens	Ki	uM	50.0
	18513465	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	O=C1c2cccn2-c2ccccc2SC1c1cccc2ccccc12		CHEMBL4214720	>	IC50	nM	50000.0	CHEMBL3589	Homo sapiens	IC50	uM	50.0
Not Determined	18513466	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccccc1		CHEMBL4203063		IC50			CHEMBL3589	Homo sapiens	IC50		
Not Determined	18513467	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	Cc1ccc(CN2C(=O)C(c3cccc4ccccc34)Oc3ccccc32)cc1		CHEMBL4204473		IC50			CHEMBL3589	Homo sapiens	IC50		
	18513468	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc(F)cc1		CHEMBL4216137	=	IC50	nM	40000.0	CHEMBL3589	Homo sapiens	IC50	uM	40.0
Not Determined	18513469	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc(Cl)cc1		CHEMBL4216653		IC50			CHEMBL3589	Homo sapiens	IC50		
Not Determined	18513470	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2ccccc2N1Cc1ccc([N+](=O)[O-])cc1		CHEMBL4211676		IC50			CHEMBL3589	Homo sapiens	IC50		
	18513471	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	COc1ccc(CN2C(=O)C(c3cccc4ccccc34)Oc3ccccc32)cc1		CHEMBL4213199	=	IC50	nM	31600.0	CHEMBL3589	Homo sapiens	IC50	uM	31.6
	18513472	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	O=C1C(c2ccc3ccccc3c2)Oc2ccccc2N1Cc1ccc(F)cc1		CHEMBL4208269	=	IC50	nM	32200.0	CHEMBL3589	Homo sapiens	IC50	uM	32.2
Not Determined	18513473	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	O=C(c1ccccc1)N1CC(c2cccc3ccccc23)Oc2ccccc21		CHEMBL4208804		IC50			CHEMBL3589	Homo sapiens	IC50		
	18513474	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	O=S(=O)(c1ccccc1)N1CC(c2cccc3ccccc23)Oc2ccccc21		CHEMBL4203924	=	IC50	nM	57400.0	CHEMBL3589	Homo sapiens	IC50	uM	57.4
	18513475	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2cc(F)ccc2N1Cc1ccc(F)cc1		CHEMBL4205360	=	IC50	nM	24700.0	CHEMBL3589	Homo sapiens	IC50	uM	24.7
	18513476	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2cc(N3CCOCC3)ccc2N1Cc1ccc(F)cc1		CHEMBL4217077	>	IC50	nM	50000.0	CHEMBL3589	Homo sapiens	IC50	uM	50.0
	18513477	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2cc3c(cc2N1Cc1ccccc1)OCO3		CHEMBL4216522	=	IC50	nM	13600.0	CHEMBL3589	Homo sapiens	IC50	uM	13.6
	18513478	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	O=C1C(c2cccc3ccccc23)Oc2cc3c(cc2N1Cc1ccc(F)cc1)OCO3		CHEMBL4204838	>	IC50	nM	50000.0	CHEMBL3589	Homo sapiens	IC50	uM	50.0
	18513479	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	CN1C(=O)C(c2cccc3ccccc23)Oc2cc3c(cc21)OCO3		CHEMBL4212073	>	IC50	nM	50000.0	CHEMBL3589	Homo sapiens	IC50	uM	50.0
	18513480	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	CCN1C(=O)C(c2cccc3ccccc23)Oc2cc3c(cc21)OCO3		CHEMBL4217051	>	IC50	nM	50000.0	CHEMBL3589	Homo sapiens	IC50	uM	50.0
	18513481	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	O=C1C(c2ccc3ccccc3c2)Oc2cc3c(cc2N1Cc1ccccc1)OCO3		CHEMBL4208658	=	IC50	nM	13700.0	CHEMBL3589	Homo sapiens	IC50	uM	13.7
	18513482	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	O=C1Nc2cc3c(c(Cc4ccccc4)c2OC1c1ccccc1)OCO3		CHEMBL4213595	>	IC50	nM	50000.0	CHEMBL3589	Homo sapiens	IC50	uM	50.0
	18513483	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	CN1C(=O)C(c2ccccc2)Oc2cc3c(cc21)OCO3		CHEMBL4204332	>	IC50	nM	50000.0	CHEMBL3589	Homo sapiens	IC50	uM	50.0
	18513484	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	CCN1C(=O)C(c2ccccc2)Oc2cc3c(cc21)OCO3		CHEMBL4209197	>	IC50	nM	50000.0	CHEMBL3589	Homo sapiens	IC50	uM	50.0
	18513485	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	CC(=O)Oc1[nH]c2ccccc2c1-c1ccc(C)cc1		CHEMBL4215567	=	IC50	nM	50000.0	CHEMBL3589	Homo sapiens	IC50	uM	50.0
	18513486	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	CC(=O)Oc1[nH]c2ccccc2c1-c1cccc2ccccc12		CHEMBL4203890	=	IC50	nM	13600.0	CHEMBL3589	Homo sapiens	IC50	uM	13.6
Not Determined	18513487	CHEMBL4192332	Inhibition of recombinant human His-tagged AK using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method	B	CCN(CC)C(=O)Oc1[nH]c2ccccc2c1-c1cccc2ccccc12		CHEMBL4207131		IC50			CHEMBL3589	Homo sapiens	IC50		
	18513512	CHEMBL4192329	Inhibition of human AK	B	CCC1(c2ccc(CSc3ccccc3)cc2)Oc2ccccc2-n2cccc2C1=O		CHEMBL1688496	=	IC50	nM	1200.0	CHEMBL3589	Homo sapiens	IC50	uM	1.2
	18513513	CHEMBL4192330	Inhibition of recombinant human His-tagged AK at 50 uM using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method relative to control	B	O=C1c2cccn2-c2ccccc2SC1c1cccc2ccccc12		CHEMBL4214720	=	Inhibition	%	33.0	CHEMBL3589	Homo sapiens	INH	%	33.0
	18513514	CHEMBL4192330	Inhibition of recombinant human His-tagged AK at 50 uM using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method relative to control	B	O=C1C(c2cccc3ccccc23)Oc2cc3c(cc2N1Cc1ccc(F)cc1)OCO3		CHEMBL4204838	=	Inhibition	%	12.0	CHEMBL3589	Homo sapiens	INH	%	12.0
	18513515	CHEMBL4192330	Inhibition of recombinant human His-tagged AK at 50 uM using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method relative to control	B	CN1C(=O)C(c2cccc3ccccc23)Oc2cc3c(cc21)OCO3		CHEMBL4212073	=	Inhibition	%	12.0	CHEMBL3589	Homo sapiens	INH	%	12.0
	18513516	CHEMBL4192330	Inhibition of recombinant human His-tagged AK at 50 uM using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method relative to control	B	CCN1C(=O)C(c2cccc3ccccc23)Oc2cc3c(cc21)OCO3		CHEMBL4217051	=	Inhibition	%	8.0	CHEMBL3589	Homo sapiens	INH	%	8.0
	18513517	CHEMBL4192330	Inhibition of recombinant human His-tagged AK at 50 uM using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method relative to control	B	O=C1Nc2cc3c(c(Cc4ccccc4)c2OC1c1ccccc1)OCO3		CHEMBL4213595	=	Inhibition	%	40.0	CHEMBL3589	Homo sapiens	INH	%	40.0
	18513518	CHEMBL4192330	Inhibition of recombinant human His-tagged AK at 50 uM using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method relative to control	B	CN1C(=O)C(c2ccccc2)Oc2cc3c(cc21)OCO3		CHEMBL4204332	=	Inhibition	%	10.0	CHEMBL3589	Homo sapiens	INH	%	10.0
	18513519	CHEMBL4192330	Inhibition of recombinant human His-tagged AK at 50 uM using [2,8-3H]-adenosine as substrate after 20 mins by microbeta counting method relative to control	B	CCN1C(=O)C(c2ccccc2)Oc2cc3c(cc21)OCO3		CHEMBL4209197	=	Inhibition	%	5.0	CHEMBL3589	Homo sapiens	INH	%	5.0
	18947289	CHEMBL4330260	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4556133	=	Drug metabolism	pmol	220.92	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	220.92
	18947290	CHEMBL4330260	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4513241	=	Drug metabolism	pmol	223.51	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	223.51
	18947291	CHEMBL4330261	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4556133	=	Drug metabolism	pmol	466.96	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	466.96
	18947292	CHEMBL4330261	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4513241	=	Drug metabolism	pmol	511.81	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	511.81
	18947293	CHEMBL4330262	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4556133	=	Drug metabolism	pmol	332.63	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	332.63
	18947294	CHEMBL4330262	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4513241	=	Drug metabolism	pmol	241.05	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	241.05
	18947295	CHEMBL4330263	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4556133	=	Drug metabolism	pmol	1079.19	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	1079.19
	18947296	CHEMBL4330263	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4513241	=	Drug metabolism	pmol	1167.4	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	1167.4
	18947297	CHEMBL4330264	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4556133	=	Drug metabolism	pmol	1531.57	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	1531.57
	18947298	CHEMBL4330264	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4513241	=	Drug metabolism	pmol	4488.64	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	4488.64
	18947299	CHEMBL4330265	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4556133	=	Drug metabolism	pmol	8868.83	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	8868.83
	18947300	CHEMBL4330265	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4513241	=	Drug metabolism	pmol	9531.67	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	9531.67
	18947301	CHEMBL4330266	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4556133	=	Drug metabolism	pmol	5041.67	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	5041.67
	18947302	CHEMBL4330266	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4513241	=	Drug metabolism	pmol	4920.41	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	4920.41
	18947303	CHEMBL4330267	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4556133	=	Drug metabolism	pmol	12049.83	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	12049.83
	18947304	CHEMBL4330267	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation level per 5x10'5 cells at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](COP(=O)([O-])O)[C@@H](O)[C@H]1O.[Na+]		CHEMBL4513241	=	Drug metabolism	pmol	12533.33	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	12533.33
	18947305	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	Cn1ccc2c1c1c(-c3ccco3)ncnc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4580524	=	Activity	%	11.0	CHEMBL3589	Homo sapiens	Activity	%	11.0
	18947306	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	Cn1ccc2c1c1c(-c3ccoc3)ncnc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4585392	=	Activity	%	9.0	CHEMBL3589	Homo sapiens	Activity	%	9.0
	18947307	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	Cn1ccc2c1c1c(-c3cc4ccccc4o3)ncnc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4470770	=	Activity	%	0.0	CHEMBL3589	Homo sapiens	Activity	%	0.0
	18947308	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4467186	=	Activity	%	42.0	CHEMBL3589	Homo sapiens	Activity	%	42.0
	18947309	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	CN(C)c1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4589668	=	Activity	%	0.0	CHEMBL3589	Homo sapiens	Activity	%	0.0
	18947310	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	Cn1ccc2c1c1c(N)ncnc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4556165	=	Activity	%	68.0	CHEMBL3589	Homo sapiens	Activity	%	68.0
	18947311	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	COc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4450152	=	Activity	%	47.0	CHEMBL3589	Homo sapiens	Activity	%	47.0
	18947312	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	CSc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4567695	=	Activity	%	33.0	CHEMBL3589	Homo sapiens	Activity	%	33.0
	18947313	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	Cn1ccc2c1c1c(Cl)ncnc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4532596	=	Activity	%	77.0	CHEMBL3589	Homo sapiens	Activity	%	77.0
	18947314	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	Cn1ccc2c3c(-c4ccco4)ncnc3n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c21		CHEMBL4576288	=	Activity	%	0.0	CHEMBL3589	Homo sapiens	Activity	%	0.0
	18947315	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	Cn1ccc2c3c(-c4ccoc4)ncnc3n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c21		CHEMBL4556038	=	Activity	%	0.0	CHEMBL3589	Homo sapiens	Activity	%	0.0
	18947316	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	Cn1ccc2c3c(-c4cc5ccccc5o4)ncnc3n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c21		CHEMBL4554008	=	Activity	%	0.0	CHEMBL3589	Homo sapiens	Activity	%	0.0
	18947317	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	Cc1ncnc2c1c1ccn(C)c1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4454930	=	Activity	%	0.0	CHEMBL3589	Homo sapiens	Activity	%	0.0
	18947318	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	CN(C)c1ncnc2c1c1ccn(C)c1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4462448	=	Activity	%	0.0	CHEMBL3589	Homo sapiens	Activity	%	0.0
	18947319	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	Cn1ccc2c3c(N)ncnc3n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c21		CHEMBL4517245	=	Activity	%	0.0	CHEMBL3589	Homo sapiens	Activity	%	0.0
	18947320	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	COc1ncnc2c1c1ccn(C)c1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4462344	=	Activity	%	0.0	CHEMBL3589	Homo sapiens	Activity	%	0.0
	18947321	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	CSc1ncnc2c1c1ccn(C)c1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4476539	=	Activity	%	0.0	CHEMBL3589	Homo sapiens	Activity	%	0.0
	18947322	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	Cn1ccc2c3c(Cl)ncnc3n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c21		CHEMBL4543054	=	Activity	%	0.0	CHEMBL3589	Homo sapiens	Activity	%	0.0
	18947323	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	OC[C@H]1O[C@@H](n2c3ccoc3c3c(-c4ccco4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4455893	=	Activity	%	34.0	CHEMBL3589	Homo sapiens	Activity	%	34.0
	18947324	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	OC[C@H]1O[C@@H](n2c3ccoc3c3c(-c4ccoc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4589727	=	Activity	%	38.0	CHEMBL3589	Homo sapiens	Activity	%	38.0
	18947325	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	OC[C@H]1O[C@@H](n2c3ccoc3c3c(-c4cc5ccccc5o4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4438098	=	Activity	%	58.0	CHEMBL3589	Homo sapiens	Activity	%	58.0
	18947326	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4585910	=	Activity	%	48.0	CHEMBL3589	Homo sapiens	Activity	%	48.0
	18947327	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	CN(C)c1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4458110	=	Activity	%	7.0	CHEMBL3589	Homo sapiens	Activity	%	7.0
	18947328	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	Nc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4447775	=	Activity	%	75.0	CHEMBL3589	Homo sapiens	Activity	%	75.0
	18947329	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	COc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4483740	=	Activity	%	35.0	CHEMBL3589	Homo sapiens	Activity	%	35.0
	18947330	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	CSc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4591383	=	Activity	%	56.0	CHEMBL3589	Homo sapiens	Activity	%	56.0
	18947331	CHEMBL4330268	Substrate activity at recombinant human ADK assessed as compound phosphorylation at 50 uM after 20 mins in presence of [3H]-adenosine by UPLC	A	Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL477	=	Activity	%	73.0	CHEMBL3589	Homo sapiens	Activity	%	73.0
	18947332	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	Cn1ccc2c1c1c(-c3ccco3)ncnc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4580524	=	IC50	nM	7120.0	CHEMBL3589	Homo sapiens	IC50	uM	7.12
	18947333	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	Cn1ccc2c1c1c(-c3ccoc3)ncnc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4585392	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947334	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	Cn1ccc2c1c1c(-c3cc4ccccc4o3)ncnc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4470770	=	IC50	nM	300.0	CHEMBL3589	Homo sapiens	IC50	uM	0.3
	18947335	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4467186	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947336	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	CN(C)c1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4589668	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947337	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	Cn1ccc2c1c1c(N)ncnc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4556165	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947338	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	COc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4450152	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947339	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	CSc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4567695	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947340	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	Cn1ccc2c1c1c(Cl)ncnc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4532596	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947341	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	Cn1ccc2c3c(-c4ccco4)ncnc3n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c21		CHEMBL4576288	=	IC50	nM	3580.0	CHEMBL3589	Homo sapiens	IC50	uM	3.58
	18947342	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	Cn1ccc2c3c(-c4ccoc4)ncnc3n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c21		CHEMBL4556038	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947343	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	Cn1ccc2c3c(-c4cc5ccccc5o4)ncnc3n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c21		CHEMBL4554008	=	IC50	nM	470.0	CHEMBL3589	Homo sapiens	IC50	uM	0.47
	18947344	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	Cc1ncnc2c1c1ccn(C)c1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4454930	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947345	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	CN(C)c1ncnc2c1c1ccn(C)c1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4462448	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947346	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	Cn1ccc2c3c(N)ncnc3n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c21		CHEMBL4517245	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947347	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	COc1ncnc2c1c1ccn(C)c1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4462344	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947348	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	CSc1ncnc2c1c1ccn(C)c1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4476539	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947349	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	Cn1ccc2c3c(Cl)ncnc3n([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c21		CHEMBL4543054	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947350	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	OC[C@H]1O[C@@H](n2c3ccoc3c3c(-c4ccco4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4455893	=	IC50	nM	3940.0	CHEMBL3589	Homo sapiens	IC50	uM	3.94
	18947351	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	OC[C@H]1O[C@@H](n2c3ccoc3c3c(-c4ccoc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4589727	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947352	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	OC[C@H]1O[C@@H](n2c3ccoc3c3c(-c4cc5ccccc5o4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4438098	=	IC50	nM	336.0	CHEMBL3589	Homo sapiens	IC50	uM	0.336
	18947353	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4585910	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947354	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	CN(C)c1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4458110	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947355	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	Nc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4447775	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947356	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	COc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4483740	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947357	CHEMBL4330269	Inhibition of recombinant human ADK using [3H]-adenosine as substrate after 20 mins by TLC scanner-based analysis relative to control	B	CSc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4591383	>	IC50	nM	10000.0	CHEMBL3589	Homo sapiens	IC50	uM	10.0
	18947552	CHEMBL4330297	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4467186	=	Drug metabolism	pmol	87.1	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	87.1
	18947553	CHEMBL4330297	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4585910	=	Drug metabolism	pmol	155.12	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	155.12
	18947554	CHEMBL4330298	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4467186	=	Drug metabolism	pmol	54.04	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	54.04
	18947555	CHEMBL4330298	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 1 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4585910	=	Drug metabolism	pmol	27.92	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	27.92
	18947556	CHEMBL4330299	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4467186	=	Drug metabolism	pmol	173.96	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	173.96
	18947557	CHEMBL4330299	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4585910	=	Drug metabolism	pmol	247.21	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	247.21
	18947558	CHEMBL4330300	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4467186	=	Drug metabolism	pmol	136.87	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	136.87
	18947559	CHEMBL4330300	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 1 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4585910	=	Drug metabolism	pmol	66.31	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	66.31
	18947560	CHEMBL4330301	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4467186	=	Drug metabolism	pmol	220.71	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	220.71
	18947561	CHEMBL4330301	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4585910	=	Drug metabolism	pmol	338.91	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	338.91
	18947562	CHEMBL4330302	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4467186	=	Drug metabolism	pmol	450.1	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	450.1
	18947563	CHEMBL4330302	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 10 umol/L after 1 hr by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4585910	=	Drug metabolism	pmol	119.93	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	119.93
	18947564	CHEMBL4330303	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4467186	=	Drug metabolism	pmol	753.01	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	753.01
	18947565	CHEMBL4330303	Drug metabolism in human BJ cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4585910	=	Drug metabolism	pmol	464.66	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	464.66
	18947566	CHEMBL4330304	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1c(ccn1C)n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4467186	=	Drug metabolism	pmol	476.53	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	476.53
	18947567	CHEMBL4330304	Drug metabolism in human HCT116 cells assessed as ADK-mediated compound phosphorylation by measuring parent compound level per 5x10'5 cells at 10 umol/L after 3 hrs by UPLC-MS/MS analysis	A	Cc1ncnc2c1c1occc1n2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4585910	=	Drug metabolism	pmol	177.9	CHEMBL3589	Homo sapiens	Drug metabolism	pmol	177.9
	19220040	CHEMBL4394895	Inhibition of purified human adenosine kinase using varying levels of [3H]Ado as substrate in presence of adenosine deaminase inhibitor deoxycoformycin by Line-weaver burk plot analysis	A	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Ki	nM	30.0	CHEMBL3589	Homo sapiens	Ki	nM	30.0
	19220059	CHEMBL4394901	Inhibition of recombinant human adenosine kinase expressed in Escherichia coli BL21 (DE3) using adenosine as substrate in presence of ATP and PEP by pyruvate kinase-lactate dehydrogenase-coupled UV-vis spectrophotometric assay	A	OC[C@H]1O[C@@H](n2cnc3c(N4CCN(c5ccccc5)CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL2042164	=	Ki	nM	5100.0	CHEMBL3589	Homo sapiens	Ki	uM	5.1
	19220060	CHEMBL4394901	Inhibition of recombinant human adenosine kinase expressed in Escherichia coli BL21 (DE3) using adenosine as substrate in presence of ATP and PEP by pyruvate kinase-lactate dehydrogenase-coupled UV-vis spectrophotometric assay	A	OC[C@H]1O[C@@H](n2cnc3c(N4CCN(c5ccc(-c6ccccc6)cc5)CC4)ccnc32)[C@H](O)[C@@H]1O		CHEMBL4448092	>	Ki	nM	50000.0	CHEMBL3589	Homo sapiens	Ki	uM	50.0
	19220061	CHEMBL4394901	Inhibition of recombinant human adenosine kinase expressed in Escherichia coli BL21 (DE3) using adenosine as substrate in presence of ATP and PEP by pyruvate kinase-lactate dehydrogenase-coupled UV-vis spectrophotometric assay	A	COc1ccc(-c2ccc(N3CCN(c4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)CC3)cc2)cn1		CHEMBL4475059	>	Ki	nM	50000.0	CHEMBL3589	Homo sapiens	Ki	uM	50.0
	19220062	CHEMBL4394901	Inhibition of recombinant human adenosine kinase expressed in Escherichia coli BL21 (DE3) using adenosine as substrate in presence of ATP and PEP by pyruvate kinase-lactate dehydrogenase-coupled UV-vis spectrophotometric assay	A	CC(C)(O)c1ccc(-c2ccc(N3CCN(c4ncnc5c4ncn5[C@@H]4O[C@H](CO)[C@@H](O)[C@H]4O)CC3)cc2)cc1		CHEMBL4566815	>	Ki	nM	50000.0	CHEMBL3589	Homo sapiens	Ki	uM	50.0
	19220063	CHEMBL4394901	Inhibition of recombinant human adenosine kinase expressed in Escherichia coli BL21 (DE3) using adenosine as substrate in presence of ATP and PEP by pyruvate kinase-lactate dehydrogenase-coupled UV-vis spectrophotometric assay	A	OC[C@H]1O[C@@H](n2cnc3c(-c4ccc(C#Cc5ccccc5)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4449169	>	Ki	nM	50000.0	CHEMBL3589	Homo sapiens	Ki	uM	50.0
	19220064	CHEMBL4394901	Inhibition of recombinant human adenosine kinase expressed in Escherichia coli BL21 (DE3) using adenosine as substrate in presence of ATP and PEP by pyruvate kinase-lactate dehydrogenase-coupled UV-vis spectrophotometric assay	A	OC[C@H]1O[C@@H](n2cnc3c(N4CCN(c5ccc(-c6ccc(C(F)(F)F)cc6)cc5)CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4525944	>	Ki	nM	50000.0	CHEMBL3589	Homo sapiens	Ki	uM	50.0
	19220065	CHEMBL4394901	Inhibition of recombinant human adenosine kinase expressed in Escherichia coli BL21 (DE3) using adenosine as substrate in presence of ATP and PEP by pyruvate kinase-lactate dehydrogenase-coupled UV-vis spectrophotometric assay	A	OC[C@H]1O[C@@H](n2cnc3c(N4CCN(c5ccc(-c6cnn(C(F)F)c6)cc5)CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4539148	>=	Ki	nM	15100.0	CHEMBL3589	Homo sapiens	Ki	uM	15.1
	19220066	CHEMBL4394901	Inhibition of recombinant human adenosine kinase expressed in Escherichia coli BL21 (DE3) using adenosine as substrate in presence of ATP and PEP by pyruvate kinase-lactate dehydrogenase-coupled UV-vis spectrophotometric assay	A	OC[C@H]1O[C@@H](n2cnc3c(N4CCN(c5ccc(-c6cccc(CN7CCOCC7)c6)cc5)CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4442160	=	Ki	nM	410.0	CHEMBL3589	Homo sapiens	Ki	uM	0.41
	19220067	CHEMBL4394901	Inhibition of recombinant human adenosine kinase expressed in Escherichia coli BL21 (DE3) using adenosine as substrate in presence of ATP and PEP by pyruvate kinase-lactate dehydrogenase-coupled UV-vis spectrophotometric assay	A	OC[C@H]1C[C@@H](n2cnc3c(N4CCN(c5ccc(-c6ccccc6)cc5)CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4458246	>	Ki	nM	50000.0	CHEMBL3589	Homo sapiens	Ki	uM	50.0
	19220068	CHEMBL4394901	Inhibition of recombinant human adenosine kinase expressed in Escherichia coli BL21 (DE3) using adenosine as substrate in presence of ATP and PEP by pyruvate kinase-lactate dehydrogenase-coupled UV-vis spectrophotometric assay	A	OC[C@H]1O[C@@H](n2cnc3c(N4CCN(c5ccc(-c6ccc(C(F)(F)F)nc6)cc5)CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4463459	=	Ki	nM	1600.0	CHEMBL3589	Homo sapiens	Ki	uM	1.6
	19220069	CHEMBL4394901	Inhibition of recombinant human adenosine kinase expressed in Escherichia coli BL21 (DE3) using adenosine as substrate in presence of ATP and PEP by pyruvate kinase-lactate dehydrogenase-coupled UV-vis spectrophotometric assay	A	OC[C@H]1O[C@@H](n2cnc3c(C#Cc4ccc(-c5ccccc5)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4474951	>	Ki	nM	50000.0	CHEMBL3589	Homo sapiens	Ki	uM	50.0
	19220070	CHEMBL4394901	Inhibition of recombinant human adenosine kinase expressed in Escherichia coli BL21 (DE3) using adenosine as substrate in presence of ATP and PEP by pyruvate kinase-lactate dehydrogenase-coupled UV-vis spectrophotometric assay	A	OC[C@H]1O[C@@H](n2cnc3c(N4CCN(c5ccc(-c6ccccc6)cc5)CC4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4475619	>	Ki	nM	50000.0	CHEMBL3589	Homo sapiens	Ki	uM	50.0
Not Active	19429622	CHEMBL4428695	Inhibition of human adenosine kinase in presence of inosine as substrate at 1 uM incubated for 4 hrs by LC-MS method	B	Nc1ncnc2c1c(I)cn2[C@]12C[C@H]1[C@H](CO)[C@@H](O)[C@H]2O		CHEMBL4518728		Inhibition	%		CHEMBL3589	Homo sapiens	INH		
Not Active	19429623	CHEMBL4428694	Substrate activity at human adenosine kinase assessed as compound phosphorylation at 1 uM incubated for 4 hrs by LC-MS method	B	Nc1ncnc2c1c(I)cn2[C@]12C[C@H]1[C@H](CO)[C@@H](O)[C@H]2O		CHEMBL4518728		Activity			CHEMBL3589	Homo sapiens	Activity		
	19429624	CHEMBL4428693	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@H]1[C@H](O)[C@H](O)[C@]2(CO)C[C@H]12		CHEMBL4571377	=	IC50	nM	2240.0	CHEMBL3589	Homo sapiens	IC50	uM	2.24
	19429625	CHEMBL4428693	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@@]12C[C@@H]1[C@@H](n1cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc31)[C@H](O)[C@@H]2O		CHEMBL4552895	=	IC50	nM	140.0	CHEMBL3589	Homo sapiens	IC50	uM	0.14
Not Determined	19429626	CHEMBL4428693	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@]12C[C@H]1[C@H](N)[C@@H](O)[C@H]2O		CHEMBL4458520		IC50			CHEMBL3589	Homo sapiens	IC50		
Not Determined	19429627	CHEMBL4428693	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	NC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4539530		IC50			CHEMBL3589	Homo sapiens	IC50		
	19429628	CHEMBL4428693	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	[N-]=[N+]=NC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4525611	=	IC50	nM	5380.0	CHEMBL3589	Homo sapiens	IC50	uM	5.38
	19429629	CHEMBL4428693	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	C[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccc(F)cc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4560021	=	IC50	nM	115.0	CHEMBL3589	Homo sapiens	IC50	uM	0.115
	19429630	CHEMBL4428693	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	C[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccccc3)c3c(Nc4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4570382	=	IC50	nM	110.0	CHEMBL3589	Homo sapiens	IC50	uM	0.11
	19429631	CHEMBL4428693	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	C[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4578381	=	IC50	nM	88.0	CHEMBL3589	Homo sapiens	IC50	uM	0.088
	19429632	CHEMBL4428693	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4439949	=	IC50	nM	114.0	CHEMBL3589	Homo sapiens	IC50	uM	0.114
	19429633	CHEMBL4428693	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4472686	=	IC50	nM	3340.0	CHEMBL3589	Homo sapiens	IC50	uM	3.34
Not Determined	19429634	CHEMBL4428693	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@]12C[C@H]1[C@H](CO)[C@@H](O)[C@H]2O		CHEMBL4518728		IC50			CHEMBL3589	Homo sapiens	IC50		
	19429635	CHEMBL4428693	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4519937	=	IC50	nM	6010.0	CHEMBL3589	Homo sapiens	IC50	uM	6.01
	19429636	CHEMBL4428693	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)nn2[C@@H]1C[C@H](N)[C@@H](O)[C@H]1O		CHEMBL4460859	=	IC50	nM	48.0	CHEMBL3589	Homo sapiens	IC50	uM	0.048
	19429637	CHEMBL4428693	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	IC50	nM	820.0	CHEMBL3589	Homo sapiens	IC50	uM	0.82
	19429638	CHEMBL4428692	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 100 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@H]1[C@H](O)[C@H](O)[C@]2(CO)C[C@H]12		CHEMBL4571377	=	Inhibition	%	12.3	CHEMBL3589	Homo sapiens	INH	%	12.3
	19429639	CHEMBL4428692	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 100 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@@]12C[C@@H]1[C@@H](n1cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc31)[C@H](O)[C@@H]2O		CHEMBL4552895	=	Inhibition	%	35.5	CHEMBL3589	Homo sapiens	INH	%	35.5
	19429640	CHEMBL4428692	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 100 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@]12C[C@H]1[C@H](N)[C@@H](O)[C@H]2O		CHEMBL4458520	=	Inhibition	%	-5.8	CHEMBL3589	Homo sapiens	INH	%	-5.8
	19429641	CHEMBL4428692	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 100 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	NC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4539530	=	Inhibition	%	8.4	CHEMBL3589	Homo sapiens	INH	%	8.4
	19429642	CHEMBL4428692	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 100 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	[N-]=[N+]=NC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4525611	=	Inhibition	%	6.1	CHEMBL3589	Homo sapiens	INH	%	6.1
	19429643	CHEMBL4428692	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 100 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	C[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccc(F)cc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4560021	=	Inhibition	%	35.6	CHEMBL3589	Homo sapiens	INH	%	35.6
	19429644	CHEMBL4428692	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 100 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	C[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccccc3)c3c(Nc4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4570382	=	Inhibition	%	39.0	CHEMBL3589	Homo sapiens	INH	%	39.0
	19429645	CHEMBL4428692	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 100 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	C[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4578381	=	Inhibition	%	49.7	CHEMBL3589	Homo sapiens	INH	%	49.7
	19429646	CHEMBL4428692	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 100 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4439949	=	Inhibition	%	41.0	CHEMBL3589	Homo sapiens	INH	%	41.0
	19429647	CHEMBL4428692	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 100 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4472686	=	Inhibition	%	2.9	CHEMBL3589	Homo sapiens	INH	%	2.9
	19429648	CHEMBL4428692	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 100 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@]12C[C@H]1[C@H](CO)[C@@H](O)[C@H]2O		CHEMBL4518728	=	Inhibition	%	1.1	CHEMBL3589	Homo sapiens	INH	%	1.1
	19429649	CHEMBL4428692	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 100 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4519937	=	Inhibition	%	6.6	CHEMBL3589	Homo sapiens	INH	%	6.6
	19429650	CHEMBL4428692	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 100 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)nn2[C@@H]1C[C@H](N)[C@@H](O)[C@H]1O		CHEMBL4460859	=	Inhibition	%	59.0	CHEMBL3589	Homo sapiens	INH	%	59.0
	19429651	CHEMBL4428692	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 100 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Inhibition	%	21.5	CHEMBL3589	Homo sapiens	INH	%	21.5
	19429652	CHEMBL4428691	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 500 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@H]1[C@H](O)[C@H](O)[C@]2(CO)C[C@H]12		CHEMBL4571377	=	Inhibition	%	23.6	CHEMBL3589	Homo sapiens	INH	%	23.6
	19429653	CHEMBL4428691	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 500 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@@]12C[C@@H]1[C@@H](n1cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc31)[C@H](O)[C@@H]2O		CHEMBL4552895	=	Inhibition	%	82.3	CHEMBL3589	Homo sapiens	INH	%	82.3
	19429654	CHEMBL4428691	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 500 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@]12C[C@H]1[C@H](N)[C@@H](O)[C@H]2O		CHEMBL4458520	=	Inhibition	%	-1.3	CHEMBL3589	Homo sapiens	INH	%	-1.3
	19429655	CHEMBL4428691	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 500 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	NC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4539530	=	Inhibition	%	-2.0	CHEMBL3589	Homo sapiens	INH	%	-2.0
	19429656	CHEMBL4428691	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 500 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	[N-]=[N+]=NC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4525611	=	Inhibition	%	6.8	CHEMBL3589	Homo sapiens	INH	%	6.8
	19429657	CHEMBL4428691	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 500 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	C[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccc(F)cc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4560021	=	Inhibition	%	87.3	CHEMBL3589	Homo sapiens	INH	%	87.3
	19429658	CHEMBL4428691	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 500 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	C[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccccc3)c3c(Nc4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4570382	=	Inhibition	%	85.2	CHEMBL3589	Homo sapiens	INH	%	85.2
	19429659	CHEMBL4428691	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 500 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	C[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4578381	=	Inhibition	%	86.0	CHEMBL3589	Homo sapiens	INH	%	86.0
	19429660	CHEMBL4428691	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 500 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4439949	=	Inhibition	%	82.2	CHEMBL3589	Homo sapiens	INH	%	82.2
	19429661	CHEMBL4428691	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 500 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4472686	=	Inhibition	%	20.7	CHEMBL3589	Homo sapiens	INH	%	20.7
	19429662	CHEMBL4428691	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 500 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@]12C[C@H]1[C@H](CO)[C@@H](O)[C@H]2O		CHEMBL4518728	=	Inhibition	%	8.8	CHEMBL3589	Homo sapiens	INH	%	8.8
	19429663	CHEMBL4428691	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 500 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4519937	=	Inhibition	%	15.6	CHEMBL3589	Homo sapiens	INH	%	15.6
	19429664	CHEMBL4428691	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 500 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)nn2[C@@H]1C[C@H](N)[C@@H](O)[C@H]1O		CHEMBL4460859	=	Inhibition	%	86.7	CHEMBL3589	Homo sapiens	INH	%	86.7
	19429665	CHEMBL4428691	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 500 nM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Inhibition	%	44.4	CHEMBL3589	Homo sapiens	INH	%	44.4
	19429666	CHEMBL4428690	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 20 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@H]1[C@H](O)[C@H](O)[C@]2(CO)C[C@H]12		CHEMBL4571377	=	Inhibition	%	79.5	CHEMBL3589	Homo sapiens	INH	%	79.5
	19429667	CHEMBL4428690	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 20 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@@]12C[C@@H]1[C@@H](n1cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc31)[C@H](O)[C@@H]2O		CHEMBL4552895	=	Inhibition	%	88.0	CHEMBL3589	Homo sapiens	INH	%	88.0
	19429668	CHEMBL4428690	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 20 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@]12C[C@H]1[C@H](N)[C@@H](O)[C@H]2O		CHEMBL4458520	=	Inhibition	%	44.9	CHEMBL3589	Homo sapiens	INH	%	44.9
	19429669	CHEMBL4428690	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 20 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	NC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4539530	=	Inhibition	%	36.0	CHEMBL3589	Homo sapiens	INH	%	36.0
	19429670	CHEMBL4428690	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 20 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	[N-]=[N+]=NC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4525611	=	Inhibition	%	75.1	CHEMBL3589	Homo sapiens	INH	%	75.1
	19429671	CHEMBL4428690	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 20 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	C[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccc(F)cc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4560021	=	Inhibition	%	88.6	CHEMBL3589	Homo sapiens	INH	%	88.6
	19429672	CHEMBL4428690	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 20 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	C[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccccc3)c3c(Nc4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4570382	=	Inhibition	%	88.0	CHEMBL3589	Homo sapiens	INH	%	88.0
	19429673	CHEMBL4428690	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 20 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	C[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4578381	=	Inhibition	%	88.4	CHEMBL3589	Homo sapiens	INH	%	88.4
	19429674	CHEMBL4428690	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 20 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4439949	=	Inhibition	%	88.1	CHEMBL3589	Homo sapiens	INH	%	88.1
	19429675	CHEMBL4428690	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 20 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4472686	=	Inhibition	%	80.9	CHEMBL3589	Homo sapiens	INH	%	80.9
	19429676	CHEMBL4428690	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 20 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@]12C[C@H]1[C@H](CO)[C@@H](O)[C@H]2O		CHEMBL4518728	=	Inhibition	%	41.7	CHEMBL3589	Homo sapiens	INH	%	41.7
	19429677	CHEMBL4428690	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 20 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4519937	=	Inhibition	%	68.9	CHEMBL3589	Homo sapiens	INH	%	68.9
	19429678	CHEMBL4428690	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 20 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)nn2[C@@H]1C[C@H](N)[C@@H](O)[C@H]1O		CHEMBL4460859	=	Inhibition	%	88.3	CHEMBL3589	Homo sapiens	INH	%	88.3
	19429679	CHEMBL4428690	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 20 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Inhibition	%	88.3	CHEMBL3589	Homo sapiens	INH	%	88.3
	19429680	CHEMBL4428689	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 50 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@H]1[C@H](O)[C@H](O)[C@]2(CO)C[C@H]12		CHEMBL4571377	=	Inhibition	%	82.5	CHEMBL3589	Homo sapiens	INH	%	82.5
	19429681	CHEMBL4428689	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 50 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@@]12C[C@@H]1[C@@H](n1cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc31)[C@H](O)[C@@H]2O		CHEMBL4552895	=	Inhibition	%	85.4	CHEMBL3589	Homo sapiens	INH	%	85.4
	19429682	CHEMBL4428689	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 50 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@]12C[C@H]1[C@H](N)[C@@H](O)[C@H]2O		CHEMBL4458520	=	Inhibition	%	60.4	CHEMBL3589	Homo sapiens	INH	%	60.4
	19429683	CHEMBL4428689	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 50 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	NC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4539530	=	Inhibition	%	50.9	CHEMBL3589	Homo sapiens	INH	%	50.9
	19429684	CHEMBL4428689	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 50 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	[N-]=[N+]=NC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4525611	=	Inhibition	%	80.5	CHEMBL3589	Homo sapiens	INH	%	80.5
	19429685	CHEMBL4428689	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 50 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	C[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccc(F)cc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4560021	=	Inhibition	%	78.4	CHEMBL3589	Homo sapiens	INH	%	78.4
	19429686	CHEMBL4428689	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 50 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	C[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccccc3)c3c(Nc4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4570382	=	Inhibition	%	86.9	CHEMBL3589	Homo sapiens	INH	%	86.9
	19429687	CHEMBL4428689	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 50 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	C[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4578381	=	Inhibition	%	88.1	CHEMBL3589	Homo sapiens	INH	%	88.1
	19429688	CHEMBL4428689	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 50 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@H]1[C@@H]2C[C@]2(n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4439949	=	Inhibition	%	88.3	CHEMBL3589	Homo sapiens	INH	%	88.3
	19429689	CHEMBL4428689	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 50 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4472686	=	Inhibition	%	85.1	CHEMBL3589	Homo sapiens	INH	%	85.1
	19429690	CHEMBL4428689	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 50 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@]12C[C@H]1[C@H](CO)[C@@H](O)[C@H]2O		CHEMBL4518728	=	Inhibition	%	58.2	CHEMBL3589	Homo sapiens	INH	%	58.2
	19429691	CHEMBL4428689	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 50 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	OC[C@H]1[C@@H]2C[C@]2(n2cc(I)c3c(Cl)ncnc32)[C@H](O)[C@@H]1O		CHEMBL4519937	=	Inhibition	%	76.5	CHEMBL3589	Homo sapiens	INH	%	76.5
	19429692	CHEMBL4428689	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 50 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)nn2[C@@H]1C[C@H](N)[C@@H](O)[C@H]1O		CHEMBL4460859	=	Inhibition	%	88.4	CHEMBL3589	Homo sapiens	INH	%	88.4
	19429693	CHEMBL4428689	Inhibition of human adenosine kinase assessed as effect on reduced nicotinamide-adenine dinculeotide appearance at 50 uM using inosine as substrate in presence of NAD, ATP incubated for 4 hrs by IMPDH based coupled enzymatic assay based non-isotopic method	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Inhibition	%	88.3	CHEMBL3589	Homo sapiens	INH	%	88.3
	19429694	CHEMBL4428688	Inhibition of human adenosine kinase assessed as reduction in conversion of adenosine to AMP	B	OC[C@H]1O[C@@H](n2c(Nc3ccccc3)nc3c(N4CCc5ccccc54)ncnc32)[C@H](O)[C@@H]1O		CHEMBL364496	=	IC50	nM	19.0	CHEMBL3589	Homo sapiens	IC50	nM	19.0
	19429695	CHEMBL4428688	Inhibition of human adenosine kinase assessed as reduction in conversion of adenosine to AMP	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccc(F)cc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL66277	=	IC50	nM	1.5	CHEMBL3589	Homo sapiens	IC50	nM	1.5
	19429696	CHEMBL4428688	Inhibition of human adenosine kinase assessed as reduction in conversion of adenosine to AMP	B	C[C@H]1O[C@@H](n2cc(-c3ccccc3)c3c(Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL100421	=	IC50	nM	0.5	CHEMBL3589	Homo sapiens	IC50	nM	0.5
	19429697	CHEMBL4428688	Inhibition of human adenosine kinase assessed as reduction in conversion of adenosine to AMP	B	Nc1ncnc2nc(-c3ccc(N4CCOCC4)nc3)cc(-c3cccc(Br)c3)c12		CHEMBL66089	=	IC50	nM	1.7	CHEMBL3589	Homo sapiens	IC50	nM	1.7
	19429698	CHEMBL4428688	Inhibition of human adenosine kinase assessed as reduction in conversion of adenosine to AMP	B	Nc1ncnc2c1c(I)nn2[C@@H]1C[C@H](N)[C@@H](O)[C@H]1O		CHEMBL4460859	=	IC50	nM	0.06	CHEMBL3589	Homo sapiens	IC50	nM	0.06
	19429699	CHEMBL4428688	Inhibition of human adenosine kinase assessed as reduction in conversion of adenosine to AMP	B	C[C@H]1O[C@@H](n2cc(I)c3c(N)ncnc32)[C@H](O)[C@@H]1O		CHEMBL66280	=	IC50	nM	9.0	CHEMBL3589	Homo sapiens	IC50	nM	9.0
	19429700	CHEMBL4428688	Inhibition of human adenosine kinase assessed as reduction in conversion of adenosine to AMP	B	Nc1ncnc2c1c(I)nn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL4441282	=	IC50	nM	40.0	CHEMBL3589	Homo sapiens	IC50	nM	40.0
	19429701	CHEMBL4428688	Inhibition of human adenosine kinase assessed as reduction in conversion of adenosine to AMP	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	IC50	nM	26.0	CHEMBL3589	Homo sapiens	IC50	nM	26.0
Active	19436059	CHEMBL4430457	Inhibition of Adk in human 1321N cells assessed as [3H]AMP formation at 10 uM measured after 30 mins using [3H]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203		Inhibition	%		CHEMBL3589	Homo sapiens	INH		
Active	19436060	CHEMBL4430457	Inhibition of Adk in human 1321N cells assessed as [3H]AMP formation at 10 uM measured after 30 mins using [3H]adenosine by liquid scintillation counting method	B	NNc1nc2ccccc2c2nc(N)nn12		CHEMBL4592393		Inhibition	%		CHEMBL3589	Homo sapiens	INH		
Active	19436061	CHEMBL4430457	Inhibition of Adk in human 1321N cells assessed as [3H]AMP formation at 10 uM measured after 30 mins using [3H]adenosine by liquid scintillation counting method	B	CCCc1nc2c(cnn2-c2ccccc2)c2n[nH]c(=S)n12		CHEMBL4460655		Inhibition	%		CHEMBL3589	Homo sapiens	INH		
Active	19436062	CHEMBL4430457	Inhibition of Adk in human 1321N cells assessed as [3H]AMP formation at 10 uM measured after 30 mins using [3H]adenosine by liquid scintillation counting method	B	Sc1nnc2c3c(nc(-c4ccccc4Cl)n12)sc1ccccc13		CHEMBL4524434		Inhibition	%		CHEMBL3589	Homo sapiens	INH		
Active	19436063	CHEMBL4430457	Inhibition of Adk in human 1321N cells assessed as [3H]AMP formation at 10 uM measured after 30 mins using [3H]adenosine by liquid scintillation counting method	B	CC1CCc2sc3nc(NCc4ccccc4)n4c(S)nnc4c3c2C1		CHEMBL4460819		Inhibition	%		CHEMBL3589	Homo sapiens	INH		
Active	19436064	CHEMBL4430457	Inhibition of Adk in human 1321N cells assessed as [3H]AMP formation at 10 uM measured after 30 mins using [3H]adenosine by liquid scintillation counting method	B	S=c1[nH]nc2c3c4c(sc3nc(-c3ccccc3)n12)CCCC4		CHEMBL494210		Inhibition	%		CHEMBL3589	Homo sapiens	INH		
	19436066	CHEMBL4430455	Inhibition of recombinant human Adk using [U-14C]adenosine by liquid scintillation counting method	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Ki	nM	26.0	CHEMBL3589	Homo sapiens	Ki	nM	26.0
	19436068	CHEMBL4430453	Reversible inhibition of recombinant human Adk-short expressed in Escherichia coli BL21[DE3] assessed as [3H]AMP formation preincubated for 15 mins followed by [3H]adenosine addition measured after 30 mins by liquid scintillation counting method	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203	=	Ki	nM	16.3	CHEMBL3589	Homo sapiens	Ki	nM	16.3
Dose-dependent effect	19436069	CHEMBL4430453	Reversible inhibition of recombinant human Adk-short expressed in Escherichia coli BL21[DE3] assessed as [3H]AMP formation preincubated for 15 mins followed by [3H]adenosine addition measured after 30 mins by liquid scintillation counting method	B	Nc1ncnc2c1c(I)cn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O		CHEMBL99203		Inhibition	%		CHEMBL3589	Homo sapiens	INH		
	19436070	CHEMBL4430453	Reversible inhibition of recombinant human Adk-short expressed in Escherichia coli BL21[DE3] assessed as [3H]AMP formation preincubated for 15 mins followed by [3H]adenosine addition measured after 30 mins by liquid scintillation counting method	B	CC(=O)Nc1nc(-c2ccccc2)nc2oc(-c3ccc(Cl)cc3)nc12		CHEMBL4574016	=	Ki	nM	25200.0	CHEMBL3589	Homo sapiens	Ki	uM	25.2
	19436071	CHEMBL4430453	Reversible inhibition of recombinant human Adk-short expressed in Escherichia coli BL21[DE3] assessed as [3H]AMP formation preincubated for 15 mins followed by [3H]adenosine addition measured after 30 mins by liquid scintillation counting method	B	Nc1nc(-c2ccccc2)nc2oc(-c3ccc(Cl)cc3)nc12		CHEMBL4545415	=	Ki	nM	11100.0	CHEMBL3589	Homo sapiens	Ki	uM	11.1
	19436072	CHEMBL4430453	Reversible inhibition of recombinant human Adk-short expressed in Escherichia coli BL21[DE3] assessed as [3H]AMP formation preincubated for 15 mins followed by [3H]adenosine addition measured after 30 mins by liquid scintillation counting method	B	CN1C(=O)c2nc(-c3ccccc3)nc(-c3ccccc3)c2C1=O		CHEMBL4520524	=	Ki	nM	25400.0	CHEMBL3589	Homo sapiens	Ki	uM	25.4
	19436073	CHEMBL4430453	Reversible inhibition of recombinant human Adk-short expressed in Escherichia coli BL21[DE3] assessed as [3H]AMP formation preincubated for 15 mins followed by [3H]adenosine addition measured after 30 mins by liquid scintillation counting method	B	O=C1NC(=O)c2c1nc(-c1ccccc1)nc2-c1ccccc1		CHEMBL4457103	=	Ki	nM	9180.0	CHEMBL3589	Homo sapiens	Ki	uM	9.18
	19436074	CHEMBL4430453	Reversible inhibition of recombinant human Adk-short expressed in Escherichia coli BL21[DE3] assessed as [3H]AMP formation preincubated for 15 mins followed by [3H]adenosine addition measured after 30 mins by liquid scintillation counting method	B	CC(=O)Oc1csc2nc(C)n3c4ccccc4nc3c12		CHEMBL4448716	=	Ki	nM	19500.0	CHEMBL3589	Homo sapiens	Ki	uM	19.5
	19436075	CHEMBL4430453	Reversible inhibition of recombinant human Adk-short expressed in Escherichia coli BL21[DE3] assessed as [3H]AMP formation preincubated for 15 mins followed by [3H]adenosine addition measured after 30 mins by liquid scintillation counting method	B	Nc1nc2c3ccccc3[nH]c(=S)n2n1		CHEMBL4445820	=	Ki	nM	15100.0	CHEMBL3589	Homo sapiens	Ki	uM	15.1
	19436076	CHEMBL4430453	Reversible inhibition of recombinant human Adk-short expressed in Escherichia coli BL21[DE3] assessed as [3H]AMP formation preincubated for 15 mins followed by [3H]adenosine addition measured after 30 mins by liquid scintillation counting method	B	NNc1nc2ccccc2c2nc(N)nn12		CHEMBL4592393	=	Ki	nM	8750.0	CHEMBL3589	Homo sapiens	Ki	uM	8.75
	19436077	CHEMBL4430453	Reversible inhibition of recombinant human Adk-short expressed in Escherichia coli BL21[DE3] assessed as [3H]AMP formation preincubated for 15 mins followed by [3H]adenosine addition measured after 30 mins by liquid scintillation counting method	B	CCCc1nc2c(cnn2-c2ccccc2)c2n[nH]c(=S)n12		CHEMBL4460655	=	Ki	nM	8560.0	CHEMBL3589	Homo sapiens	Ki	uM	8.56
	19436078	CHEMBL4430453	Reversible inhibition of recombinant human Adk-short expressed in Escherichia coli BL21[DE3] assessed as [3H]AMP formation preincubated for 15 mins followed by [3H]adenosine addition measured after 30 mins by liquid scintillation counting method	B	Sc1nnc2c3c(nc(-c4ccccc4Cl)n12)sc1ccccc13		CHEMBL4524434	=	Ki	nM	5640.0	CHEMBL3589	Homo sapiens	Ki	uM	5.64
	19436079	CHEMBL4430453	Reversible inhibition of recombinant human Adk-short expressed in Escherichia coli BL21[DE3] assessed as [3H]AMP formation preincubated for 15 mins followed by [3H]adenosine addition measured after 30 mins by liquid scintillation counting method	B	CC1CCc2sc3nc(NCc4ccccc4)n4c(S)nnc4c3c2C1		CHEMBL4460819	=	Ki	nM	5440.0	CHEMBL3589	Homo sapiens	Ki	uM	5.44
	19436080	CHEMBL4430453	Reversible inhibition of recombinant human Adk-short expressed in Escherichia coli BL21[DE3] assessed as [3H]AMP formation preincubated for 15 mins followed by [3H]adenosine addition measured after 30 mins by liquid scintillation counting method	B	S=c1[nH]nc2c3c4c(sc3nc(-c3ccccc3)n12)CCCC4		CHEMBL494210	=	Ki	nM	5040.0	CHEMBL3589	Homo sapiens	Ki	uM	5.04
	19436081	CHEMBL4430453	Reversible inhibition of recombinant human Adk-short expressed in Escherichia coli BL21[DE3] assessed as [3H]AMP formation preincubated for 15 mins followed by [3H]adenosine addition measured after 30 mins by liquid scintillation counting method	B	Sc1nnc2c3c4c(sc3n3c(S)nnc3n12)CCCC4		CHEMBL4570031	=	Ki	nM	184.0	CHEMBL3589	Homo sapiens	Ki	uM	0.184
Active	19436113	CHEMBL4430465	Reversible inhibition of recombinant human Adk-short expressed in Escherichia coli BL21[DE3] assessed as [3H]AMP formation at 3 to 10 uM preincubated for 15 mins followed by [3H]adenosine addition measured after 30 mins by liquid scintillation counting method	B	Sc1nnc2c3c4c(sc3n3c(S)nnc3n12)CCCC4		CHEMBL4570031		Inhibition	%		CHEMBL3589	Homo sapiens	INH		
	22891777	CHEMBL4729632	Inhibition of recombinant human ADK measured at interval of 1 to 2 mins for 30 to 40 mins by spectrophotometric method	B	COc1ccc(S(=O)(=O)[N-]C(=O)c2cc3c(Nc4cccc(OC)c4)ccc(Cl)c3n2C)cc1.[Na+]		CHEMBL4759496	>	IC50	nM	100000.0	CHEMBL3589	Homo sapiens	IC50	uM	100.0
